
<html lang="en"     class="pb-page"  data-request-id="fd9985e4-dd00-42d9-8aa4-a9185ab8fd9f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2016.59.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.6b00680"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor" /></meta><meta name="dc.Creator" content="Jorge  Garcia Fortanet" /></meta><meta name="dc.Creator" content="Christine Hiu-Tung  Chen" /></meta><meta name="dc.Creator" content="Ying-Nan P.  Chen" /></meta><meta name="dc.Creator" content="Zhouliang  Chen" /></meta><meta name="dc.Creator" content="Zhan  Deng" /></meta><meta name="dc.Creator" content="Brant  Firestone" /></meta><meta name="dc.Creator" content="Peter  Fekkes" /></meta><meta name="dc.Creator" content="Michelle  Fodor" /></meta><meta name="dc.Creator" content="Pascal D.  Fortin" /></meta><meta name="dc.Creator" content="Cary  Fridrich" /></meta><meta name="dc.Creator" content="Denise  Grunenfelder" /></meta><meta name="dc.Creator" content="Samuel  Ho" /></meta><meta name="dc.Creator" content="Zhao B.  Kang" /></meta><meta name="dc.Creator" content="Rajesh  Karki" /></meta><meta name="dc.Creator" content="Mitsunori  Kato" /></meta><meta name="dc.Creator" content="Nick  Keen" /></meta><meta name="dc.Creator" content="Laura R.  LaBonte" /></meta><meta name="dc.Creator" content="Jay  Larrow" /></meta><meta name="dc.Creator" content="Francois  Lenoir" /></meta><meta name="dc.Creator" content="Gang  Liu" /></meta><meta name="dc.Creator" content="Shumei  Liu" /></meta><meta name="dc.Creator" content="Franco  Lombardo" /></meta><meta name="dc.Creator" content="Dyuti  Majumdar" /></meta><meta name="dc.Creator" content="Matthew J.  Meyer" /></meta><meta name="dc.Creator" content="Mark  Palermo" /></meta><meta name="dc.Creator" content="Lawrence  Perez" /></meta><meta name="dc.Creator" content="Minying  Pu" /></meta><meta name="dc.Creator" content="Timothy  Ramsey" /></meta><meta name="dc.Creator" content="William R.  Sellers" /></meta><meta name="dc.Creator" content="Michael D.  Shultz" /></meta><meta name="dc.Creator" content="Travis  Stams" /></meta><meta name="dc.Creator" content="Christopher  Towler" /></meta><meta name="dc.Creator" content="Ping  Wang" /></meta><meta name="dc.Creator" content="Sarah L.  Williams" /></meta><meta name="dc.Creator" content="Ji-Hu  Zhang" /></meta><meta name="dc.Creator" content="Matthew J.  LaMarche" /></meta><meta name="dc.Description" content="SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also purportedly plays an import..." /></meta><meta name="Description" content="SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also purportedly plays an import..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 12, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b00680" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00680" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b00680" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b00680" /></link>
        
    
    

<title>Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b00680" /></meta><meta property="og:title" content="Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0011.jpeg" /></meta><meta property="og:description" content="SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1). Because it is an oncoprotein associated with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest. Recently in our laboratories, a small molecule inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2. A high throughput screen was performed to identify progressable chemical matter, and X-ray crystallography revealed the location of binding in a previously undisclosed allosteric binding pocket. Structure-based drug design was employed to optimize for SHP2 inhibition, and several new protein–ligand interactions were characterized. These studies culminated in the discovery of 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (SHP099, 1), a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b00680"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b00680">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b00680&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b00680&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b00680&amp;href=/doi/10.1021/acs.jmedchem.6b00680" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7773-7782</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01210" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Featured Article</span><a href="/doi/10.1021/acs.jmedchem.6b00041" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jorge++Garcia+Fortanet">Jorge Garcia Fortanet</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+Hiu-Tung++Chen">Christine Hiu-Tung Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ying-Nan+P.++Chen">Ying-Nan P. Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhouliang++Chen">Zhouliang Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhan++Deng">Zhan Deng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brant++Firestone">Brant Firestone</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Fekkes">Peter Fekkes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Fodor">Michelle Fodor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal+D.++Fortin">Pascal D. Fortin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cary++Fridrich">Cary Fridrich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Denise++Grunenfelder">Denise Grunenfelder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samuel++Ho">Samuel Ho</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhao+B.++Kang">Zhao B. Kang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rajesh++Karki">Rajesh Karki</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mitsunori++Kato">Mitsunori Kato</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nick++Keen">Nick Keen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura+R.++LaBonte">Laura R. LaBonte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay++Larrow">Jay Larrow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Francois++Lenoir">Francois Lenoir</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gang++Liu">Gang Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shumei++Liu">Shumei Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Franco++Lombardo">Franco Lombardo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dyuti++Majumdar">Dyuti Majumdar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+J.++Meyer">Matthew J. Meyer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Palermo">Mark Palermo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lawrence++Perez">Lawrence Perez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Minying++Pu">Minying Pu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy++Ramsey">Timothy Ramsey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+R.++Sellers">William R. Sellers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+D.++Shultz">Michael D. Shultz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Travis++Stams">Travis Stams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Towler">Christopher Towler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ping++Wang">Ping Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sarah+L.++Williams">Sarah L. Williams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ji-Hu++Zhang">Ji-Hu Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+J.++LaMarche">Matthew J. LaMarche</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Global Discovery Chemistry, <sup>‡</sup>Oncology Disease Area, <sup>§</sup>Center for Proteomic Chemistry, <sup>∥</sup>Metabolism and Pharmacokinetics, Novartis Institutes for Biomedical Research, and <sup>⊥</sup>Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#34595540405c51431a5855595546575c51745a5b425546405d471a575b59"><span class="__cf_email__" data-cfemail="5835392c2c303d2f76343935392a3b303d1836372e392a2c312b763b3735">[email protected]</span></a>. Telephone: 617-871-7729.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00680&amp;href=/doi/10.1021%2Facs.jmedchem.6b00680" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7773–7782</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 27, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 May 2016</li><li><span class="item_label"><b>Published</b> online</span>12 July 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 September 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b00680" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00680</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7773%26pageCount%3D10%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJorge%2BGarcia%2BFortanet%252C%2BChristine%2BHiu-Tung%2BChen%252C%2BYing-Nan%2BP.%2BChen%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D17%26contentID%3Dacs.jmedchem.6b00680%26title%3DAllosteric%2BInhibition%2Bof%2BSHP2%253A%2BIdentification%2Bof%2Ba%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BEfficacious%2BPhosphatase%2BInhibitor%26numPages%3D10%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7782%26publicationDate%3DSeptember%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b00680"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">10054</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">105</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b00680" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jorge&quot;,&quot;last_name&quot;:&quot;Garcia Fortanet&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Hiu-Tung Chen&quot;},{&quot;first_name&quot;:&quot;Ying-Nan&quot;,&quot;last_name&quot;:&quot;P. Chen&quot;},{&quot;first_name&quot;:&quot;Zhouliang&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Zhan&quot;,&quot;last_name&quot;:&quot;Deng&quot;},{&quot;first_name&quot;:&quot;Brant&quot;,&quot;last_name&quot;:&quot;Firestone&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Fekkes&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Fodor&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;D. Fortin&quot;},{&quot;first_name&quot;:&quot;Cary&quot;,&quot;last_name&quot;:&quot;Fridrich&quot;},{&quot;first_name&quot;:&quot;Denise&quot;,&quot;last_name&quot;:&quot;Grunenfelder&quot;},{&quot;first_name&quot;:&quot;Samuel&quot;,&quot;last_name&quot;:&quot;Ho&quot;},{&quot;first_name&quot;:&quot;Zhao&quot;,&quot;last_name&quot;:&quot;B. Kang&quot;},{&quot;first_name&quot;:&quot;Rajesh&quot;,&quot;last_name&quot;:&quot;Karki&quot;},{&quot;first_name&quot;:&quot;Mitsunori&quot;,&quot;last_name&quot;:&quot;Kato&quot;},{&quot;first_name&quot;:&quot;Nick&quot;,&quot;last_name&quot;:&quot;Keen&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;R. LaBonte&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;Larrow&quot;},{&quot;first_name&quot;:&quot;Francois&quot;,&quot;last_name&quot;:&quot;Lenoir&quot;},{&quot;first_name&quot;:&quot;Gang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Shumei&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Franco&quot;,&quot;last_name&quot;:&quot;Lombardo&quot;},{&quot;first_name&quot;:&quot;Dyuti&quot;,&quot;last_name&quot;:&quot;Majumdar&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;J. Meyer&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Palermo&quot;},{&quot;first_name&quot;:&quot;Lawrence&quot;,&quot;last_name&quot;:&quot;Perez&quot;},{&quot;first_name&quot;:&quot;Minying&quot;,&quot;last_name&quot;:&quot;Pu&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;Ramsey&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;R. Sellers&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;D. Shultz&quot;},{&quot;first_name&quot;:&quot;Travis&quot;,&quot;last_name&quot;:&quot;Stams&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Towler&quot;},{&quot;first_name&quot;:&quot;Ping&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;L. Williams&quot;},{&quot;first_name&quot;:&quot;Ji-Hu&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;J. LaMarche&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;7773-7782&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b00680&quot;},&quot;abstract&quot;:&quot;SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the PTPN11 gene involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1). Because it is an oncoprotein associated with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest. Recently in our laboratories, a small molecule inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2. A high throughput screen was performed to identify progressable chemical matter, and X-ray crystallography revealed the location of binding in a previously undisclosed allosteric binding pocket. Structure-based drug design was employed to optimize for SHP2 inhibition, and several new protein–ligand interactions were characterized. These studies culminated in the discovery of 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00680&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00680" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00680&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00680" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b00680&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00680" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b00680&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b00680&amp;href=/doi/10.1021/acs.jmedchem.6b00680" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b00680" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b00680" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b00680%26sid%3Dliteratum%253Aachs%26pmid%3D27347692%26genre%3Darticle%26aulast%3DGarcia%2BFortanet%26date%3D2016%26atitle%3DAllosteric%2BInhibition%2Bof%2BSHP2%253A%2BIdentification%2Bof%2Ba%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BEfficacious%2BPhosphatase%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D17%26spage%3D7773%26epage%3D7782%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291026" title="Conformation">Conformation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/jmcmar.2016.59.issue-17/20160908/jmcmar.2016.59.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">SHP2 is a nonreceptor protein tyrosine phosphatase (PTP) encoded by the <i>PTPN11</i> gene involved in cell growth and differentiation via the MAPK signaling pathway. SHP2 also purportedly plays an important role in the programmed cell death pathway (PD-1/PD-L1). Because it is an oncoprotein associated with multiple cancer-related diseases, as well as a potential immunomodulator, controlling SHP2 activity is of significant therapeutic interest. Recently in our laboratories, a small molecule inhibitor of SHP2 was identified as an allosteric modulator that stabilizes the autoinhibited conformation of SHP2. A high throughput screen was performed to identify progressable chemical matter, and X-ray crystallography revealed the location of binding in a previously undisclosed allosteric binding pocket. Structure-based drug design was employed to optimize for SHP2 inhibition, and several new protein–ligand interactions were characterized. These studies culminated in the discovery of 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (SHP099, <b>1</b>), a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34010" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34010" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">SHP2 phosphatase, encoded by the <i>PTPN11</i> gene, is a nonreceptor PTP containing two N-terminal Src homology 2 (SH2) domains, a PTP domain, and a C-terminal tail. X-ray structures have demonstrated that SHP2 adopts an autoinhibited conformation in its basal state, whereby the N-terminal SH2 domain interacts with the PTP domain and blocks access to the catalytic site.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Others have previously demonstrated that bis-phosphotyrosyl peptides (e.g., IRS-1) or proteins bind to the SH2 domains of SHP2 and activate the phosphatase,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> which imparts cancer dependence.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In cells, SHP2 functions in the cytoplasm downstream of multiple receptor-tyrosine kinases and is involved in numerous oncogenic cell signaling cascades (e.g., RAS–ERK, PI3K–AKT, JAK–STAT); however, its role in those pathways is not yet fully understood.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> More recently, SHP2 was reported to bind and dephosphorylate RAS and increase its association with effector protein RAF to activate downstream proliferative RAS/ERK/MAPK signaling.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Furthermore, germline or somatic mutations in <i>PTPN11</i> that cause hyperactivation of SHP2 have been identified in Noonan syndrome (50%),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> juvenile myelomonocytic leukemia (JMML, 35%), myelodysplastic syndrome (10%), B-cell acute lymphoblastic leukemia (7%), acute myeloid leukemia (AML, 4%),<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and solid tumors including lung adenocarcinoma, colon cancer, neuroblastoma, melanoma, and hepatocellular carcinoma.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">SHP2 may also participate in the programmed cell death pathway (PD-1/PD-L1) and contribute to immune evasion.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The PD-1/SHP2/STAT1/T-bet signaling axis mediates the suppressive effects of PD-1 on Th1 immunity at tumor sites. Therefore, inhibition of PD-1 or SHP2 should be sufficient to restore robust Th1 immunity and T-cell activation, reversing immunosuppression in the tumor microenvironment. Given recent clinical success of anti-PD-1 and PD-L1 therapeutics,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> investigating the inhibition of SHP2 for cancer immunotherapy is also of great interest.</div><div class="NLM_p">In view of the importance of SHP2 as a potential anticancer target, the discovery of SHP2 small molecule inhibitors has attracted wide interest in the scientific community.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> High protein sequence homology within the catalytic site among PTPs creates a distinct challenge in achieving selectivity among phosphatases. In addition, the positive-charged environment of the PTP catalytic pocket presents unique drug discovery challenges, thus most catalytic site inhibitors require multiple ionizable functional groups in order to inhibit the enzyme. These functional groups, in turn, complicate drug discovery and development due to low cell permeability and bioavailability.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Indeed many small molecule SHP2 inhibitors have been described in the literature (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>); however these catalytic site inhibitors often lack robust selectivity among other PTPs (e.g., SHP1, PTP1B) and also suffer from poor cell permeability and oral bioavailability due to the presence of polar and ionic functional groups.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Despite these challenges, researchers have recently achieved moderately potent inhibitors (up to 0.200 μM) targeting the active site, which have proven effective in intracranial xenograft models of glioma.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Others have turned to allosteric modes of phosphatase inhibition and detection, but these efforts have yet to progress viable chemical matter to the clinic.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Highly selective and potent SHP2 inhibitors with appropriate pharmacokinetic and pharmacological properties are needed as tools for further mechanistic studies and ultimately, for the development of agents to treat SHP2-dependent malignancies. In this article, we describe the identification and initial optimization of a new pyrazinyl class of SHP2 allosteric inhibitors, which targets the autoinhibited conformation of SHP2.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Crystal-guided optimization led to the discovery of <b>1</b>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> a potent, selective, orally bioavailable, and efficacious SHP2 inhibitor.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative SHP2 inhibitors reported in the literature possessing ionizable functional groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12830" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12830" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our efforts toward the discovery of allosteric SHP2 inhibitors began with the identification of a phosphatase assay that exploited the autoinhibitory mechanism of SHP2.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> We reasoned that screening compounds at 50% enzyme activation would allow for the protein to equilibrate and sample the continuum of conformations between the autoinhibited (closed) and active (open) conformations (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). Control of this equilibrium was achieved by titrating an activating bisphosphotyrosyl peptide in a well-precedented, fluorescence-based phosphatase assay measuring dephosphorylation of 6,8-difluoro-4-methylumbelliferyl phosphate (0.5 μM 2P-IRS-1, DIFMUP assay,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). A focused library of the Novartis compound archive (100 000 compounds) was next evaluated in a high throughput screen.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Equilibrium of SHP2 in closed (blocked active site) and open (free active site) states via a diphosphotyrosyl peptide.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (B) DIFMUP assay measuring phosphatase activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compounds that inhibited phosphatase activity using a near full length construct (residues 1–525) were also evaluated using a truncated construct of SHP2 (residues 237–529, PTP domain only). We utilized PTP domain activity in order to identify and deprioritize undesired catalytic site inhibitors. This process led to the identification of known ion channel inhibitor <b>2</b>,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> which had an IC<sub>50</sub> = 12 μM against the full length enzyme and an IC<sub>50</sub> > 100 μM against the PTP domain (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>A). Compound <b>2</b> binding and thermal stabilization of the protein was confirmed in biophysics experiments by differential scanning fluorometry (Δ<i>T</i><sub>m</sub> = 3.02 °C) and, furthermore, by X-ray crystallography (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHP">5EHP</a>). Interestingly, <b>2</b> did not bind to the PTP catalytic site but to a tunnel-like region formed between the C-terminal SH2, N-terminal SH2, and PTP domains (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>B). By binding to this allosteric site comprised of all three domains, <b>2</b> stabilizes the inactive conformation for SHP2 where the catalytic site is blocked and no longer accessible to substrate. This small molecule bound structure is reminiscent of the apo inactive structure (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>),<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> whereby the N-terminal SH2 domain binds the phosphatase domain and blocks the active site.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Pyrimidine HTS hit, <b>2</b>. (B) X-ray of <b>2</b> with SHP2, 1.85 Å, in the closed, inactive conformation; inset, allosteric binding pocket at the junction of three domains. (C) Binding mode of <b>2</b>, showing protein interactions (e.g., Glu250).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The X-ray cocrystal for <b>2</b> with SHP2 (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a> B, C) revealed several protein–ligand interactions. Aniline H-bonding occurs with backbone carbonyl of Glu250, the methyl groups make van der Waals contacts with His114 and Glu249, the dichlorophenyl resides in a hydrophobic cleft (Leu254, Gln257, Pro491), and various interactions exist with waters (e.g., pyrimidine nitrogen, piperazine). Interestingly, Arg111 occupies two conformations in the unit cell: one resembling the apo structure and the other in a weak cationic-π stacking interaction with the dichlorophenyl (circled in orange, <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>C), perhaps indicating a suboptimal interaction (3.75 Å distance from Arg111 to centroid of the ring) and opportunity for optimization. With this information in-hand, we decided to initially maintain the Glu250 and water interactions of the central pyrimidine ring and independently explore the SAR of the dichlorophenyl and the piperazine regions.</div><div class="NLM_p">In our approach toward building SAR around the aminopyrimidine, we took advantage of the orthogonal reactivity of the two halogens in 5-bromo-2-chloropyrimidin-4-amine. Thus, introducing the hydrophobic phenyl regioselectively via Pd-catalyzed Suzuki–Miyaura was followed by introduction of the piperidine via S<sub>N</sub>Ar in high overall yields (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>, ca. 20–60%, 3 steps). The synthesis was flexible, since the synthetic steps were alternatively also carried out in reverse order. Pyrimidines and triazines (<a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) were prepared in either order with similar high yields. In the synthesis of the pyrazines, however (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), Suzuki coupling followed by amine S<sub>n</sub>Ar was preferred.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of the Amine and Phenyl Regions</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0008.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the Central Ring</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0009.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0010.gif" alt="" id="fx4" /></img><div></div></div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PdCl<sub>2</sub>(dppf), K<sub>3</sub>PO<sub>4</sub>, MeCN/H<sub>2</sub>O, 120 °C, 4 h, 74%; (b) K<sub>3</sub>PO<sub>4</sub>, NMP, 140 °C, 36 h, 55%; (c) HCl, THF/H<sub>2</sub>O, 60 °C, 2 h, 95%.</p></p></figure><div class="NLM_p">Attempts to remove or reposition the chlorines in the phenyl ring resulted in a significant loss in phosphatase inhibition (e.g., <b>3</b>, <b>4</b>, and <b>5</b>). The difference in activity between <b>2</b> and <b>3</b> led us to conclude that the <i>ortho</i>-chlorine was required for activity. The activity difference between <b>2</b> and <b>5</b> was also striking, since Cl and Me functional groups are approximate isosteres.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Upon further X-ray analysis, however, the chlorines effectively fill a hydrophobic pocket formed by residues Arg111, Thr253, Leu254, Gln257, and Gln495. Our attention next turned to the piperazine motif, which occupies a polar region of the allosteric binding pocket (e.g., Phe113, His114, Glu249, Glu250, Thr218, etc.) and is also solvent (water) exposed. We hypothesized that extending the terminal amine toward these polar residues would allow for new interactions and an increase in phosphatase inhibition. Morphing the piperazine ring to a 4-aminopiperidine motif increased the biochemical activity 10-fold (e.g., <b>6</b>, IC<sub>50</sub> = 1.3 μM). Increasing the nitrogen substitution reduced inhibition (e.g., <b>7</b>, IC<sub>50</sub> = 6.5 μM); however activity was further improved by stabilizing the pseudo-equatorial amine conformation by adding a geminal methyl in the piperidine ring (e.g., <b>8</b>, IC<sub>50</sub> = 0.26 μM). Importantly, compound <b>8</b> showed modulation of phospho-ERK (p-ERK) activity in the esophageal squamous cell carcinoma KYSE-520 (IC<sub>50</sub> = 1.98 μM).</div><div class="NLM_p">With preferred aromatic and amine fragments in hand, we then turned our attention to the central pyrimidine ring. At the outset, we preserved the aniline interaction with Glu250 and found that the 1,2,4-triazine retained biochemical inhibition (<b>9</b>, IC<sub>50</sub> = 0.30 μM). Recognizing that the <i>N</i>-1 nitrogen (see numbering on <b>9</b>) was tolerated in relation to the triazine and maintained a trajectory toward Arg111, we removed the adjacent nitrogen (<i>N</i>-2). We hypothesized that this modification would increase the basicity of the nitrogen and strengthen the interaction with Arg111. As expected, the measured p<i>K</i><sub>a</sub>’s of the protonated triazine and pyrazine rings were 4.7 and 2.9, respectively. As a result, the pyrazine ring significantly increased both biochemical inhibition (<b>1</b>, IC<sub>50</sub> = 0.07 μM) and p-ERK modulation in cells (IC<sub>50</sub> = 0.250 μM). Furthermore, upon extended incubation (5 days), <b>1</b> showed inhibition of cell proliferation (KYSE-520 model) with an IC<sub>50</sub> of 1.4 μM. Removing the amine group (<b>10</b>) or increasing the steric hindrance around the amine (<b>11</b>) lessened inhibition, presumably due to disturbance of the Glu250 interaction (<i>vide infra</i>).</div><div class="NLM_p">The X-ray cocrystal for <b>1</b> with SHP2 (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a>) revealed a new interaction with the basic amine and the Phe113 backbone carbonyl. In addition, the pyrazine core maintained the aniline–Glu250 H-bond, and a new H-bond to Arg111 was observed. This new H-bond interaction preorganized Arg111 for cationic-π stacking with the dichlorophenyl motif. As previously observed, Arg111 occupied two conformations in the unit cell. The π stacking interaction with <b>1</b> appeared stronger than <b>2</b>, as measured by the distance of Arg111 to the centroid of the ring (3.45 versus 3.75 Å, respectively). We speculate that the H-bond preorganization of Arg111 via the pyrazine accounts for this more optimal interaction.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray structure of <b>1</b> and SHP2, 1.70 Å. (A) Arg111 cationic π stacking interaction. (B) Phe113 interaction with 4-aminopiperidine motif of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The synthesis of <b>1</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) started with the Suzuki–Miyaura coupling between (2,3-dichlorophenyl)boronic acid (<b>12</b>) and 3-bromo-6-chloropyrazin-2-amino (<b>13</b>) affording intermediate <b>14</b> in good yield and regioselectivity. S<sub>N</sub>Ar reaction on this biphenyl intermediate <b>14</b> with <i>tert</i>-butyl (4-methylpiperidin-4-yl)carbamate (<b>15</b>) provided the Boc-protected intermediate <b>16</b>. Final deprotection using aq HCl in a mixture of THF/H<sub>2</sub>O gave high yields of <b>1</b> as free base after acid/base extraction (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_001.pdf" class="ext-link">Supporting Information</a>).</div><div class="NLM_p">Due to the interesting biochemical and cellular activity of <b>1</b>, extensive phosphatase selectivity profiling was performed over a panel of 21 human phosphatases (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_001.pdf" class="ext-link">Supporting Information</a>). And due to recent reports of aminopyrazines as kinase inhibitors,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> we also evaluated <b>1</b> against a panel of 66 serine-threonine and tyrosine kinases. In both phosphatase and kinase panels, no biochemical inhibitory activity was evident, suggesting that the aminopyrazine series was quite selective for SHP2. Moreover, <b>1</b> showed high solubility (>0.5 mM in pH 6.8 buffer) and high permeability with no apparent efflux in Caco-2 cells (<i>P</i><sub>app</sub>(A–B), 13.2 × 10<sup>–6</sup> cm/s).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Pharmacokinetic studies in mice for <b>1</b> showed acceptable oral exposure (5 mg/kg PO, 565 μM/h) and bioavailability (46% <i>F</i>).</div><div class="NLM_p">We next evaluated <b>1</b> in the EGFR amplified human esophageal squamous cell carcinoma KYSE-520 xenograft model subcutaneously implanted into immunocompromised mice (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A,B). After a single doses of 30 and 100 mg/kg (red and blue lines, respectively), dose-dependent exposure and modulation of the pharmacodynamic marker p-ERK was observed in the xenografts (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>A). The antitumor activity of <b>1</b> was then evaluated in a multidose efficacy study with mice bearing KYSE-520 xenografts (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b). A daily oral dose of 10 or 30 mg/kg yielded 19% and 61% tumor growth inhibition, respectively, relative to vehicle control treated mice. Tumor stasis was achieved at 100 mg/kg, which compared equally with erlotinib administered at 80 mg/kg daily (see <a href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_001.pdf" class="ext-link">Supporting Information</a>).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Dose-dependent exposure and p-ERK modulation of <b>1</b> in KYSE-520 tumor bearing nude mouse. (B) Dose-dependent efficacy of <b>1</b> in KYSE-520 tumor bearing nude mouse.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Small molecule modulation of SHP2 is of considerable therapeutic interest given its importance in known oncogenic pathways and emerging role in immuno-oncology. A high throughput screen was designed and conducted on full length SHP2 in order to identify allosteric inhibitors. Identification and deprioritization of undesired orthosteric inhibitors was possible via evaluation of hits against the PTP domain of SHP2. This methodology allowed for the identification of aminopyrimidine <b>2</b>. X-ray analysis of <b>2</b> with SHP2 revealed a new allosteric binding mode with ligand interactions to all three domains of SHP2. This new allosteric mode of binding stabilizes SHP2 in the autoinhibited and inactive conformation. The aminopyrimidine template was optimized and morphed via structure based drug design, and several new protein–ligand interactions were identified. These studies culminated in the identification of pyrazine <b>1</b>, a potent, selective, highly soluble, orally bioavailable, and efficacious SHP2 inhibitor exhibiting dose-dependent pathway inhibition and antitumor activity in xenograft models. The studies described herein illustrate that appropriate pharmacokinetic and pharmaceutical properties can be achieved by inhibitors of the allosteric site of SHP2. The methodology described to identify allosteric inhibitors also avoids the drug discovery challenges related to the polarity and homology of the orthosteric binding pocket of SHP2. Significantly, this new molecular tool <b>1</b> should enable further interrogation of the multifaceted roles of SHP2 in general signal transduction and related molecular pathologies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Compound Synthesis and Characterization</h3><div class="NLM_p">Compound purity was assessed by HPLC to confirm >95% purity. All solvents employed were commercially available anhydrous grade, and reagents were used as received unless otherwise noted. A Biotage Initiator Sixty system was used for microwave heating. Flash column chromatography was performed on either an Analogix Intelliflash 280 using Si 50 columns (32–63 μm, 230–400 mesh, 60 Å) or a Biotage SP1 system (32–63 μm particle size, KP-Sil, 60 Å pore size). Preparative high pressure liquid chromatography (HPLC) was performed using a Waters 2525 pump with 2487 dual wavelength detector and 2767 sample manager. Columns were Waters C18 OBD 5 μm, either 50 mm × 100 mm Xbridge or 30 mm × 100 mm Sunfire. NMR spectra were recorded on a Bruker AV400 (Avance 400 MHz) or AV600 (Avance 600 MHz) instruments. Analytical LC-MS was conducted using an Agilent 1100 series with UV detection at 214 and 254 nm, and an electrospray mode (ESI) coupled with a Waters ZQ single quad mass detector. One of two methods was used: method A, 5–95% acetonitrile/H<sub>2</sub>O with 5 mM ammonium formate with a 2 min run, 3 μL injection through an inertisil C8 3 cm × 5 mm × 3 μm; method B, 20–95% acetonitrile/H<sub>2</sub>O with 10 mM ammonium formate with a 2 min run, 3 μL injection through an inertisil C8 3 cm × 5 mm × 3 μm. Purity of all tested compounds was determined by LC/ESI-MS data recorded using an Agilent 6220 mass spectrometer with electrospray ionization source and Agilent 1200 liquid chromatography. The mass accuracy of the system has been found to be <5 ppm. HPLC separation was performed at 75 mL/min flow rate with the indicated gradient within 3.5 min with an initial hold of 10 s. Ten millimolar ammonia hydroxide or 0.1 M TFA was used as the modifier additive in the aqueous phase.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> General Method A for Compounds <b>3</b>–<b>5</b> and <b>8</b></h4><div id="sec20" class="NLM_sec NLM_sec_level_4"><div id="ac_i10" class="anchor-spacer"></div><h5 class="article-section__title" id="_i10"> 2-(4-Amino-4-methylpiperidin-1-yl)-5-(2,3-dichlorophenyl)pyrimidin-4-amine (<b>8</b>)</h5><div class="NLM_p">A solution of <i>tert</i>-butyl-4-methylpiperidine-4-ylcarbamate (3.21 g, 14.99 mmol), 5-bromo-2-chloropyrimidin-4-amine (2.5 g, 11.99 mmol), and <i>N</i>-methylmorpholine (1.58 mL, 14.39 mmol) in NMP (15 mL) was stirred in a microwave reactor at 130 °C for 2 h. After cooling to RT, the resulting mixture was poured into H<sub>2</sub>O (600 mL); the suspension was stirred at RT for 5 min and then filtered to afford <i>tert</i>-butyl (1-(4-amino-5-bromopyrimidin-2-yl)-4-methylpiperidin-4-yl)carbamate (7.5 g, 9.71 mmol).</div><div class="NLM_p last">A suspension of <i>tert-</i>butyl (1-(4-amino-5-bromopyrimidin-2-yl)-4-methylpiperidin-4-yl)carbamate (966 mg, 2.50 mmol), (2,3-dichlophenyl)boronic acid (596 mg, 3.13 mmol), potassium phosphate (1.59 g, 7.50 mmol), and PdCl<sub>2</sub>(dppf)·DCM adduct (204 mg, 0.25 mmol) in MeCN/H<sub>2</sub>O (9:1, 10 mL, degassed) was stirred in a microwave reactor for 3 h at 110 °C. After cooling to RT, the reaction was filtered through a pad of Celite followed by EtOAc (50 mL) wash. The combined filtrates were concentrated, and the resulting residue was purified by silica chromatography (0 to 5% gradient of MeOH/DCM) to give <i>tert-</i>butyl (1-(4-amino-5-(2,3-dichlorophenyl)pyrimidin-2-yl)-4-methylpiperidin-4-yl)carbamate (1.07 g, 2.37 mmol). MS <i>m</i>/<i>z</i> 452.4 (M + H)<sup>+</sup>. To a solution of <i>tert-</i>butyl (1-(4-amino-5-(2,3-dichlorophenyl)pyrimidin-2-yl)-4-methylpiperidin-4-yl)carbamate (2.14 g, 4.73 mmol) in DCM (50 mL) was added TFA (31.7 mL). After stirring at 0 °C until no starting material remained (30 min, monitored by LC/MS), the volatiles were removed under reduced pressure and the resulting residue was purified by HPLC (gradient elution 10–30% acetonitrile in water, 0.1% TFA modifier) to give 2-(4-amino-4-methylpiperidin-1-yl)-5-(2,3-dichlorophenyl)pyrimidin-4-amine (<b>8,</b> 657 mg, 1.69 mmol; HCl salt). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.49–7.63 (m, 2 H) 7.34 (t, <i>J</i> = 7.71 Hz, 1 H) 7.26 (d, <i>J</i> = 7.33 Hz, 1 H) 4.18 (d, <i>J</i> = 12.13 Hz, 2 H) 3.38–3.61 (m, 2 H) 1.88 (br. s., 4 H) 1.45 (s, 3 H). HRMS calcd for C<sub>16</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>5</sub> (M + H)<sup>+</sup> 352.1096, found 352.1086.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i11" class="anchor-spacer"></div><h5 class="article-section__title" id="_i11"> 5-(3-Chlorophenyl)-2-(<i>cis</i>-3,5-dimethylpiperazin-1-yl)pyrimidin-4-amine (<b>3</b>)</h5><div class="NLM_p last">Prepared following the general method A (no Boc-deprotection necessary). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.71 (s, 1 H) 7.36–7.47 (m, 2 H) 7.26–7.36 (m, 2 H) 4.59 (dd, <i>J</i> = 13.05, 2.01 Hz, 2 H) 2.81 (td, <i>J</i> = 6.78, 3.26 Hz, 2 H) 2.43 (dd, <i>J</i> = 13.05, 11.04 Hz, 2 H) 1.14 (d, <i>J</i> = 6.53 Hz, 6 H). HRMS calcd for C<sub>16</sub>H<sub>21</sub>ClN<sub>5</sub> (M + H)<sup>+</sup> 318.1485, found 318.1283.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i12" class="anchor-spacer"></div><h5 class="article-section__title" id="_i12"> 5-(3,4-Dichlorophenyl)-2-(<i>cis</i>-3,5-dimethylpiperazin-1-yl)pyrimidin-4-amine (<b>4</b>)</h5><div class="NLM_p last">Prepared following the general method A (no Boc-deprotection necessary). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.72 (s, 1 H) 7.46–7.61 (m, 2 H) 7.30 (dd, <i>J</i> = 8.28, 2.01 Hz, 1 H) 4.59 (dd, <i>J</i> = 13.05, 2.26 Hz, 2 H) 2.80 (ddd, <i>J</i> = 10.29, 6.65, 3.14 Hz, 2 H) 2.42 (dd, <i>J</i> = 13.05, 10.79 Hz, 2 H) 1.13 (d, <i>J</i> = 6.27 Hz, 6 H). HRMS calcd for C<sub>16</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>5</sub> (M + H)<sup>+</sup> 352.1097, found 352.1096.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i13" class="anchor-spacer"></div><h5 class="article-section__title" id="_i13"> 5-(3,4-Dimethylphenyl)-2-(cis-3,5-dimethylpiperazin-1-yl)pyrimidin-4-amine (<b>5</b>)</h5><div class="NLM_p last">Prepared following the general method A (no Boc-deprotection necessary). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.60 (s, 1 H) 7.08–7.24 (m, 2 H) 6.96 (d, <i>J</i> = 7.28 Hz, 1 H) 4.79 (d, <i>J</i> = 14.05 Hz, 2 H) 3.18 (br. s., 2 H) 2.60–2.79 (m, 2 H) 2.33 (s, 3 H) 2.08 (s, 3 H) 1.30 (d, <i>J</i> = 6.27 Hz, 6 H). HRMS calcd for C<sub>16</sub>H<sub>21</sub>ClN<sub>5</sub> (M + H)<sup>+</sup> 312.2188, found 312.2189.</div></div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> General Method B for Compounds <b>6</b> and <b>7</b></h4><div id="sec21" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15"> 2-(4-Aminopiperidin-1-yl)-5-(2,3-dichlorophenyl)pyrimidin-4-amine (<b>6</b>)</h5><div class="NLM_p">A mixture of Xphos second generation precatalyst (72.3 mg, 0.098 mmol), 2,3-dichlorophenylboronic acid (411 mg, 2.153 mmol), potasium phosphate (0.5 M in H<sub>2</sub>O, 11.75 mL, 5.87 mmol), and 2-chloro-5-iodopyrimidin-4-amine (500 mg, 1.957 mmol) in THF (5 mL) was stirred for 16 h at 40 °C. After cooling to RT, the organic phase was separated and the aqueous phase was washed with EtOAc (3 × 5 mL); the combined organic phases were dried over MgSO<sub>4</sub> and filtered, and the volatiles were removed under reduced pressure. The resulting residue was purified by silica chromatography (10–50% gradient of EtOAc in heptane) to give 2-chloro-5-(2,3-dichlorophenyl)pyrimidin-4-amine (398 mg, 1.087 mmol).</div><div class="NLM_p last">A mixture of 2-chloro-5-(2,3-dichlorophenyl)pyrimidin-4-amine (41 mg, 0.188 mmol) and <i>tert</i>-butyl piperidin-4-ylcarbamate (38 mg, 0.188 mmol) in H<sub>2</sub>O (2 mL) was stirred in a microwave reactor for 90 min at 125 °C followed by 30 min at 200 °C (Boc deprotection occurs under the reaction conditions). After cooling to RT, the volatiles were removed under reduced pressure, and the resulting residue was purified by HPLC (gradient elution 25–50% acetonitrile in water, 5 mM NH<sub>4</sub>OH modifier) to give 5-(2,3-dichlorophenyl)-2-(4-(dimethylamino)piperidin-1-yl)pyrimidin-4-amine (11.4 mg, 0.031 mmol). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.64–7.70 (m, 1 H), 7.58 (dd, <i>J</i> = 8.03, 1.51 Hz, 1 H), 7.38 (t, <i>J</i> = 7.78 Hz, 1 H), 7.27 (dd, <i>J</i> = 7.78, 1.51 Hz, 1 H), 4.90 (d, <i>J</i> = 14.05 Hz, 2 H), 3.20 (s, 1 H), 2.81–2.97 (m, 2 H), 2.73 (s, 6 H), 2.04–2.13 (m, 2 H), 1.60 (dd, <i>J</i> = 12.30, 4.27 Hz, 2 H). HRMS calcd for C<sub>17</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>5</sub> (M + H)<sup>+</sup> 366.1252, found 366.1249.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> 2-(4-Aminopiperidin-1-yl)-5-(2,3-dichlorophenyl)pyrimidin-4-amine (<b>7</b>)</h5><div class="NLM_p last">Prepared following the general method B. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.60–7.69 (m, 1 H) 7.57 (dd, <i>J</i> = 8.03, 1.76 Hz, 1 H) 7.32–7.43 (m, 1 H) 7.24–7.32 (m, 1 H) 4.70 (d, <i>J</i> = 13.30 Hz, 2 H) 2.86–3.08 (m, 3 H) 1.84–1.97 (m, 2 H) 1.38 (qd, <i>J</i> = 12.00, 4.14 Hz, 2 H). HRMS calcd for C<sub>15</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>5</sub> (M + H)<sup>+</sup> 338.0939, found 338.0931</div></div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 3-(4-Amino-4-methylpiperidin-1-yl)-6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine (<b>9</b>)</h4><div class="NLM_p">A solution of 6-azauracil (1.0 g, 8.84 mmol), POCl<sub>3</sub> (10 mL, 107 mmol), and <i>N</i>,<i>N</i>-dimethylaniline (2 mL, 1.784 mmol) was stirred in a microwave reactor for 25 min at 90 °C. After cooling to RT, the reaction was poured into a beaker containing heptane (200 mL) and stirred for 5 min at RT, and the phases were separated. This procedure was repeated twice (200 mL of heptane each). The heptane phases were filtered through a pad of Celite and MgSO<sub>4</sub>, the volatiles were removed under reduced pressure, and the resulting residue was treated with NH<sub>3</sub> (7 N in MeOH, 5 mL in 10 mL of MeOH) precooled at 0 °C. The mixture was stirred for 5 min at RT; then, the volatiles were removed to give 3-chloro-1,2,4-triazin-5-amine (200 mg, 17.3% yield). This compound was used in next step without further purification.</div><div class="NLM_p">A solution of 3-chloro-1,2,4-triazin-5-amine (165 mg, 1.264 mmol), <i>tert-</i>butyl (4-methylpiperidin-4-yl)carbamate (271 mg, 1.264 mmol), and <i>N</i>-methylmorpholine (208 μL, 1.896 mmol) in NMP (5 mL) was stirred in a microwave reactor for 3 h at 130 °C. After cooling to RT, the resulting residue was purified by HPLC (gradient elution 15–40% acetonitrile in water, 5 mM NH<sub>4</sub>OH modifier) to give <i>tert-</i>butyl (1-(5-amino-1,2,4-triazin-3-yl)-4-methylpiperidin-4-yl)carbamate (71.0 mg, 0.23 mmol). MS <i>m</i>/<i>z</i> 308.4 (M + H)<sup>+</sup>.</div><div class="NLM_p">A solution of <i>tert-</i>butyl (1-(5-amino-1,2,4-triazin-3-yl)-4-methylpiperidin-4-yl)carbamate (71 mg, 0.230 mmol) and NBS (41 mg, 0.230 mmol) in CHCl<sub>3</sub> (2 mL) was stirred 16 h at RT. The volatiles were removed under reduced pressure, and the resulting residue was purified by silica chromatography (0–5% gradient of MeOH (containing 1% NH<sub>3</sub>)/DCM) to give <i>tert-</i>butyl (1-(5-amino-6-bromo-1,2,4-triazin-3-yl)-4-methylpiperidin-4-yl)carbamate (87 mg, 0.23 mmol). MS <i>m</i>/<i>z</i> 387.3 (M + H)<sup>+</sup>.</div><div class="NLM_p">A suspension of (1-(5-amino-6-bromo-1,2,4-triazin-3-yl)-4-methylpiperidin-4-yl)carbamate (250 mg, 0.646 mmol), 2,3-dichlorophenylboronic acid (154 mg, 0.807 mmol), potassium phosphate (411 mg, 1.937 mmol), and XPhos second generation precatalyst (25.4 mg, 0.032 mmol) in MeCN/H<sub>2</sub>O (9:1, 5 mL, degassed) was stirred in a microwave reactor for 2 h at 120 °C. After cooling to RT, the reaction was filtered through a pad of Celite followed by EtOAc (20 mL) wash. The combined filtrates were concentrated, and the resulting residue was purified by silica chromatography (0–5% gradient of MeOH (containing 1% NH<sub>3</sub>)/DCM) to give <i>tert</i>-butyl (1-(5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl)-4-methylpiperidin-4-yl)carbamate (78% purity). This mixture was further purified by HPLC (gradient elution 35–60% acetonitrile in water, 5 mM NH<sub>4</sub>OH modifier) to give <i>tert-</i>butyl (1-(5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl)-4-methylpiperidin-4-yl)carbamate (155 mg, 0.646 mmol). MS <i>m</i>/<i>z</i> 453.0 (M + H)<sup>+</sup>.</div><div class="NLM_p last">To a solution of <i>tert-</i>butyl (1-(5-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-3-yl)-4-methylpiperidin-4-yl)carbamate (155 mg, 0.342 mmol) in dioxane (2 mL) was added HCl (4 M in dioxane, 4 mL). After stirring at RT until no starting material remained (monitored by LCMS), the volatiles were removed under reduced pressure, and the resulting residue was purified by silica chromatography (0–5% gradient of MeOH (containing 1% NH<sub>3</sub>)/DCM) to give 3-(4-amino-4-methylpiperidin-1-yl)-6-(2,3-dichlorophenyl)-1,2,4-triazin-5-amine (130 mg, 0.342 mmol, HCl salt). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.80 (dd, <i>J</i> = 7.78, 2.01 Hz, 1 H), 7.42–7.58 (m, 2 H), 4.29 (m., 2 H), 3.64 (ddd, <i>J</i> = 14.24, 9.47, 4.64 Hz, 2 H), 1.92–2.06 (m, 4 H), 1.57 (s, 3 H). HRMS calcd for C<sub>15</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>6</sub> (M + H)<sup>+</sup> 353.1048, found 353.1042.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 6-(4-Amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (<b>1</b>)</h4><div class="NLM_p">A mixture of 3-bromo-6-chloropyrazine-2-amine (1.5 g, 7.2 mmol), (2,3-dichlorophenyl)boronic acid (1.37 g, 7.2 mmol), PdCl<sub>2</sub>(dppf)·DCM adduct (294 mg, 0.36 mmol), and potassium phosphate (4.58 g, 21.59 mmol) in MeCN/H<sub>2</sub>O (9:1, 15 mL) was stirred for 4 h at 120 °C. After cooling to RT, the reaction mixture was filtered through a pad of Celite followed by EtOAc wash. The solvent was removed under reduced pressure, and the resulting residue was purified by silica chromatography (5–30% gradient of EtOAc in heptane) to give 6-chloro-3-(2,3-dichlorophenyl)pyrazin-2-amine (1.46 g, 5.32 mmol) as yellow solid. MS <i>m</i>/<i>z</i> 453.0 (M + H)<sup>+</sup>.</div><div class="NLM_p">A mixture of 6-chloro-3-(2,3-dichlorophenyl)pyrazin-2-amine (125 mg, 0.455 mmol), <i>tert</i>-butyl (4-methylpiperidin-4-yl)carbamate (195 mg, 0.911 mmol), and potassium phosphate (97 mg, 0.455 mmol) in NMP (1 mL) was stirred for 36 h at 140 °C. After cooling to RT, the mixture was poured into a separation funnel containing aq. sat NH<sub>4</sub>Cl, and it was extracted with EtOAc (3 × 5 mL). The combined organic phases were dried over MgSO<sub>4</sub> and filtered, and the solvents were removed under reduced pressure. The resulting residue was purified by silica chromatography (5–30% gradient of EtOAc in heptane) to give <i>tert</i>-butyl (1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)carbamate (113 mg, 0.250 mmol) as yellow solid. MS <i>m</i>/<i>z</i> 452.4 (M + H)<sup>+</sup>.</div><div class="NLM_p last">A solution of <i>tert</i>-butyl (1-(6-amino-5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-yl)carbamate (113 mg, 0.250 mmol) in THF/H<sub>2</sub>O (4:1, 2.5 mL) was treated with HCl (4 M in dioxane, 230 μL, 0.928 mmol). The resulting mixture was stirred for 2 h at 140 °C. After cooling to RT, the volatiles were removed under reduced pressure, and the resulting residue was diluted with EtOAc (10 mL) and H<sub>2</sub>O (10 mL). The phases were separated, and the aqueous phase was further extracted with EtOAc (2 × 5 mL). The combined organic phases were discarded; the aqueous phase was basified to pH 9 with NaOH 2 M and extracted with EtOAc (3 × 10 mL). The combined organic phases were dried over MgSO<sub>4</sub> and filtered, and the solvent was removed under reduced pressure to afford 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)pyrazin-2-amine (84 mg, 0.238 mmol) as a yellow solid. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.61 (dd, <i>J</i> = 7.91, 1.63 Hz, 1 H) 7.47 (s, 1 H) 7.40 (t, <i>J</i> = 7.78 Hz, 1 H) 7.34 (dd, <i>J</i> = 7.65, 1.63 Hz, 1 H) 3.78 (ddd, <i>J</i> = 13.43, 7.15, 4.27 Hz, 2 H) 3.50–3.64 (m, 2 H) 1.55–1.75 (m, 4 H) 1.25 (s, 3 H). HRMS calcd for C<sub>16</sub>H<sub>20</sub>Cl<sub>2</sub>N (M + H)<sup>+</sup> 352.1096, found 352.1099.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-(5-(2,3-Dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-amine (<b>10</b>)</h4><div class="NLM_p">A mixture of 2,5-dichloropyrazine (466 mg, 3.13 mmol), (2,3-dichlorophenyl)boronic acid (477 mg, 2.5 mmol), PdCl<sub>2</sub>(dppf)·DCM adduct (102 mg, 0.125 mmol), and potassium phosphate (1.6 g, 7.5 mmol) in MeCN/H<sub>2</sub>O (9:1; 10 mL) was stirred in a microwave reactor for 1 h at 120 °C. After cooling to RT, the volatiles were removed under reduced pressure, and the resulting residue was purified by silica chromatography (5–30% gradient of EtOAc in heptane) to give 2-chloro-5-(2,3-dichlorophenyl)pyrazine (435 mg, 1.676 mmol). MS <i>m</i>/<i>z</i> 261.0 (M + H)<sup>+</sup>.</div><div class="NLM_p last">A mixture of 2-chloro-5-(2,3-dichlorophenyl)pyrazine (100 mg, 0.385 mmol), <i>tert</i>-butyl (4-methylpiperidin-4-yl)carbamate (165 mg, 0.771 mmol), and <i>N</i>-methylmorpholine (127 μL, 1.156 mmol) was stirred in a microwave reactor for 2 h at 120 °C and 30 min at 220 °C (Boc deprotection under the reaction conditions). After cooling to RT, the volatiles were removed under reduced pressure, and the resulting residue was purified by HPLC (gradient elution 25–50% acetonitrile in water, 5 mM NH<sub>4</sub>OH modifier) to give 1-(5-(2,3-dichlorophenyl)pyrazin-2-yl)-4-methylpiperidin-4-amine (17.2 mg, 0.05 mmol). <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ ppm 7.61–7.71 (m, 2 H) 7.51 (dd, <i>J</i> = 7.65, 1.63 Hz, 1 H) 7.44 (t, <i>J</i> = 7.78 Hz, 1 H) 7.37 (d, <i>J</i> = 9.79 Hz, 1 H) 3.82–3.96 (m, 2 H) 3.65–3.80 (m, 2 H) 1.58–1.77 (m, 4 H) 1.27 (s, 3 H). HRMS calcd for C<sub>16</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>4</sub> (M + H)<sup>+</sup> 337.0987, found 337.0983.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 6-(4-Amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)-<i>N</i>-methylpyrazin-2-amine (<b>11</b>)</h4><div class="NLM_p last">To a 0 °C solution of 2-chloro-5-(2,3-dichlorophenyl)pyrazine (80 mg, 0.291 mmol) in DMF (1 mL) was added NaH (60% in mineral oil, 13 mg, 0.321 mmol). After stirring at RT for 15 min, methyl iodide was added at 0 °C, and the mixture was stirred at RT for 1 h. Water (1 mL) was added to quench the reaction, and the resulting mixture was purified by HPLC (gradient elution 35–60% acetonitrile in water, 5 mM NH<sub>4</sub>OH modifier) to give 6-chloro-3-(2,3-dichlorophenyl)-<i>N</i>-methylpyrazin-2-amine (31 mg, 0.107 mmol). MS <i>m</i>/<i>z</i> 289.9 (M + H)<sup>+</sup>. A mixture of 6-chloro-3-(2,3-dichlorophenyl)-<i>N</i>-methylpyrazin-2-amine (31 mg, 0.107 mmol), <i>tert</i>-butyl (4-methylpiperidin-4-yl)carbamate (46 mg, 0.215 mmol), and <i>N</i>-methylmorpholine (24 μL, 0.215 mmol) was stirred in a microwave reactor for 1 h at 250 °C (Boc deprotection under the reaction conditions). After the mixture was cooled to RT, the volatiles were removed under reduced pressure, and the resulting residue was purified by HPLC (gradient elution 25–50% acetonitrile in water, 5 mM NH<sub>4</sub>OH modifier) to give 6-(4-amino-4-methylpiperidin-1-yl)-3-(2,3-dichlorophenyl)-<i>N</i>-methylpyrazin-2-amine (16.0 mg, 0.041 mmol). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.64 (dd, <i>J</i> = 8.03, 1.51 Hz, 1 H) 7.34–7.47 (m, 2 H) 7.29 (dd, <i>J</i> = 7.65, 1.63 Hz, 1 H) 5.72–5.85 (m, 1 H) 3.60–3.75 (m, 2 H) 3.49 (ddd, <i>J</i> = 12.92, 8.78, 3.89 Hz, 2 H) 2.72 (d, <i>J</i> = 4.52 Hz, 3 H) 1.59 (br. s., 2 H) 1.34–1.52 (m, 4 H) 1.09 (s, 3 H). HRMS calcd for C<sub>17</sub>H<sub>22</sub>Cl<sub>2</sub>N<sub>5</sub> (M + H)<sup>+</sup> 366.1252, found 366.1237.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Protein Expression and Purification</h3><div class="NLM_p">The gene encoding human SHP2 from residues Met1–Leu525 was inserted into a pET30 vector. A coding sequence for a 6× histidine tag followed by a TEV protease consensus sequence was added 5′ to the SHP2 gene sequence. The construct was transformed into BL21 Star (DE3) cells and grown at 37 °C in Terrific Broth containing 100 μg/mL kanamycin. At an OD<sub>600</sub> of 4.0, SHP2 expression was induced using 1 mM IPTG. Cells were harvested following overnight growth at 18 °C.</div><div class="NLM_p last">Cell pellets were resuspended in lysis buffer containing 50 mM Tris-HCl, pH 8.5, 25 mM imidazole, 500 mM NaCl, 2.5 mM MgCl<sub>2,</sub> 1 mM TCEP, 1 μg/mL DNase1, and complete EDTA-free protease inhibitor and lysed using a microfluidizer, followed by ultracentrifugation. The supernatant was loaded onto a HisTrap HP chelating column in 50 mM Tris-HCl, 25 mM imidazole, 500 mM NaCl, 1 mM TCEP and protein was eluted with the addition of 250 mM imidazole. The <i>N</i>-terminal histidine tag was removed with an overnight incubation using TEV protease at 4 °C. The protein was subsequently diluted to 50 mM NaCl with 20 mM Tris-HCl, pH 8.5, 1 mM TCEP, then applied to a HiTrap Q FastFlow column equilibrated with 20 mM Tris, pH 8.5, 50 mM NaCl, 1 mM TCEP. The protein was eluted with a 10 column volume gradient from 50 to 500 mM NaCl. Fractions containing SHP2 were pooled and concentrated then loaded onto a HiLoad Superdex200 PG 16/100 column, exchanging the protein into the crystallization buffer, 20 mM Tris-HCl, pH 8.5, 150 mM NaCl, and 3 mM TCEP. The protein was concentrated to 15 mg/mL for use in crystallization. Crystallization, DSF, and high throughput screening assays used the 1–525 construct of SHP2, while biochemical assays used the 2–593 construct.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Biochemical Assay</h3><div class="NLM_p">SHP2 is allosterically activated through binding of bis-tyrosyl-phorphorylated peptides to its Src Homology 2 (SH2) domains. The latter activation step leads to the release of the autoinhibitory interface of SHP2, which in turn renders the SHP2 PTP active and available for substrate recognition and reaction catalysis. The catalytic activity of SHP2 was monitored using the surrogate substrate DiFMUP in a prompt fluorescence assay format. More specifically, the phosphatase reactions were performed at room temperature in 384-well black polystyrene plate, flat bottom, low flange, nonbinding surface (Corning, cat. no. 3575) using a final reaction volume of 25 μL and the following assay buffer conditions: 60 mM HEPES, pH 7.2, 75 mM NaCl, 75 mM KCl, 1 mM EDTA, 0.05% P-20, 5 mM DTT.</div><div class="NLM_p last">The inhibition of SHP2 from the tested compounds (concentrations varying from 0.003 to 100 μM) was monitored using an assay in which 0.5 nM of SHP2 was incubated with of 0.5 μM of peptide IRS1_pY1172(dPEG8)pY1222(sequence H<sub>2</sub>N-LN(pY)IDLDLV(dPEG8)LST(pY)ASINFQK-amide). After 30–60 min incubation at 25 °C, the surrogate substrate DiFMUP (Invitrogen, cat. no. D6567, 200 μM) was added to the reaction and incubated at 25 °C for 30 min (200 μM for residue 2–593, 100 μM for residue 1–525 construct). The reaction was then quenched by the addition of 5 μL of a 160 μM solution of bpV(Phen) (Enzo Life Sciences cat. no. ALX-270–204). The fluorescence signal was monitored using a microplate reader (Envision, Perki-Elmer) using excitation and emission wavelengths of 340 and 450 nm, respectively. The inhibitor dose–response curves were analyzed using normalized IC<sub>50</sub> regression curve fitting with control based normalization.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Cellular Assay</h3><div class="NLM_p last">p-ERK cellular assay using the AlphaScreen <i>SureFire</i> Phospho-ERK 1/2 Kit (PerkinElmer) was performed as follows: KYSE-520 cells (30,000 cells/well) were grown in 96-well plate culture overnight and treated with SHP2 inhibitors at concentrations of 20, 6.6, 2.2, 0.74, 0.24, 0.08, and 0.027 μM for 2 h at 37 °C. Incubations were terminated by addition of 30 μL of lysis buffer (PerkinElmer) supplied with the SureFire phospho-extracellular signal-regulated kinase (p-ERK) assay kit (PerkinElmer). Samples were processed according to the manufacturer’s directions. The fluorescence signal from p-ERK was measured in duplicate using a 2101 multilabel reader (PerkinElmer Envision). The percentage of inhibition was normalized by the total ERK signal and compared with the DMSO vehicle control.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Cell Proliferation Assay</h3><div class="NLM_p last">Cells (1500-cells/well) were plated onto 96-well plates in 100 μL medium (RPMI-1640 containing 10% FBS, Lonza). Compounds with various concentrations (1.25, 2.5, 5, 10, and 20 μM) were added 24 h after cell plating. At day 5, 50 μL of Celltiter-Glo reagent (Promega) was added, and the luminescent signal was determined according to the supplier’s instruction (Promega).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Selectivity Assays</h3><div class="NLM_p last">Activity of <b>1</b> vs other phosphatases and kinases is found in the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Differential Scanning Fluorimetry</h3><div class="NLM_p last">Differential scanning fluorimetry (DSF) was used as a method to identify compounds that stabilize SHP2 from thermal denaturation. The following assay conditions were used: 100 μg/mL SHP2, 5× SYPRO Orange dye (5000× concentrate in DMSO; Life Technologies), 100 mM Bis-Tris (pH 6.5), 100 mM NaCl, 0.25 mM TCEP, and 5% DMSO. The final compound concentration evaluated was 100 μM. To carry out the experiment, 9.5 μL of DSF assay solution was dispensed into an assay plate (LightCycler; 480 multiwell plate 384 white) containing 500 nL of compound dissolved in DMSO then mixed. The final assay volume was 10 μL per well in a 384-well format. Plates were then sealed after reagent addition, centrifuged at 1000 rpm for 1 min, and read on a Bio-Rad C1000 thermal cycler with a CFX384 real time system using an excitation of 465 nm and an emission at 580 nm. The temperature was ramped from 25 to 75 °C, and measurements were taken at 0.5 °C increments. The melting temperature (<i>T</i><sub>m</sub>) of the raw fluorescence data was identified as the midpoint of the transitions via a semiparametric fit. The Δ<i>T</i><sub>m</sub> was determined by comparing the individual <i>T</i><sub>m</sub> values for each compound with the mean <i>T</i><sub>m</sub> of the apo SHP2 protein controls (32 per plate) containing DMSO only.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Crystallization and Structure Determination</h3><div class="NLM_p">Sitting drop vapor diffusion method was used for crystallization, with the crystallization well containing 17% PEG 3350 and 200 mM ammonium phosphate and a drop with a 1:1 volume of SHP2 protein and crystallization solution. Crystals were formed within 5 days and subsequently soaked in the crystallization solution with 2.5 mM of <b>2</b>. This was followed by cryoprotection using the crystallization solution with the addition of 20% glycerol and 1 mM compound <b>2</b>, followed by flash freezing directly into liquid nitrogen.</div><div class="NLM_p last">Diffraction data for the SHP2/compound <b>1</b> complex is reported elswhere,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and those for SHP2/compound <b>2</b> complex were collected on a Dectris Pilatus 6M detector at beamline 17ID (IMCA-CAT) at the Advanced Photon Source at Argonne National Laboratories. The data were measured from a single crystal maintained at 100 K at a wavelength of 1 Å, and the reflections were indexed, integrated, and scaled using XDS.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The spacegroup of the complex was <i>P</i>2<sub>1</sub> with two molecules in the asymmetric unit. The structure was determined with Fourier methods, using the SHP2 apo structure<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> (PDB accession <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP">2SHP</a>) with all waters removed. Structure determination was achieved through iterative rounds of positional and simulated annealing refinement using BUSTER,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> with model building using COOT.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Individual B-factors were refined using an overall anisotropic B-factor refinement along with bulk solvent correction. The solvent, phosphate ions, and inhibitor were built into the density in later rounds of the refinement. Data collection and refinement statistics are shown in Table 1 of the <a href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Pharmacokinetics</h3><div class="NLM_p">All animal related procedures were conducted under a Novartis IACUC approved protocol in compliance with Animal Welfare Act regulations and the Guide for the Care and Use of Laboratory Animals. Male C57BL/6 mice were obtained from Harlan Laboratories. Following iv administration (via tail vein) at 1 mg/kg, approximately 50 μL of whole blood was collected via tail transection, at 0.083, 0.5, 1, 2, 4, and 7 h postdose and transferred to an Eppendorf microcentrifuge tube containing EDTA. Oral administration (at 5 mg/kg) and collection procedures were similar to IV, except with whole blood collection at 0.25, 0.5, 1, 2, 4, and 7 h. The blood was centrifuged at 5000 rpm, and plasma was transferred to a Matrix 96 well plate, capped, and stored frozen (−20 °C) for parent compound analysis. Samples were precipitated and diluted with acetonitrile containing internal standard and prepared for LC/MS/MS. An aliquot (20 μL) of each sample was injected into an API4000 LC/MS/MS system for analysis, and transitions of 352.05 amu (Q1) and 267.10 amu (Q3) were monitored.</div><div class="NLM_p">All pharmacokinetic (PK) parameters were derived from concentration–time data by noncompartmental analyses. All PK parameters were calculated with the computer program WinNonlin (Version 6.4) purchased from Certara Company (St. Louis, MO).</div><div class="NLM_p">For the intravenous dose, the concentration of unchanged compound at time 0 was calculated based on a log–linear regression of first two data points to back-extrapolate <i>C</i>(0). The area under the concentration–time curve (AUC<sub>last</sub>) was calculated using the linear trapezoidal rule.</div><div class="NLM_p">The bioavailability was estimated as following equation:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/jm-2016-00680y_m001.gif" alt="" /></img></span></div><div class="NLM_p last">Results are expressed as mean. No further statistical analysis was performed.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Tumor Xenograft Experiments</h3><div class="NLM_p last">All animal studies were carried out according to the Novartis Guide for the Care and Use of Laboratory Animals. Female nude mice were inoculated subcutaneously (3 × 10<sup>6</sup> cells) in a suspension containing 50% phenol red-free matrigel (BD Biosciences) in Hank’s balanced salt solution with parental KYSE-520 cells. For PK/PD studies, mice were administered a single dose of vehicle control or <b>1</b> by oral gavage once tumors reached roughly 500 mm<sup>3</sup>. Mice were subsequently euthanized at predetermined time points following a single dose of compound at which point plasma and xenograft fragments were harvested for determination of <b>1</b> concentrations and p-ERK modulation, respectively. For efficacy studies, mice were calipered twice weekly by calipering in two dimensions. Once tumors reached roughly 200 mm<sup>3</sup>, mice were randomly assigned to treatment groups. For the efficacy study, mice were assigned to receive either vehicle, <b>1</b> (10, 30, or 100 mg/kg qd), or erlotinib (80 mg/kg qd) by oral gavage. Tumor volume and mouse body weight was assessed twice weekly. To assess MAPK pathway modulation in xenograft protein lysates, total and phospho-ERK1/2 was assessed using a commercially available kit (Meso Scale Discovery catalog number K15107D). The assay was conducted as recommended by Meso Scale Discovery with the exception that protein lysate was incubated overnight.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00680">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62707" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62707" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b00680" class="ext-link">10.1021/acs.jmedchem.6b00680</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Selectivity assays, Xray data table, and additional pharmacology results (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Machine-readable representation of structures with key data (<a href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_001.pdf">jm6b00680_si_001.pdf (294.56 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_002.csv">jm6b00680_si_002.csv (0.65 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHP">5EHP</a> for SHP2 in compex with compound <b>2</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a> for SHP2 in complex with compound <b>1</b>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b00680" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87251" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87251" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew J. LaMarche</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#573a3623233f3220793b363a3625343f32173938213625233e247934383a"><span class="__cf_email__" data-cfemail="c6aba7b2b2aea3b1e8aaa7aba7b4a5aea386a8a9b0a7b4b2afb5e8a5a9ab">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jorge Garcia Fortanet</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Hiu-Tung Chen</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ying-Nan P. Chen</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhouliang Chen</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhan Deng</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brant Firestone</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Fekkes</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Fodor</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal D. Fortin</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cary Fridrich</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Denise Grunenfelder</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samuel Ho</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhao B. Kang</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rajesh Karki</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mitsunori Kato</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nick Keen</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura R. LaBonte</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay Larrow</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Francois Lenoir</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gang Liu</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shumei Liu</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Franco Lombardo</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dyuti Majumdar</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew J. Meyer</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Palermo</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lawrence Perez</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minying Pu</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy Ramsey</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William R. Sellers</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael D. Shultz</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Travis Stams</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Towler</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ping Wang</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah L. Williams</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ji-Hu Zhang</span> - <span class="hlFld-Affiliation affiliation">†Global Discovery Chemistry, ‡Oncology Disease
Area, §Center
for Proteomic Chemistry, ∥Metabolism and Pharmacokinetics, Novartis Institutes
for Biomedical Research, and ⊥Chemical and Pharmaceutical Profiling, Novartis Pharmaceuticals, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e1885-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30626" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30626" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The authors thank the entire SHP2 team.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i33" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i33"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i34" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i34"> Abbreviations Used</h2><tr><td class="NLM_term">PTP</td><td class="NLM_def"><p class="first last">protein tyrosine phosphatase</p></td></tr><tr><td class="NLM_term">RAS</td><td class="NLM_def"><p class="first last">rat sarcoma protein</p></td></tr><tr><td class="NLM_term">AKT</td><td class="NLM_def"><p class="first last">protein kinase B</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription proteins</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term">PI3K</td><td class="NLM_def"><p class="first last">phosphoinositide 3-kinase</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last">tris(2-carboxyethyl)phosphine</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">isopropyl β-<span class="smallcaps smallerCapital">d</span>-1-thiogalactopyranoside</p></td></tr><tr><td class="NLM_term">EDTA</td><td class="NLM_def"><p class="first last">ethylenediaminetetraacetic acid</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11224" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11224" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Crystal structure of the tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+structure+of+the+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0ljBR1bIYpFx-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520the%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450%26doi%3D10.1016%2FS0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/S0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+mechanisms+for+SH2+domain+mediated+regulation+of+the+protein+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0ljBR1bIYpFx-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520mechanisms%2520for%2520SH2%2520domain%2520mediated%2520regulation%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254%26doi%3D10.1016%2FS0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Plusky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wandless, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Potent Stimulation of SH-PTP2 Phosphatase Activity by Simultaneous Occupancy of Both SH2 Domains</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">2897</span><span class="NLM_x">–</span> <span class="NLM_lpage">2900</span><span class="refDoi"> DOI: 10.1074/jbc.270.7.2897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1074%2Fjbc.270.7.2897" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=2897-2900&author=S.+Pluskyauthor=T.+J.+Wandlessauthor=C.+T.+Walshauthor=S.+E.+Shoelson&title=Potent+Stimulation+of+SH-PTP2+Phosphatase+Activity+by+Simultaneous+Occupancy+of+Both+SH2+Domains&doi=10.1074%2Fjbc.270.7.2897"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.7.2897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.7.2897%26sid%3Dliteratum%253Aachs%26aulast%3DPlusky%26aufirst%3DS.%26aulast%3DWandless%26aufirst%3DT.%2BJ.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DPotent%2520Stimulation%2520of%2520SH-PTP2%2520Phosphatase%2520Activity%2520by%2520Simultaneous%2520Occupancy%2520of%2520Both%2520SH2%2520Domains%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D2897%26epage%3D2900%26doi%3D10.1074%2Fjbc.270.7.2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Prahallad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynen, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecchione, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambino, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieftink, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijersbergen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nicolantonio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">PTPN11 Is a Central Node in Intrinsic and Aquired Resistance to Targeted Cancer Drugs</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1978</span><span class="refDoi"> DOI: 10.1016/j.celrep.2015.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.celrep.2015.08.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=26365186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2ls7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1978&author=A.+Prahalladauthor=G.+J.+Heynenauthor=G.+Germanoauthor=S.+M.+Willemsauthor=B.+Eversauthor=L.+Vecchioneauthor=V.+Gambinoauthor=C.+Lieftinkauthor=R.+L.+Beijersbergenauthor=F.+Di+Nicolantonioauthor=A.+Bardelliauthor=R.+Bernards&title=PTPN11+Is+a+Central+Node+in+Intrinsic+and+Aquired+Resistance+to+Targeted+Cancer+Drugs&doi=10.1016%2Fj.celrep.2015.08.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs</span></div><div class="casAuthors">Prahallad, Anirudh; Heynen, Guus J. J. E.; Germano, Giovanni; Willems, Stefan M.; Evers, Bastiaan; Vecchione, Loredana; Gambino, Valentina; Lieftink, Cor; Beijersbergen, Roderick L.; Di Nicolantonio, Federica; Bardelli, Alberto; Bernards, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1978-1985</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Most BRAF (V600E) mutant melanomas are sensitive to selective BRAF inhibitors, but BRAF mutant colon cancers are intrinsically resistant to these drugs because of feedback activation of EGFR.  We performed an RNA-interference-based genetic screen in BRAF mutant colon cancer cells to search for phosphatases whose knockdown induces sensitivity to BRAF inhibition.  We found that suppression of protein tyrosine phosphatase non-receptor type 11 (PTPN11) confers sensitivity to BRAF inhibitors in colon cancer.  Mechanistically, we found that inhibition of PTPN11 blocks signaling from receptor tyrosine kinases (RTKs) to the RAS-MEK-ERK pathway.  PTPN11 suppression is lethal to cells that are driven by activated RTKs and prevents acquired resistance to targeted cancer drugs that results from RTK activation.  Our findings identify PTPN11 as a drug target to combat both intrinsic and acquired resistance to several targeted cancer drugs.  Moreover, activated PTPN11 can serve as a biomarker of drug resistance resulting from RTK activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2cE8g_Ejr7Vg90H21EOLACvtfcHk0liPkn1MJWS6HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2ls7fN&md5=521d9847bba4c7c6529ad355da097787</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DPrahallad%26aufirst%3DA.%26aulast%3DHeynen%26aufirst%3DG.%2BJ.%26aulast%3DGermano%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DS.%2BM.%26aulast%3DEvers%26aufirst%3DB.%26aulast%3DVecchione%26aufirst%3DL.%26aulast%3DGambino%26aufirst%3DV.%26aulast%3DLieftink%26aufirst%3DC.%26aulast%3DBeijersbergen%26aufirst%3DR.%2BL.%26aulast%3DDi%2BNicolantonio%26aufirst%3DF.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DPTPN11%2520Is%2520a%2520Central%2520Node%2520in%2520Intrinsic%2520and%2520Aquired%2520Resistance%2520to%2520Targeted%2520Cancer%2520Drugs%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D1978%26doi%3D10.1016%2Fj.celrep.2015.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, H.</span><span> </span><span class="NLM_article-title">Src Homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="refDoi"> DOI: 10.1186/1471-2407-14-442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1186%2F1471-2407-14-442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=24931737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVymtrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=442&author=H.+Wangauthor=W.+Chiangauthor=H.+Huangauthor=Y.+Shenauthor=H.+Chiang&title=Src+Homology+2+domain-containing+tyrosine+phosphatase+2+promotes+oral+cancer+invasion+and+metastasis&doi=10.1186%2F1471-2407-14-442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis</span></div><div class="casAuthors">Wang, Hsueh-Chun; Chiang, Wei-Fan; Huang, Hsin-Hsiu; Shen, Ying-Ying; Chiang, Hung-Che</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">442/1-442/13</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Tumor invasion and metastasis represent a major unsolved problem in cancer pathogenesis.  Recent studies have indicated the involvement of Src-homol. 2 domain-contg. tyrosine phosphatase 2 (SHP2) in multiple malignancies; however, the role of SHP2 in oral cancer progression has yet to be elucidated.  We propose that SHP2 is involved in the progression of oral cancer toward metastasis.  Methods: SHP2 expression was evaluated in paired oral cancer tissues by using immunohistochem. staining and real-time reverse transcription polymerase chain reaction.  Isogenic highly invasive oral cancer cell lines from their resp. low invasive parental lines were established using a Boyden chamber assay, and changes in the hallmarks of the epithelial-mesenchymal transition (EMT) were assessed to evaluate SHP2 function.  SHP2 activity in oral cancer cells was reduced using si-RNA knockdown or enforced expression of a catalytically deficient mutant to analyze migratory and invasive ability in vitro and metastasis toward the lung in mice in vivo.  Results: We obsd. the significant upregulation of SHP2 in oral cancer tissues and cell lines.  Following SHP2 knockdown, the oral cancer cells markedly attenuated migratory and invasion ability.  We obsd. similar results in phosphatase-dead SHP2 C459S mutant expressing cells.  Enhanced invasiveness was assocd. with significant upregulation of E-cadherin, vimentin, Snail/Twist1, and matrix metalloproteinase-2 in the highly invasive clones.  In addn., we detd. that SHP2 activity is required for the downregulation of phosphorylated ERK1/2, which modulates the downstream effectors, Snail and Twist1 at a transcript level.  In lung tissue sections of mice, we obsd. that HSC3 tumors with SHP2 deletion exhibited significantly reduced metastatic capacity, compared with tumors administered control si-RNA.  Conclusions: Our data suggest that SHP2 promotes the invasion and metastasis of oral cancer cells.  These results provide a rationale for further investigating the effects of small-mol. SHP2 inhibitors on the progression of oral cancer, and indicate a previously unrecognized SHP2-ERK1/2-Snail/Twist1 pathway that is likely to play a crucial role in oral cancer invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4fInuWtOHl7Vg90H21EOLACvtfcHk0liPkn1MJWS6HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVymtrfM&md5=b1dd0157d70ac01327bbdbc473dab8ee</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-14-442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-14-442%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChiang%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DChiang%26aufirst%3DH.%26atitle%3DSrc%2520Homology%25202%2520domain-containing%2520tyrosine%2520phosphatase%25202%2520promotes%2520oral%2520cancer%2520invasion%2520and%2520metastasis%26jtitle%3DBMC%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D442%26doi%3D10.1186%2F1471-2407-14-442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L.</span><span> </span><span class="NLM_article-title">The ‘Shp’ing News: SH2 Domain-Containing Tyrosine Phosphatases in Cell Signaling</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1016/S0968-0004(03)00091-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS0968-0004%2803%2900091-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=12826400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%98Shp%E2%80%99ing+News%3A+SH2+Domain-Containing+Tyrosine+Phosphatases+in+Cell+Signaling&doi=10.1016%2FS0968-0004%2803%2900091-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span></div><div class="casAuthors">Neel, Benjamin G.; Gu, Haihua; Pao, Lily</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Src homol.-2 (SH2) domain-contg. phosphatases (Shps) are a small, highly conserved subfamily of protein tyrosine phosphatases, members of which are present in both vertebrates and invertebrates.  The mechanism of regulation of Shps by ligand binding is now well understood.  Much is also known about the normal signaling pathways regulated by each Shp and the consequences of Shp deficiency.  Recent studies have identified mutations in human Shp2 as the cause of the inherited disorder, Noonan syndrome.  Shp2 mutations might also contribute to the pathogenesis of some leukemias.  In addn., Shp2 might be a key virulence determinant for the important human pathogen, Helicobacter pylori.  Despite these efforts, however, the key targets of each Shp have remained elusive.  Identifying these substrates remains a major challenge for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zIEChntK0rVg90H21EOLACvtfcHk0lh6mnhF_15jLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D&md5=bce9fc3db0a41b29ba605251dc46c64f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2803%2900091-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252803%252900091-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2598Shp%25E2%2580%2599ing%2520News%253A%2520SH2%2520Domain-Containing%2520Tyrosine%2520Phosphatases%2520in%2520Cell%2520Signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293%26doi%3D10.1016%2FS0968-0004%2803%2900091-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G. S.</span><span> </span><span class="NLM_article-title">PTPN11 is the First Identified Proto-Oncogene That Encodes a Tyrosine Phosphatase</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.1182/blood-2006-07-028829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1182%2Fblood-2006-07-028829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=17053061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+First+Identified+Proto-Oncogene+That+Encodes+a+Tyrosine+Phosphatase&doi=10.1182%2Fblood-2006-07-028829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span></div><div class="casAuthors">Chan, Rebecca J.; Feng, Gen-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-867</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Elucidation of the mol. mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes.  One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homol. 2 (SH2) domains (Shp2).  This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis.  More recently, somatic missense PTPN11 gain-of-function mutations were detected in leukemias and rarely in solid tumors, and were found to induce aberrant hyperactivation of the Ras-Erk pathway.  This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the mol. mechanisms underlying cell transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqsuOora-d37Vg90H21EOLACvtfcHk0lh6mnhF_15jLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D&md5=8c5760a6ac385635f9794acbf5b64a03</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-028829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-028829%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520First%2520Identified%2520Proto-Oncogene%2520That%2520Encodes%2520a%2520Tyrosine%2520Phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867%26doi%3D10.1182%2Fblood-2006-07-028829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tiganis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, A. M.</span><span> </span><span class="NLM_article-title">Protein Tyrosine Phosphatase Function: the Substrated Perspective</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1042/BJ20061548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1042%2FBJ20061548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=17238862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2007&pages=1-15&author=T.+Tiganisauthor=A.+M.+Bennett&title=Protein+Tyrosine+Phosphatase+Function%3A+the+Substrated+Perspective&doi=10.1042%2FBJ20061548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatase function: the substrate perspective</span></div><div class="casAuthors">Tiganis, Tony; Bennett, Anton M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now well established that the members of the protein tyrosine phosphatase (PTP) superfamily play crit. roles in fundamental biol. processes.  Although there has been much progress in defining the function of PTPs, the task of identifying substrates for these enzymes still presents a challenge.  Many PTPs have yet to have their physiol. substrates identified.  The focus of this review is on the current state of knowledge of PTP substrates and the approaches used to identify them.  The authors propose exptl. criteria that should be satisfied in order to rigorously assign PTP substrates as bona fide.  Finally, the progress that has been made in defining the biol. roles of PTPs through the identification of their substrates is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod89zW3LtOs7Vg90H21EOLACvtfcHk0lh6mnhF_15jLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFOisQ%253D%253D&md5=e0b404da50fc57e25efe140026d6cd53</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1042%2FBJ20061548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061548%26sid%3Dliteratum%253Aachs%26aulast%3DTiganis%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DA.%2BM.%26atitle%3DProtein%2520Tyrosine%2520Phosphatase%2520Function%253A%2520the%2520Substrated%2520Perspective%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D402%26spage%3D1%26epage%3D15%26doi%3D10.1042%2FBJ20061548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bunda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heir, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alamsahebpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raught, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadeh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohh, M.</span><span> </span><span class="NLM_article-title">Inhibition of SHP2-Mediated Dephosphorylation of Ras Suppresses Oncogenesis</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8859</span><span class="refDoi"> DOI: 10.1038/ncomms9859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fncomms9859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=26617336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8859&author=S.+Bundaauthor=K.+Burrellauthor=P.+Heirauthor=L.+Zengauthor=A.+Alamsahebpourauthor=Y.+Kanoauthor=B.+Raughtauthor=Z.-Y.+Zhangauthor=G.+Zadehauthor=M.+Ohh&title=Inhibition+of+SHP2-Mediated+Dephosphorylation+of+Ras+Suppresses+Oncogenesis&doi=10.1038%2Fncomms9859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis</span></div><div class="casAuthors">Bunda, Severa; Burrell, Kelly; Heir, Pardeep; Zeng, Lifan; Alamsahebpour, Amir; Kano, Yoshihito; Raught, Brian; Zhang, Zhong-Yin; Zadeh, Gelareh; Ohh, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8859</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ras is phosphorylated on a conserved tyrosine at position 32 within the switch I region via Src kinase.  This phosphorylation inhibits the binding of effector Raf while promoting the engagement of GTPase-activating protein (GAP) and GTP hydrolysis.  Here we identify SHP2 as the ubiquitously expressed tyrosine phosphatase that preferentially binds to and dephosphorylates Ras to increase its assocn. with Raf and activate downstream proliferative Ras/ERK/MAPK signalling.  In comparison to normal astrocytes, SHP2 activity is elevated in astrocytes isolated from glioblastoma multiforme (GBM)-prone H-Ras(12V) knock-in mice as well as in glioma cell lines and patient-derived GBM specimens exhibiting hyperactive Ras.  Pharmacol. inhibition of SHP2 activity attenuates cell proliferation, soft-agar colony formation and orthotopic GBM growth in NOD/SCID mice and decelerates the progression of low-grade astrocytoma to GBM in a spontaneous transgenic glioma mouse model.  These results identify SHP2 as a direct activator of Ras and a potential therapeutic target for cancers driven by a previously 'undruggable' oncogenic or hyperactive Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhWi25AJiphrVg90H21EOLACvtfcHk0ljjdrs3F9jX6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP&md5=8524ad9cc6f2e85abaff6b07c698f464</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fncomms9859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9859%26sid%3Dliteratum%253Aachs%26aulast%3DBunda%26aufirst%3DS.%26aulast%3DBurrell%26aufirst%3DK.%26aulast%3DHeir%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAlamsahebpour%26aufirst%3DA.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26aulast%3DZadeh%26aufirst%3DG.%26aulast%3DOhh%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520SHP2-Mediated%2520Dephosphorylation%2520of%2520Ras%2520Suppresses%2520Oncogenesis%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8859%26doi%3D10.1038%2Fncomms9859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Burgt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalidas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11, Encoding the Protein Tyrosine Phosphatase SHP-2, Cause Noonan syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1038/ng772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-468&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+Van+Der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=J.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+PTPN11%2C+Encoding+the+Protein+Tyrosine+Phosphatase+SHP-2%2C+Cause+Noonan+syndrome&doi=10.1038%2Fng772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0ljjdrs3F9jX6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3DVan%2BDer%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DJ.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520PTPN11%252C%2520Encoding%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%252C%2520Cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D468%26doi%3D10.1038%2Fng772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fragale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buechner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hählen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Somatic Mutations in PTPN11 in Juvenile Myelomonocytic Leukemia, Myelodysplactic Syndromes and Acute Myeloid Leukemia</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1038/ng1156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+H%C3%A4hlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+Mutations+in+PTPN11+in+Juvenile+Myelomonocytic+Leukemia%2C+Myelodysplactic+Syndromes+and+Acute+Myeloid+Leukemia&doi=10.1038%2Fng1156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0ljjdrs3F9jX6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DH%25C3%25A4hlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520Mutations%2520in%2520PTPN11%2520in%2520Juvenile%2520Myelomonocytic%2520Leukemia%252C%2520Myelodysplactic%2520Syndromes%2520and%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150%26doi%3D10.1038%2Fng1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The Tyrosine Phosphoatase Shp2 (<i>PTPN11</i>) in Cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+Tyrosine+Phosphoatase+Shp2+%28PTPN11%29+in+Cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0lir5yrI1SUp7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520Tyrosine%2520Phosphoatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Miyamoto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomogita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">Isolation of a Distinct Class of Gain-of-Function SHP-2 mutants with Oncogenic RAS-like Transforming Activity From Solid Tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3508</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span><span class="refDoi"> DOI: 10.1038/sj.onc.1211019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+Distinct+Class+of+Gain-of-Function+SHP-2+mutants+with+Oncogenic+RAS-like+Transforming+Activity+From+Solid+Tumors&doi=10.1038%2Fsj.onc.1211019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0lir5yrI1SUp7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520Distinct%2520Class%2520of%2520Gain-of-Function%2520SHP-2%2520mutants%2520with%2520Oncogenic%2520RAS-like%2520Transforming%2520Activity%2520From%2520Solid%2520Tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515%26doi%3D10.1038%2Fsj.onc.1211019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jie, H.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gildener-Leapman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-1215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1158%2F0008-5472.CAN-14-1215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=25480946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVenurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=508-518&author=J.+Liauthor=H.-B.+Jieauthor=Y.+Leiauthor=N.+Gildener-Leapmanauthor=S.+Trivedi&title=PD-1%2FSHP-2+Inhibits+Tc1%2FTh1+Phenotypic+Responses+and+the+Activation+of+T+Cells+in+the+Tumor+Microenvironment&doi=10.1158%2F0008-5472.CAN-14-1215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span></div><div class="casAuthors">Li, Jing; Jie, Hyun-Bae; Lei, Yu; Gildener-Leapman, Neil; Trivedi, Sumita; Green, Tony; Kane, Lawrence P.; Ferris, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">508-518</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study addresses the mechanisms through which PD-1 antibody therapy restores the ability of the immune system to recognize and attack tumors by skewing intratumoral T cells toward a more potent activation phenotype that is assocd. with enhanced signaling and a reversal of their immunosuppressed phenotype.  Immune rejection of tumors is mediated by IFNγ prodn. and T-cell cytolytic activity.  These processes are impeded by PD-1, a coinhibitory mol. expressed on T cells that is elevated in tumor-infiltrating lymphocytes (TIL).  PD-1 elevation may reflect T-cell exhaustion marked by decreased proliferation, prodn. of type I cytokines, and poor cytolytic activity.  Although anti-PD-1 antibodies enhance IFNγ secretion after stimulation of the T-cell receptor (TCR), the mechanistic link between PD-1 and its effects on T-cell help (Tc1/Th1 skewing) remains unclear.  In prospectively collected cancer tissues, we found that TIL exhibited dampened Tc1/Th1 skewing and activation compared with peripheral blood lymphocytes (PBL).  When PD-1 bound its ligand PD-L1, we obsd. a marked suppression of crit. TCR target genes and Th1 cytokines.  Conversely, PD-1 blockade reversed these suppressive effects of PD-1:PD-L1 ligation.  We also found that the TCR-regulated phosphatase SHP-2 was expressed higher in TIL than in PBL, tightly correlating with PD-1 expression and neg. regulation of TCR target genes.  Overall, these results defined a PD-1/SHP-2/STAT1/T-bet signaling axis mediating the suppressive effects of PD-1 on Th1 immunity at tumor sites.  Our findings argue that PD-1 or SHP-2 blockade will be sufficient to restore robust Th1 immunity and T-cell activation and thereby reverse immunosuppression in the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe6jAWHNatvLVg90H21EOLACvtfcHk0lir5yrI1SUp7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVenurY%253D&md5=695007f0715b5eee2b7e47deaf87ae23</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1215%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJie%26aufirst%3DH.-B.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DGildener-Leapman%26aufirst%3DN.%26aulast%3DTrivedi%26aufirst%3DS.%26atitle%3DPD-1%252FSHP-2%2520Inhibits%2520Tc1%252FTh1%2520Phenotypic%2520Responses%2520and%2520the%2520Activation%2520of%2520T%2520Cells%2520in%2520the%2520Tumor%2520Microenvironment%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D508%26epage%3D518%26doi%3D10.1158%2F0008-5472.CAN-14-1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Topalian, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodi, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahmer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettinger, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powderly, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leming, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigel, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonia, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoll, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharfman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anders, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taube, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMiller, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jure-Kunkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollia, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigginton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sznol, M.</span><span> </span><span class="NLM_article-title">Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2454</span><span class="refDoi"> DOI: 10.1056/NEJMoa1200690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1056%2FNEJMoa1200690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=22658127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2rs7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=2443-2454&author=S.+L.+Topalianauthor=F.+S.+Hodiauthor=J.+R.+Brahmerauthor=S.+N.+Gettingerauthor=D.+C.+Smithauthor=D.+F.+McDermottauthor=J.+D.+Powderlyauthor=R.+D.+Carvajalauthor=J.+A.+Sosmanauthor=M.+B.+Atkinsauthor=P.+D.+Lemingauthor=D.+R.+Spigelauthor=S.+J.+Antoniaauthor=L.+Hornauthor=C.+G.+Drakeauthor=D.+M.+Pardollauthor=L.+Chenauthor=W.+H.+Sharfmanauthor=R.+A.+Andersauthor=J.+M.+Taubeauthor=T.+L.+McMillerauthor=H.+Xuauthor=A.+J.+Kormanauthor=M.+Jure-Kunkelauthor=S.+Agrawalauthor=D.+McDonaldauthor=G.+D.+Kolliaauthor=A.+Guptaauthor=J.+M.+Wiggintonauthor=M.+Sznol&title=Safety%2C+Activity%2C+and+Immune+Correlates+of+Anti-PD-1+Antibody+in+Cancer&doi=10.1056%2FNEJMoa1200690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, activity, and immune correlates of anti-PD-1 antibody in cancer</span></div><div class="casAuthors">Topalian, Suzanne L.; Hodi, F. Stephen; Brahmer, Julie R.; Gettinger, Scott N.; Smith, David C.; McDermott, David F.; Powderly, John D.; Carvajal, Richard D.; Sosman, Jeffrey A.; Atkins, Michael B.; Leming, Philip D.; Spigel, David R.; Antonia, Scott J.; Horn, Leora; Drake, Charles G.; Pardoll, Drew M.; Chen, Lieping; Sharfman, William H.; Anders, Robert A.; Taube, Janis M.; McMiller, Tracee L.; Xu, Haiying; Korman, Alan J.; Jure-Kunkel, Maria; Agrawal, Shruti; McDonald, Daniel; Kollia, Georgia D.; Gupta, Ashok; Wigginton, Jon M.; Sznol, Mario</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2443-2454</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance.  We assessed the antitumor activity and safety of BMS-936558, an antibody that specifically blocks PD-1.  Methods: We enrolled patients with advanced melanoma, non-small-cell lung cancer, castration-resistant prostate cancer, or renal-cell or colorectal cancer to receive anti-PD-1 antibody at a dose of 0.1 to 10.0 mg per kg of body wt. every 2 wk.  Response was assessed after each 8-wk treatment cycle.  Patients received up to 12 cycles until disease progression or a complete response occurred.  Results: A total of 296 patients received treatment through Feb. 24, 2012.  Grade 3 or 4 drug-related adverse events occurred in 14% of patients; there were three deaths from pulmonary toxicity.  No max. tolerated dose was defined.  Adverse events consistent with immune-related causes were obsd.  Among 236 patients in whom response could be evaluated, objective responses (complete or partial responses) were obsd. in those with non-small-cell lung cancer, melanoma, or renal-cell cancer.  Cumulative response rates (all doses) were 18% among patients with non-small-cell lung cancer (14 of 76 patients), 28% among patients with melanoma (26 of 94 patients), and 27% among patients with renal-cell cancer (9 of 33 patients).  Responses were durable; 20 of 31 responses lasted 1 yr or more in patients with 1 yr or more of follow-up.  To assess the role of intratumoral PD-1 ligand (PD-L1) expression in the modulation of the PD-1-PD-L1 pathway, immunohistochem. anal. was performed on pretreatment tumor specimens obtained from 42 patients.  Of 17 patients with PD-L1-neg. tumors, none had an objective response; 9 of 25 patients (36%) with PD-L1-pos. tumors had an objective response (P = 0.006).  Conclusions: Anti-PD-1 antibody produced objective responses in approx. one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse-event profile does not appear to preclude its use.  Preliminary data suggest a relationship between PD-L1 expression on tumor cells and objective response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLOPvHybmlvbVg90H21EOLACvtfcHk0ljjzxBJk22mbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2rs7fN&md5=7c13f228ef92b6089982fc878d3a394b</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1200690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1200690%26sid%3Dliteratum%253Aachs%26aulast%3DTopalian%26aufirst%3DS.%2BL.%26aulast%3DHodi%26aufirst%3DF.%2BS.%26aulast%3DBrahmer%26aufirst%3DJ.%2BR.%26aulast%3DGettinger%26aufirst%3DS.%2BN.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DMcDermott%26aufirst%3DD.%2BF.%26aulast%3DPowderly%26aufirst%3DJ.%2BD.%26aulast%3DCarvajal%26aufirst%3DR.%2BD.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DAtkins%26aufirst%3DM.%2BB.%26aulast%3DLeming%26aufirst%3DP.%2BD.%26aulast%3DSpigel%26aufirst%3DD.%2BR.%26aulast%3DAntonia%26aufirst%3DS.%2BJ.%26aulast%3DHorn%26aufirst%3DL.%26aulast%3DDrake%26aufirst%3DC.%2BG.%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSharfman%26aufirst%3DW.%2BH.%26aulast%3DAnders%26aufirst%3DR.%2BA.%26aulast%3DTaube%26aufirst%3DJ.%2BM.%26aulast%3DMcMiller%26aufirst%3DT.%2BL.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DKorman%26aufirst%3DA.%2BJ.%26aulast%3DJure-Kunkel%26aufirst%3DM.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DMcDonald%26aufirst%3DD.%26aulast%3DKollia%26aufirst%3DG.%2BD.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DWigginton%26aufirst%3DJ.%2BM.%26aulast%3DSznol%26aufirst%3DM.%26atitle%3DSafety%252C%2520Activity%252C%2520and%2520Immune%2520Correlates%2520of%2520Anti-PD-1%2520Antibody%2520in%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D2443%26epage%3D2454%26doi%3D10.1056%2FNEJMoa1200690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ohigashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsurui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoriki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashizuka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsushima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, Y.</span><span> </span><span class="NLM_article-title">Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2947</span><span class="NLM_x">–</span> <span class="NLM_lpage">2953</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-1469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1158%2F1078-0432.CCR-04-1469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=15837746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlejt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2947-2953&author=Y.+Ohigashiauthor=M.+Shoauthor=Y.+Yamadaauthor=Y.+Tsuruiauthor=K.+Hamadaauthor=N.+Ikedaauthor=T.+Mizunoauthor=R.+Yorikiauthor=H.+Kashizukaauthor=K.+Yaneauthor=F.+Tsushimaauthor=N.+Otsukiauthor=H.+Yagitaauthor=M.+Azumaauthor=Y.+Nakajima&title=Clinical+Significance+of+Programmed+Death-1+Ligand-1+and+Programmed+Death-1+Ligand-2+Expression+in+Human+Esophageal+Cancer&doi=10.1158%2F1078-0432.CCR-04-1469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer</span></div><div class="casAuthors">Ohigashi, Yuichiro; Sho, Masayuki; Yamada, Yukishige; Tsurui, Yoshikazu; Hamada, Kaoru; Ikeda, Naoya; Mizuno, Takashi; Yoriki, Ryo; Kashizuka, Hisanori; Yane, Katsunari; Tsushima, Fumihiko; Otsuki, Noriko; Yagita, Hideo; Azuma, Miyuki; Nakajima, Yoshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2947-2953</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The neg. regulatory programmed death-1/programmed death-1 ligand (PD-1/PD-L) pathway in T-cell activation has been suggested to play an important role in tumor evasion from host immunity.  In this study, we investigated the expression of PD-L1 and PD-L2 in human esophageal cancer to define their clin. significance in patients' prognosis after surgery.  Exptl. Design: PD-L1 and PD-L2 gene expression was evaluated in 41 esophagectomy patients by real-time quant. PCR.  The protein expression was also evaluated with newly generated monoclonal antibodies that recognize human PD-L1 (MIH1) and PD-L2 (MIH18).  Results: The protein and the mRNA levels of detn. by immunohistochem. and real-time quant. PCR were closely correlated.  PD-L-pos. patients had a significantly poorer prognosis than the neg. patients.  This was more pronounced in the advanced stage of tumor than in the early stage.  Furthermore, multivariate anal. indicated that PD-L status was an independent prognostic factor.  Although there was no significant correlation between PD-L1 expression and tumor-infiltrating T lymphocytes, PD-L2 expression was inversely correlated with tumor-infiltrating CD8+ T cells.  Conclusions: These data suggest that PD-L1 and PD-L2 status may be a new predictor of prognosis for patients with esophageal cancer and provide the rationale for developing novel immunotherapy of targeting PD-1/PD-L pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIMQiC4R0LD7Vg90H21EOLACvtfcHk0ljjzxBJk22mbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlejt7k%253D&md5=1dd37b483171a10070310ccd559c9e35</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1469%26sid%3Dliteratum%253Aachs%26aulast%3DOhigashi%26aufirst%3DY.%26aulast%3DSho%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DTsurui%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DN.%26aulast%3DMizuno%26aufirst%3DT.%26aulast%3DYoriki%26aufirst%3DR.%26aulast%3DKashizuka%26aufirst%3DH.%26aulast%3DYane%26aufirst%3DK.%26aulast%3DTsushima%26aufirst%3DF.%26aulast%3DOtsuki%26aufirst%3DN.%26aulast%3DYagita%26aufirst%3DH.%26aulast%3DAzuma%26aufirst%3DM.%26aulast%3DNakajima%26aufirst%3DY.%26atitle%3DClinical%2520Significance%2520of%2520Programmed%2520Death-1%2520Ligand-1%2520and%2520Programmed%2520Death-1%2520Ligand-2%2520Expression%2520in%2520Human%2520Esophageal%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2947%26epage%3D2953%26doi%3D10.1158%2F1078-0432.CCR-04-1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Butterworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overduin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, A. J.</span><span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatase SHP2 for Therapeutic Intervention</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+Protein+Tyrosine+Phosphatase+SHP2+for+Therapeutic+Intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0lj9ki8hy4H0tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520for%2520Therapeutic%2520Intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Scott, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1843</span><span class="NLM_x">–</span> <span class="NLM_lpage">1862</span><span class="refDoi"> DOI: 10.2174/138161210791209027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.2174%2F138161210791209027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=20337577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1ClsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1843-1862&author=L.+M.+Scottauthor=H.+R.+Lawrenceauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Targeting+Protein+Tyrosine+Phosphatases+for+Anticancer+Drug+Discovery&doi=10.2174%2F138161210791209027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatases for anticancer drug discovery</span></div><div class="casAuthors">Scott, Latanya M.; Lawrence, Harshani R.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1843-1862</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases (PTPs) are a diverse family of enzymes encoded by 107 genes in the human genome.  Together with protein tyrosine kinases (PTKs), PTPs regulate various cellular activities essential for the initiation and maintenance of malignant phenotypes.  While PTK inhibitors are now used routinely for cancer treatment, the PTP inhibitor development field is still in the discovery phase.  In this article, the suitability of targeting PTPs for novel anticancer drug discovery is discussed.  Examples are presented for PTPs that have been targeted for anticancer drug discovery as well as potential new PTP targets for novel anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHuBrNeSP0n7Vg90H21EOLACvtfcHk0lj9ki8hy4H0tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1ClsLY%253D&md5=17813d1fba0225fd5e54692b1159bc4a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138161210791209027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210791209027%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BM.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatases%2520for%2520Anticancer%2520Drug%2520Discovery%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D1843%26epage%3D1862%26doi%3D10.2174%2F138161210791209027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Small Molecule Tools for Functional Interrogation of Protein Tyrosine Phosphatases</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2012.08718.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1111%2Fj.1742-4658.2012.08718.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=22816879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=731-750&author=R.+Heauthor=L.-F.+Zengauthor=Y.+Heauthor=S.+Zhangauthor=Z.-Y.+Zhang&title=Small+Molecule+Tools+for+Functional+Interrogation+of+Protein+Tyrosine+Phosphatases&doi=10.1111%2Fj.1742-4658.2012.08718.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule tools for functional interrogation of protein tyrosine phosphatases</span></div><div class="casAuthors">He, Rongjun; Zeng, Li-Fan; He, Yantao; Zhang, Sheng; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">731-750</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The importance of protein tyrosine phosphatases (PTPs) in the regulation of cellular signalling is well established.  Malfunction of PTP activity is also known to be assocd. with cancer, metabolic syndromes and autoimmune disorders, as well as neurodegenerative and infectious diseases.  However, a detailed understanding of the roles played by the PTPs in normal physiol. and in pathogenic conditions has been hampered by the absence of PTP-specific small mol. agents.  In addn., the therapeutic benefits of modulating this target class are underexplored as a result of a lack of suitable chem. probes.  Potent and specific PTP inhibitors could significantly facilitate functional anal. of the PTPs in complex cellular signal transduction pathways and may constitute valuable therapeutics in the treatment of several human diseases.  We highlight the current challenges to and opportunities for developing PTP-specific small mol. agents.  We also review available selective small mol. inhibitors developed for a no. of PTPs, including PTP1B, TC-PTP, SHP2, lymphoid-specific tyrosine phosphatase, hematopoietic protein tyrosine phosphatase, CD45, PTPβ, PTPγ, PTPRO, Vaccinia H1-related phosphatase, mitogen-activated protein kinase phosphatase-1, mitogen-activated protein kinase phosphatase-3, Cdc25, YopH, mPTPA and mPTPB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokl-YBrjLX1bVg90H21EOLACvtfcHk0lj9ki8hy4H0tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7Y%253D&md5=a30f63b9e20bcff3b00bf61e77a95bce</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08718.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08718.x%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSmall%2520Molecule%2520Tools%2520for%2520Functional%2520Interrogation%2520of%2520Protein%2520Tyrosine%2520Phosphatases%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D731%26epage%3D750%26doi%3D10.1111%2Fj.1742-4658.2012.08718.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrsosine Phosphatase-2 (SHP2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2482</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span><span class="refDoi"> DOI: 10.1021/jm901645u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-2493&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.+X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawanauthor=L.+Wangauthor=R.+J.+Chanauthor=Z.+Y.+Zhang&title=Salicylic+Acid+Based+Small+Molecule+Inhibitor+for+the+Oncogenic+Src+Homology-2+Domain+Containing+Protein+Tyrsosine+Phosphatase-2+%28SHP2%29&doi=10.1021%2Fjm901645u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)</span></div><div class="casAuthors">Zhang, Xian; He, Yantao; Liu, Sijiu; Yu, Zhihong; Jiang, Zhong-Xing; Yang, Zhenyun; Dong, Yuanshu; Nabinger, Sarah C.; Wu, Li; Gunawan, Andrea M.; Wang, Lina; Chan, Rebecca J.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2482-2493</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol.-2 domain contg. protein tyrosine phosphatase-2 (SHP2) plays a pivotal role in growth factor and cytokine signaling.  Gain-of-function SHP2 mutations are assocd. with Noonan syndrome, various kinds of leukemias, and solid tumors.  Thus, there is considerable interest in SHP2 as a potential target for anticancer and antileukemia therapy.  We report a salicylic acid based combinatorial library approach aimed at binding both active site and unique nearby subpockets for enhanced affinity and selectivity.  Screening of the library led to the identification of a SHP2 inhibitor II-B08 (compd. 9) with highly efficacious cellular activity.  Compd. 9 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation, providing supporting evidence that chem. inhibition of SHP2 may be therapeutically useful for anticancer and antileukemia treatment.  X-ray crystallog. anal. of the structure of SHP2 in complex with 9 reveals mol. determinants that can be exploited for the acquisition of more potent and selective SHP2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC82T5JpCRArVg90H21EOLACvtfcHk0lgOXooHh-CrCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D&md5=6f87897eda38ea485dc08e189f1b5ca8</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DSalicylic%2520Acid%2520Based%2520Small%2520Molecule%2520Inhibitor%2520for%2520the%2520Oncogenic%2520Src%2520Homology-2%2520Domain%2520Containing%2520Protein%2520Tyrsosine%2520Phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D2493%26doi%3D10.1021%2Fjm901645u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zeng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mali, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6594</span><span class="NLM_x">–</span> <span class="NLM_lpage">6609</span><span class="refDoi"> DOI: 10.1021/jm5006176</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006176" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6594-6609&author=L.+F.+Zengauthor=R.+Y.+Zhangauthor=Z.+H.+Yuauthor=S.+Liauthor=L.+Wuauthor=A.+M.+Gunawanauthor=B.+S.+Laneauthor=R.+S.+Maliauthor=X.+Liauthor=R.+J.+Chanauthor=R.+Kapurauthor=C.+D.+Wellsauthor=Z.+Y.+Zhang&title=Therapeutic+Potential+of+Targeting+the+Oncogenic+SHP2+Phosphatase&doi=10.1021%2Fjm5006176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase</span></div><div class="casAuthors">Zeng, Li-Fan; Zhang, Ruo-Yu; Yu, Zhi-Hong; Li, Sijiu; Wu, Li; Gunawan, Andrea M.; Lane, Brandon S.; Mali, Raghuveer S.; Li, Xingjun; Chan, Rebecca J.; Kapur, Reuben; Wells, Clark D.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6594-6609</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol. 2 domain contg. protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase assocd. with various kinds of leukemia and solid tumors.  Thus, there is substantial interest in developing SHP2 inhibitors as potential anticancer and antileukemia agents.  Using a structure-guided and fragment-based library approach, we identified a novel hydroxyindole carboxylic acid-based SHP2 inhibitor (I), with an IC50 value of 200 nM and greater than 5-fold selectivity against 20 mammalian PTPs.  Structural and modeling studies reveal that the hydroxyindole carboxylic acid anchors the inhibitor to the SHP2 active site, while interactions of the oxalamide linker and the phenylthiophene tail with residues in the β5-β6 loop contribute to I's binding potency and selectivity.  Evidence suggests that I specifically attenuates the SHP2-dependent signaling inside the cell.  Moreover, I blocks growth factor mediated Erk1/2 and Akt activation and exhibits excellent antiproliferative activity in lung cancer and breast cancer as well as leukemia cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ko-q4-PSXbVg90H21EOLACvtfcHk0lgOXooHh-CrCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtrvO&md5=ac8e5359387e614782c95c02f32fd97d</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm5006176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006176%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%2BF.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DYu%26aufirst%3DZ.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DLane%26aufirst%3DB.%2BS.%26aulast%3DMali%26aufirst%3DR.%2BS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DKapur%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DC.%2BD.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DTherapeutic%2520Potential%2520of%2520Targeting%2520the%2520Oncogenic%2520SHP2%2520Phosphatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6594%26epage%3D6609%26doi%3D10.1021%2Fjm5006176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bunda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heir, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alamsahebpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raught, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadeh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohh, M.</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8859</span><span class="refDoi"> DOI: 10.1038/ncomms9859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fncomms9859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=26617336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bunda%2C+S.%3B+Burrell%2C+K.%3B+Heir%2C+P.%3B+Zeng%2C+L.%3B+Alamsahebpour%2C+A.%3B+Kano%2C+Y.%3B+Raught%2C+B.%3B+Zhang%2C+Z.+Y.%3B+Zadeh%2C+G.%3B+Ohh%2C+M.Nat.+Commun.+2015%2C+6%2C+8859+10.1038%2Fncomms9859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis</span></div><div class="casAuthors">Bunda, Severa; Burrell, Kelly; Heir, Pardeep; Zeng, Lifan; Alamsahebpour, Amir; Kano, Yoshihito; Raught, Brian; Zhang, Zhong-Yin; Zadeh, Gelareh; Ohh, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8859</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ras is phosphorylated on a conserved tyrosine at position 32 within the switch I region via Src kinase.  This phosphorylation inhibits the binding of effector Raf while promoting the engagement of GTPase-activating protein (GAP) and GTP hydrolysis.  Here we identify SHP2 as the ubiquitously expressed tyrosine phosphatase that preferentially binds to and dephosphorylates Ras to increase its assocn. with Raf and activate downstream proliferative Ras/ERK/MAPK signalling.  In comparison to normal astrocytes, SHP2 activity is elevated in astrocytes isolated from glioblastoma multiforme (GBM)-prone H-Ras(12V) knock-in mice as well as in glioma cell lines and patient-derived GBM specimens exhibiting hyperactive Ras.  Pharmacol. inhibition of SHP2 activity attenuates cell proliferation, soft-agar colony formation and orthotopic GBM growth in NOD/SCID mice and decelerates the progression of low-grade astrocytoma to GBM in a spontaneous transgenic glioma mouse model.  These results identify SHP2 as a direct activator of Ras and a potential therapeutic target for cancers driven by a previously 'undruggable' oncogenic or hyperactive Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhWi25AJiphrVg90H21EOLACvtfcHk0lgOXooHh-CrCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP&md5=8524ad9cc6f2e85abaff6b07c698f464</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1038%2Fncomms9859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9859%26sid%3Dliteratum%253Aachs%26aulast%3DBunda%26aufirst%3DS.%26aulast%3DBurrell%26aufirst%3DK.%26aulast%3DHeir%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAlamsahebpour%26aufirst%3DA.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26aulast%3DZadeh%26aufirst%3DG.%26aulast%3DOhh%26aufirst%3DM.%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8859%26doi%3D10.1038%2Fncomms9859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gilmartin, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faitg, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seefeld, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federowicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaworski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnamon, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Allosteric WIP1 Phosphatase Inhibition Through Flap-Subdomain Interaction</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span><span class="refDoi"> DOI: 10.1038/nchembio.1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fnchembio.1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=24390428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=181-187&author=A.+G.+Gilmartinauthor=T.+H.+Faitgauthor=M.+Richterauthor=A.+Groyauthor=M.+A.+Seefeldauthor=M.+G.+Darcyauthor=X.+Pengauthor=K.+Federowiczauthor=J.+Yangauthor=S.+Y.+Zhangauthor=E.+Minthornauthor=J.+P.+Jaworskiauthor=M.+Schaberauthor=S.+Martensauthor=D.+E.+McNultyauthor=R.+H.+Sinnamonauthor=H.+Zhangauthor=R.+B.+Kirkpatrickauthor=N.+Nevinsauthor=G.+Cuiauthor=B.+Pietrakauthor=E.+Diazauthor=A.+Jonesauthor=M.+Brandtauthor=B.+Schwartzauthor=D.+A.+Heerdingauthor=R.+Kumar&title=Allosteric+WIP1+Phosphatase+Inhibition+Through+Flap-Subdomain+Interaction&doi=10.1038%2Fnchembio.1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction</span></div><div class="casAuthors">Gilmartin, Aidan G.; Faitg, Thomas H.; Richter, Mark; Groy, Arthur; Seefeld, Mark A.; Darcy, Michael G.; Peng, Xin; Federowicz, Kelly; Yang, Jingsong; Zhang, Shu-Yun; Minthorn, Elisabeth; Jaworski, Jon-Paul; Schaber, Michael; Martens, Stan; McNulty, Dean E.; Sinnamon, Robert H.; Zhang, Hong; Kirkpatrick, Robert B.; Nevins, Neysa; Cui, Guanglei; Pietrak, Beth; Diaz, Elsie; Jones, Amber; Brandt, Martin; Schwartz, Benjamin; Heerding, Dirk A.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-187</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although therapeutic interventions of signal-transduction cascades with targeted kinase inhibitors are a well-established strategy, drug-discovery efforts to identify targeted phosphatase inhibitors have proven challenging.  Herein we report a series of allosteric, small-mol. inhibitors of wild-type p53-induced phosphatase (Wip1), an oncogenic phosphatase common to multiple cancers.  Compd. binding to Wip1 is dependent on a 'flap' subdomain located near the Wip1 catalytic site that renders Wip1 structurally divergent from other members of the protein phosphatase 2C (PP2C) family and that thereby confers selectivity for Wip1 over other phosphatases.  Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of Wip1 substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53.  Oral administration of Wip1 inhibitors in mice results in expected pharmacodynamic effects and causes inhibition of lymphoma xenograft growth.  To our knowledge, GSK2830371 is the first orally active, allosteric inhibitor of Wip1 phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jXZXKTKTL7Vg90H21EOLACvtfcHk0liqcFij2GgvnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D&md5=47524caa70df233fb152a2d683417e7d</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1427%26sid%3Dliteratum%253Aachs%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DFaitg%26aufirst%3DT.%2BH.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DSeefeld%26aufirst%3DM.%2BA.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFederowicz%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DS.%2BY.%26aulast%3DMinthorn%26aufirst%3DE.%26aulast%3DJaworski%26aufirst%3DJ.%2BP.%26aulast%3DSchaber%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DSinnamon%26aufirst%3DR.%2BH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DAllosteric%2520WIP1%2520Phosphatase%2520Inhibition%2520Through%2520Flap-Subdomain%2520Interaction%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D181%26epage%3D187%26doi%3D10.1038%2Fnchembio.1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chio, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, A. C.</span><span> </span><span class="NLM_article-title">Rational Design of Allosteric-Inhibition Sites in Classical Protein Tyrosine Phosphatases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2828</span><span class="NLM_x">–</span> <span class="NLM_lpage">2838</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.bmc.2015.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=25828055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVWhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2828-2838&author=C.+M.+Chioauthor=X.+Yuauthor=A.+C.+Bishop&title=Rational+Design+of+Allosteric-Inhibition+Sites+in+Classical+Protein+Tyrosine+Phosphatases&doi=10.1016%2Fj.bmc.2015.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases</span></div><div class="casAuthors">Chio, Cynthia M.; Yu, Xiaoling; Bishop, Anthony C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2828-2838</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs), which catalyze the dephosphorylation of phosphotyrosine in protein substrates, are crit. regulators of metazoan cell signaling and have emerged as potential drug targets for a range of human diseases.  Strategies for chem. targeting the function of individual PTPs selectively could serve to elucidate the signaling roles of these enzymes and would potentially expedite validation of the therapeutic promise of PTP inhibitors.  Here we report a novel strategy for the design of non-natural allosteric-inhibition sites in PTPs; these sites, which can be introduced into target PTPs through protein engineering, serve to sensitize target PTPs to potent and selective inhibition by a biarsenical small mol.  Building on the recent discovery of a naturally occurring cryptic allosteric site in wild-type Src-homol.-2 domain contg. PTP (Shp2) that can be targeted by biarsenical compds., we hypothesized that Shp2's unusual sensitivity to biarsenicals could be strengthened through rational design and that the Shp2-specific site could serve as a blueprint for the introduction of non-natural inhibitor sensitivity in other PTPs.  Indeed, we show here that the strategic introduction of a cysteine residue at a position removed from the Shp2 active site can serve to increase the potency and selectivity of the interaction between Shp2's allosteric site and the biarsenical inhibitor.  Moreover, we find that 'Shp2-like' allosteric sites can be installed de novo in PTP enzymes that do not possess naturally occurring sensitivity to biarsenical compds.  Using primary-sequence alignments to guide our enzyme engineering, we have successfully introduced allosteric-inhibition sites in four classical PTPs-PTP1B, PTPH-1, FAP-1, and HePTP-from four different PTP subfamilies, suggesting that our sensitization approach can likely be applied widely across the classical PTP family to generate biarsenical-responsive PTPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwDXbkv2RdC7Vg90H21EOLACvtfcHk0liqcFij2GgvnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVWhs7s%253D&md5=14a48e70c722a586a2e3ccb3fa9006ae</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DC.%2BM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DBishop%26aufirst%3DA.%2BC.%26atitle%3DRational%2520Design%2520of%2520Allosteric-Inhibition%2520Sites%2520in%2520Classical%2520Protein%2520Tyrosine%2520Phosphatases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2828%26epage%3D2838%26doi%3D10.1016%2Fj.bmc.2015.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Schneider, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beumer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span> </span><span class="NLM_article-title">Selective Detection of Allosteric Phosphatase Inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">6838</span><span class="NLM_x">–</span> <span class="NLM_lpage">6841</span><span class="refDoi"> DOI: 10.1021/ja4030484</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4030484" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlWhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=6838-6841&author=R.+Schneiderauthor=C.+Beumerauthor=J.+R.+Simardauthor=C.+Grutterauthor=D.+Rauh&title=Selective+Detection+of+Allosteric+Phosphatase+Inhibitors&doi=10.1021%2Fja4030484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Detection of Allosteric Phosphatase Inhibitors</span></div><div class="casAuthors">Schneider, Ralf; Beumer, Claudia; Simard, Jeffrey R.; Gruetter, Christian; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6838-6841</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Normal cellular function, such as signal transduction, is largely controlled by the reversible phosphorylation of cellular proteins catalyzed by two major classes of enzymes, kinases and phosphatases.  A misbalance in this complex and dynamic interplay leads to a variety of severe diseases, such as cancer, inflammation, or autoimmune diseases.  This makes kinases as well as phosphatases equally attractive targets for therapeutic manipulation by small mols.  While the development of kinase inhibitors has resulted in several blockbuster drugs, such as imatinib, with remarkable success in the clinic and sales of many billions of U.S. dollars per yr, not a single phosphatase inhibitor has yet been approved for clin. use.  Similar to the kinase world, substrate-competitive phosphatase inhibitors have been developed but were not suitable for further development into clin. candidates due to their charge and limited selectivity.  Research efforts, therefore, have shifted to the exploitation of allosteric sites that can regulate phosphatase activity and may enable the discovery of novel modulators of phosphatase activity with much improved pharmacol. properties.  However, assay systems, which enable the straightforward discovery of these inhibitor types, are missing.  Here, we present a novel binding assay capable of detecting ligands of an allosteric pocket of the protein tyrosine phosphatase 1B.  This assay is suitable for high-throughput screening and selectively detects ligands which bind to this unique site with a clear discrimination from substrate-competitive ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMMpcm8RfGWrVg90H21EOLACvtfcHk0lgJIM1OjCdhsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlWhtbk%253D&md5=49a980ad7f749718803f1afe1d8d1a04</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Fja4030484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4030484%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DBeumer%26aufirst%3DC.%26aulast%3DSimard%26aufirst%3DJ.%2BR.%26aulast%3DGrutter%26aufirst%3DC.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DSelective%2520Detection%2520of%2520Allosteric%2520Phosphatase%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D6838%26epage%3D6841%26doi%3D10.1021%2Fja4030484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Chen, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaMarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fekkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Fortanet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labonte, l.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slisz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, P. D.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">535</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-152&author=Y.+P.+Chenauthor=M.+J.+LaMarcheauthor=P.+Fekkesauthor=J.+Garcia-Fortanetauthor=M.+Ackerauthor=H.+Chanauthor=Z.+Chenauthor=Z.+Dengauthor=F.+Feiauthor=B.+Firestoneauthor=M.+Fodorauthor=H.+Gaoauthor=S.+Hoauthor=K.+Hsiaoauthor=Z.+Kangauthor=N.+Keenauthor=l.+Labonteauthor=S.+Liuauthor=M.+Meyerauthor=M.+Puauthor=E.+Priceauthor=T.+Ramseyauthor=J.+Sliszauthor=P.+Wangauthor=G.+Yangauthor=J.+Zhangauthor=P.+Zhuauthor=W.+R.+Sellersauthor=T.+Stamsauthor=P.+D.+Fortin&title=Allosteric+inhibition+of+SHP2+phosphatase+inhibits+cancers+driven+by+receptor+tyrosine+kinases&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 μM), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0lgJIM1OjCdhsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BP.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarcia-Fortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DF.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLabonte%26aufirst%3Dl.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%2520phosphatase%2520inhibits%2520cancers%2520driven%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D152%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Chen, C. H.-T.; Chen, Z.; Fortanet, J. G.; Grunenfelder, D.; Karki, R.; Kato, M.; Lamarche, M. J.; Perez, L. B.; Stams, T. M.; Williams, S.</span><span> </span><span class="NLM_article-title">Preparation of 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrrolidine derivatives for inhibiting the activity of SHP2</span>. International Patent WO2015107493,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+H.-T.+Chen&author=Z.+Chen&author=J.+G.+Fortanet&author=D.+Grunenfelder&author=R.+Karki&author=M.+Kato&author=M.+J.+Lamarche&author=L.+B.+Perez&author=T.+M.+Stams&author=S.+Williams&title=Preparation+of+1-pyridazin-%2Ftriazin-3-yl-piper%28-azine%29%2Fidine%2Fpyrrolidine+derivatives+for+inhibiting+the+activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26atitle%3DPreparation%2520of%25201-pyridazin-%252Ftriazin-3-yl-piper%2528-azine%2529%252Fidine%252Fpyrrolidine%2520derivatives%2520for%2520inhibiting%2520the%2520activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gee, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalgat, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaubert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latham, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugland, R. P.</span><span> </span><span class="NLM_article-title">Fluorogenic Substrates Based on Fluorinated Umbelliferones for Continuous Assays of Phosphatases and Beta-Galactosidases</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="refDoi"> DOI: 10.1006/abio.1999.4202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1006%2Fabio.1999.4202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10452797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1Wktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1999&pages=41&author=K.+R.+Geeauthor=W.+C.+Sunauthor=M.+K.+Bhalgatauthor=R.+H.+Upsonauthor=D.+H.+Klaubertauthor=K.+A.+Lathamauthor=R.+P.+Haugland&title=Fluorogenic+Substrates+Based+on+Fluorinated+Umbelliferones+for+Continuous+Assays+of+Phosphatases+and+Beta-Galactosidases&doi=10.1006%2Fabio.1999.4202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorogenic Substrates Based on Fluorinated Umbelliferones for Continuous Assays of Phosphatases and β-Galactosidases</span></div><div class="casAuthors">Gee, Kyle R.; Sun, Wei-Chuan; Bhalgat, Mahesh K.; Upson, Rosalyn H.; Klaubert, Dieter H.; Latham, Katherine A.; Haugland, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Fluorogenic substrates based on 4-methylumbelliferone (4-MU) have been widely used for the detection of phosphatase and glycosidase activities.  One disadvantage of these substrates, however, is that max. fluorescence of the reaction product requires an alk. pH, since 4-MU has a pKa ≈ 8.  In an initial screening of five phosphatase substrates based on fluorinated derivs. of 4-MU, all with pKa values lower than that of 4-MU, we found that one substrate, 6,8-difluoro-4-methylumbelliferyl phosphate (DiFMUP), was much improved for the detection of acid phosphatase activity.  When measured at the preferred acid phosphatase reaction pH (5.0), DiFMUP yielded fluorescence signals that were more than 10-fold higher than those of 4-methylumbelliferyl phosphate (MUP).  DiFMUP was also superior to MUP for the detection of protein phosphatase 1 activity at pH 7 and was just as sensitive as MUP for the detection of alk. phosphatase activity at pH 10.  A β-galactosidase substrate was also prepd. based on 6,8-difluoro-4-methylumbelliferone.  This substrate, 6,8-difluoro-4-methylumbelliferyl β-D-galactopyranoside (DiFMUG), was found to be considerably more sensitive than the commonly used substrate 4-methylumbelliferyl β-D-galactopyranoside (MUG), for the detection of β-galactosidase activity at pH 7.  DiFMUP and DiFMUG should have great utility for the continuous assay of phosphatase and β-galactosidase activity, resp., at neutral and acid pH.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZOR_jnhxiLrVg90H21EOLACvtfcHk0ljZs5w7RK-PIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1Wktbs%253D&md5=879424dc5f8830990218385ccb9d8fe0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4202%26sid%3Dliteratum%253Aachs%26aulast%3DGee%26aufirst%3DK.%2BR.%26aulast%3DSun%26aufirst%3DW.%2BC.%26aulast%3DBhalgat%26aufirst%3DM.%2BK.%26aulast%3DUpson%26aufirst%3DR.%2BH.%26aulast%3DKlaubert%26aufirst%3DD.%2BH.%26aulast%3DLatham%26aufirst%3DK.%2BA.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26atitle%3DFluorogenic%2520Substrates%2520Based%2520on%2520Fluorinated%2520Umbelliferones%2520for%2520Continuous%2520Assays%2520of%2520Phosphatases%2520and%2520Beta-Galactosidases%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D273%26spage%3D41%26doi%3D10.1006%2Fabio.1999.4202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">SHP2 activation has been extensively reviewed:</p></div><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Revealing Mechanisms for SH2 Domain Mediated Regulation of the Protein Tyrosine Phosphatase SHP-2</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/S0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+Mechanisms+for+SH2+Domain+Mediated+Regulation+of+the+Protein+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2FS0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0ljZs5w7RK-PIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520Mechanisms%2520for%2520SH2%2520Domain%2520Mediated%2520Regulation%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254%26doi%3D10.1016%2FS0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The Tyrosine Phosphatase SHP2 (PTPN11) in Cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span><span class="refDoi"> DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-182&author=G.+Chanauthor=+Kalaitzidisauthor=B.+G.+Neel&title=The+Tyrosine+Phosphatase+SHP2+%28PTPN11%29+in+Cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0ljZs5w7RK-PIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520Tyrosine%2520Phosphatase%2520SHP2%2520%2528PTPN11%2529%2520in%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D182%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Poole, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. L.</span><span> </span><span class="NLM_article-title">A SHPing Tale: Perspectives on the Regulation of SHP-1 and SHP-2 Tyrosine Phosphatases by the C-terminal Tail</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1323</span><span class="NLM_x">–</span> <span class="NLM_lpage">1332</span><span class="refDoi"> DOI: 10.1016/j.cellsig.2005.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.cellsig.2005.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=16084691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptVWnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=1323-1332&author=A.+W.+Pooleauthor=M.+L.+Jones&title=A+SHPing+Tale%3A+Perspectives+on+the+Regulation+of+SHP-1+and+SHP-2+Tyrosine+Phosphatases+by+the+C-terminal+Tail&doi=10.1016%2Fj.cellsig.2005.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">A SHPing tale: Perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail</span></div><div class="casAuthors">Poole, Alastair W.; Jones, Matthew L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1323-1332</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphorylation is a ubiquitous signaling mechanism and is regulated by a balance between the action of kinases and phosphatases.  The SH2 domain-contg. phosphatases, SHP-1 and SHP-2, are the best studied of the classical non-receptor tyrosine phosphatases, but it is intriguing that despite their close sequence and structural homol. these 2 phosphatases play quite different cellular roles.  In particular, whereas SHP-1 plays a largely neg. signaling role suppressing cellular activation, SHP-2 plays a largely pos. signaling role.  Major sequence differences between the 2 mols. are apparent in the ∼100 amino acid residues at the extreme C-terminus of the proteins, beyond the phosphatase catalytic domain.  Here, the authors review how the differences in the tails of these proteins may regulate their activities and explain some of their functional differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQNdG8bGaIjLVg90H21EOLACvtfcHk0lhmCujGI2BlqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptVWnsLY%253D&md5=2980ba96216967f7b89fb347415199c4</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DPoole%26aufirst%3DA.%2BW.%26aulast%3DJones%26aufirst%3DM.%2BL.%26atitle%3DA%2520SHPing%2520Tale%253A%2520Perspectives%2520on%2520the%2520Regulation%2520of%2520SHP-1%2520and%2520SHP-2%2520Tyrosine%2520Phosphatases%2520by%2520the%2520C-terminal%2520Tail%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D1323%26epage%3D1332%26doi%3D10.1016%2Fj.cellsig.2005.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Butterworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overduin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, A. J.</span><span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatase SHP2 for Therapeutic Intervention</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+Protein+Tyrosine+Phosphatase+SHP2+for+Therapeutic+Intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0lhmCujGI2BlqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520for%2520Therapeutic%2520Intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Clare, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanos, M. A.</span><span> </span><span class="NLM_article-title">Voltage-Gated Sodium Channels as Therapeutic Targets</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1016/S1359-6446(00)01570-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS1359-6446%2800%2901570-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=11084387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVKqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=506-520&author=J.+J.+Clareauthor=S.+N.+Tateauthor=M.+Nobbsauthor=M.+A.+Romanos&title=Voltage-Gated+Sodium+Channels+as+Therapeutic+Targets&doi=10.1016%2FS1359-6446%2800%2901570-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channels as therapeutic targets</span></div><div class="casAuthors">Clare, J. J.; Tate, S. N.; Nobbs, M.; Romanos, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">506-520</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 60 refs. Voltage-gated sodium channels (VGSCs) play a central role in the generation and propagation of action potentials in neurons and other cells.  VGSC modulators have their origins in empirical pharmacol. and are being used as local anesthetics, antiarrhythmics, analgesics and antiepileptics, and for other disorders.  However, the identification of a multigene family of VGSCs, along with tools to study the different subtypes in pathophysiol., is now providing a rational basis for selective intervention.  Recent advances have addressed the tech. challenges of expressing and assaying these complex proteins, enabling the correlation of empirical pharmacol. with subtypes and the screening of individual subtypes for novel inhibitors with increased potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptiZ3aRMaOo7Vg90H21EOLACvtfcHk0lhmCujGI2BlqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVKqtL0%253D&md5=484b625c930128754c2c679bd127a944</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2800%2901570-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252800%252901570-1%26sid%3Dliteratum%253Aachs%26aulast%3DClare%26aufirst%3DJ.%2BJ.%26aulast%3DTate%26aufirst%3DS.%2BN.%26aulast%3DNobbs%26aufirst%3DM.%26aulast%3DRomanos%26aufirst%3DM.%2BA.%26atitle%3DVoltage-Gated%2520Sodium%2520Channels%2520as%2520Therapeutic%2520Targets%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2000%26volume%3D5%26spage%3D506%26epage%3D520%26doi%3D10.1016%2FS1359-6446%2800%2901570-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Large, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinichev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carignani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartori, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruffo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span> </span><span class="NLM_article-title">The Relationship Between Sodium Channel Inhibition and Anticonvulsant Activity in a Model of Generalised Seizure in the Rat</span> <span class="citation_source-journal">Epilepsy Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1016/j.eplepsyres.2009.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.eplepsyres.2009.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=19329281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1eqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=96-106&author=C.+H.+Largeauthor=M.+Kalinichevauthor=A.+Lucasauthor=C.+Carignaniauthor=A.+Bradfordauthor=N.+Garbatiauthor=I.+Sartoriauthor=N.+E.+Austinauthor=A.+Ruffoauthor=D.+N.+C.+Jonesauthor=G.+Alvaroauthor=K.+D.+Read&title=The+Relationship+Between+Sodium+Channel+Inhibition+and+Anticonvulsant+Activity+in+a+Model+of+Generalised+Seizure+in+the+Rat&doi=10.1016%2Fj.eplepsyres.2009.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the rat</span></div><div class="casAuthors">Large, Charles H.; Kalinichev, Mikhail; Lucas, Adam; Carignani, Corrado; Bradford, Andrea; Garbati, Nicoletta; Sartori, Ilaria; Austin, Nigel E.; Ruffo, Alberto; Jones, Declan N. C.; Alvaro, Giuseppe; Read, Kevin D.</div><div class="citationInfo"><span class="NLM_cas:title">Epilepsy Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-106</span>CODEN:
                <span class="NLM_cas:coden">EPIRE8</span>;
        ISSN:<span class="NLM_cas:issn">0920-1211</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Summary: The development of novel anticonvulsant drugs with improved efficacy for the treatment of epilepsy is hindered by a lack of information regarding the quant. relationship between target mechanism and in vivo efficacy.  In the present study we have examd. the correlation between the potency of structurally diverse compds. at voltage-gated sodium channels in vitro and their efficacy in a rodent model of acute generalised seizures induced by electroshock.  We obsd. a significant correlation between the estd. affinity (Ki) of the compds. for the inactivated state of human recombinant NaV1.2 channels and the unbound brain concn. required for anticonvulsant efficacy.  Furthermore, the data suggest that an unbound concn. equiv. to less than 50% of the Ki is sufficient for anticonvulsant effect.  We noted that increasing sodium channel blocking potency was assocd. with increasing brain tissue binding and lipophilicity.  These data suggest that there is a balance between sodium channel blocking potency in vitro and good pharmacokinetic characteristics necessary for anticonvulsant efficacy in vivo.  Finally, we examd. the sodium channel blocking potency of sodium valproate in relation to its anticonvulsant efficacy in vivo.  We found that a higher unbound concn. of the drug in the brain was required for anticonvulsant efficacy than would be expected given its sodium channel blocking potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ9SvFTQSLj7Vg90H21EOLACvtfcHk0ljfvLI2JyzBlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1eqs7g%253D&md5=6efa4dd1f79ea320cff094315a4c9efd</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1016%2Fj.eplepsyres.2009.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eplepsyres.2009.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DLarge%26aufirst%3DC.%2BH.%26aulast%3DKalinichev%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DA.%26aulast%3DCarignani%26aufirst%3DC.%26aulast%3DBradford%26aufirst%3DA.%26aulast%3DGarbati%26aufirst%3DN.%26aulast%3DSartori%26aufirst%3DI.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DRuffo%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%2BN.%2BC.%26aulast%3DAlvaro%26aufirst%3DG.%26aulast%3DRead%26aufirst%3DK.%2BD.%26atitle%3DThe%2520Relationship%2520Between%2520Sodium%2520Channel%2520Inhibition%2520and%2520Anticonvulsant%2520Activity%2520in%2520a%2520Model%2520of%2520Generalised%2520Seizure%2520in%2520the%2520Rat%26jtitle%3DEpilepsy%2520Res.%26date%3D2009%26volume%3D85%26spage%3D96%26epage%3D106%26doi%3D10.1016%2Fj.eplepsyres.2009.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Patani, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a Rationale Approach in Drug Design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span><span class="refDoi"> DOI: 10.1021/cr950066q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Pataniauthor=E.+J.+Lavoie&title=Bioisosterism%3A+a+Rationale+Approach+in+Drug+Design&doi=10.1021%2Fcr950066q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26aulast%3DLavoie%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520Rationale%2520Approach%2520in%2520Drug%2520Design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176%26doi%3D10.1021%2Fcr950066q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">For example:</p></div><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Burger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiguchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindval, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beans, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span> </span><span class="NLM_article-title">Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span><span class="refDoi"> DOI: 10.1021/ml400307j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400307j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1193-1197&author=M.+T.+Burgerauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=C.+Bellamacinaauthor=M.+Lindvalauthor=G.+Atallahauthor=Y.+Dingauthor=M.+Mathurauthor=C.+McBrideauthor=E.+L.+Beansauthor=K.+Mullerauthor=V.+Tamezauthor=Y.+Zhangauthor=K.+Huhauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Holashauthor=J.+Castilloauthor=J.+Langowskiauthor=Y.+Wangauthor=M.+Y.+Chenauthor=P.+D.+Garcia&title=Structure+Guided+Optimization%2C+in+Vitro+Activity%2C+and+in+Vivo+Activity+of+Pan-PIM+Kinase+Inhibitors&doi=10.1021%2Fml400307j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors</span></div><div class="casAuthors">Burger, Matthew T.; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele; Bellamacina, Cornelia; Lindval, Mika; Atallah, Gordana; Ding, Yu; Mathur, Michelle; McBride, Chris; Beans, Elizabeth L.; Muller, Kristine; Tamez, Victoriano; Zhang, Yanchen; Huh, Kay; Feucht, Paul; Zavorotinskaya, Tatiana; Dai, Yumin; Holash, Jocelyn; Castillo, Joseph; Langowski, John; Wang, Yingyun; Chen, Min Y.; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1193-1197</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proviral insertion of Moloney virus (PIM) 1, 2, and 3 kinases are serine/threonine kinases that normally function in survival and proliferation of hematopoietic cells.  As high expression of PIM1, 2, and 3 is frequently obsd. in many human malignancies, including multiple myeloma, non-Hodgkins lymphoma, and myeloid leukemias, there is interest in detg. whether selective PIM inhibition can improve outcomes of these human cancers.  Herein, we describe our efforts toward this goal.  The structure guided optimization of a singleton high throughput screening hit in which the potency against all three PIM isoforms was increased >10,000-fold to yield compds. (e.g., I) with pan PIM Kis < 10 pM, nanomolar cellular potency, and in vivo activity in an acute myeloid leukemia Pim-dependent tumor model is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw9BIpeJhw1rVg90H21EOLACvtfcHk0liJZS7cHFlmIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nK&md5=f4644a2ad9bcd35c952676e492eb3b71</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fml400307j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400307j%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindval%26aufirst%3DM.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DMcBride%26aufirst%3DC.%26aulast%3DBeans%26aufirst%3DE.%2BL.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DStructure%2520Guided%2520Optimization%252C%2520in%2520Vitro%2520Activity%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520Pan-PIM%2520Kinase%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1193%26epage%3D1197%26doi%3D10.1021%2Fml400307j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eriksson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höglund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhagen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleskog, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekholm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fhölenhag, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löthgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scobie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrow, V.</span><span> </span><span class="NLM_article-title">Identification of AKN-032, a Novel 2-Aminopyrazine Tyrosine Kinase Inhibitor, with Significant Preclinical Activity in Acute Myeloid Leukemia</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1507</span><span class="NLM_x">–</span> <span class="NLM_lpage">1516</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.bcp.2010.08.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1507-1516&author=A.+L.+Erikssonauthor=M.+H%C3%B6glundauthor=E.+Lindhagenauthor=A.+Aleskogauthor=S.+B.+Hassanauthor=C.+Ekholmauthor=K.+Fh%C3%B6lenhagauthor=A.+J.+Jensenauthor=A.+L%C3%B6thgrenauthor=M.+Scobieauthor=R.+Larssonauthor=V.+Parrow&title=Identification+of+AKN-032%2C+a+Novel+2-Aminopyrazine+Tyrosine+Kinase+Inhibitor%2C+with+Significant+Preclinical+Activity+in+Acute+Myeloid+Leukemia&doi=10.1016%2Fj.bcp.2010.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DA.%2BL.%26aulast%3DH%25C3%25B6glund%26aufirst%3DM.%26aulast%3DLindhagen%26aufirst%3DE.%26aulast%3DAleskog%26aufirst%3DA.%26aulast%3DHassan%26aufirst%3DS.%2BB.%26aulast%3DEkholm%26aufirst%3DC.%26aulast%3DFh%25C3%25B6lenhag%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DA.%2BJ.%26aulast%3DL%25C3%25B6thgren%26aufirst%3DA.%26aulast%3DScobie%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DParrow%26aufirst%3DV.%26atitle%3DIdentification%2520of%2520AKN-032%252C%2520a%2520Novel%25202-Aminopyrazine%2520Tyrosine%2520Kinase%2520Inhibitor%252C%2520with%2520Significant%2520Preclinical%2520Activity%2520in%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1507%26epage%3D1516%26doi%3D10.1016%2Fj.bcp.2010.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubbon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Aminopyrazine Derivatives as Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5402</span><span class="NLM_x">–</span> <span class="NLM_lpage">5408</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.bmcl.2015.09.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5402-5408&author=S.+Linauthor=S.+Malkaniauthor=M.+Lombardoauthor=Y.+Yangauthor=S.+G.+Millsauthor=K.+Chapmanauthor=J.+E.+Thompsonauthor=W.+X.+Zhangauthor=R.+Wangauthor=R.+M.+Cubbonauthor=E.+A.+O%E2%80%99Neillauthor=J.+J.+Hale&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Aminopyrazine+Derivatives+as+Inhibitors+of+Mitogen-Activated+Protein+Kinase-Activated+Protein+Kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2015.09.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DMalkani%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DW.%2BX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DCubbon%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Aminopyrazine%2520Derivatives%2520as%2520Inhibitors%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Activated%2520Protein%2520Kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5402%26epage%3D5408%26doi%3D10.1016%2Fj.bmcl.2015.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Artursson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavelin, S.</span><span> </span><span class="NLM_article-title">Caco-2 and Emerging Alternatives for Prediction of Intestinal Drug Transport: A General Overview</span> <span class="citation_source-journal">Methods Princ. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1002/3527601473.ch4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1002%2F3527601473.ch4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=72-82&author=P.+Arturssonauthor=S.+Tavelin&title=Caco-2+and+Emerging+Alternatives+for+Prediction+of+Intestinal+Drug+Transport%3A+A+General+Overview&doi=10.1002%2F3527601473.ch4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1002%2F3527601473.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F3527601473.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DTavelin%26aufirst%3DS.%26atitle%3DCaco-2%2520and%2520Emerging%2520Alternatives%2520for%2520Prediction%2520of%2520Intestinal%2520Drug%2520Transport%253A%2520A%2520General%2520Overview%26jtitle%3DMethods%2520Princ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D18%26spage%3D72%26epage%3D82%26doi%3D10.1002%2F3527601473.ch4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ungell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J.</span><span> </span><span class="NLM_article-title">Cell Cultures in Drug Discovery: an Industrial Perspective. Methods and Principles in Medicinal Chemistry</span> <span class="citation_source-journal">Drug Bioavailability: Estimation of Solubility, Permeability, Absorption, and Bioavailability</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1002/3527601473.ch5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1002%2F3527601473.ch5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=90-131&author=A.+Ungellauthor=J.+Karlsson&title=Cell+Cultures+in+Drug+Discovery%3A+an+Industrial+Perspective.+Methods+and+Principles+in+Medicinal+Chemistry&doi=10.1002%2F3527601473.ch5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1002%2F3527601473.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F3527601473.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DUngell%26aufirst%3DA.%26aulast%3DKarlsson%26aufirst%3DJ.%26atitle%3DCell%2520Cultures%2520in%2520Drug%2520Discovery%253A%2520an%2520Industrial%2520Perspective.%2520Methods%2520and%2520Principles%2520in%2520Medicinal%2520Chemistry%26jtitle%3DDrug%2520Bioavailability%253A%2520Estimation%2520of%2520Solubility%252C%2520Permeability%252C%2520Absorption%252C%2520and%2520Bioavailability%26date%3D2003%26volume%3D18%26spage%3D90%26epage%3D131%26doi%3D10.1002%2F3527601473.ch5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0ljQcDG5PT0dMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER, version 2.8.0; <span class="NLM_publisher-name">Global Phasing Ltd</span>, <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Devlopment of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Devlopment+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Devlopment%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b','cit4c'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10a','cit10b'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c'],'ref15':['cit15a','cit15b','cit15c'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b','cit19c','cit19d'],'ref20':['cit20a','cit20b'],'ref21':['cit21'],'ref22':['cit22a','cit22b','cit22c'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 105 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yelena Mostinski, Guus J. J. E. Heynen, Maria Pascual López-Alberca, Jerome Paul, Sandra Miksche, Silke Radetzki, David Schaller, Elena Shanina, Carola Seyffarth, Yuliya Kolomeets, Nandor Ziebart, Judith de Schryver, Sylvia Oestreich, Martin Neuenschwander, Yvette Roske, Udo Heinemann, Christoph Rademacher, Andrea Volkamer, Jens Peter von Kries, Walter Birchmeier, <span class="NLM_string-name hlFld-ContribAuthor">Marc Nazaré</span>. </span><span class="cited-content_cbyCitation_article-title">From Pyrazolones to Azaindoles: Evolution of Active-Site SHP2 Inhibitors Based on Scaffold Hopping and Bioisosteric Replacement. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14780-14804. <a href="https://doi.org/10.1021/acs.jmedchem.0c01265" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01265</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01265&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01265%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BPyrazolones%252Bto%252BAzaindoles%25253A%252BEvolution%252Bof%252BActive-Site%252BSHP2%252BInhibitors%252BBased%252Bon%252BScaffold%252BHopping%252Band%252BBioisosteric%252BReplacement%26aulast%3DMostinski%26aufirst%3DYelena%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28072020%26date%3D19112020%26volume%3D63%26issue%3D23%26spage%3D14780%26epage%3D14804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Matthew J. LaMarche, Michael Acker, Andreea Argintaru, Daniel Bauer, Julie Boisclair, Homan Chan, Christine Hiu-Tung Chen, Ying-Nan Chen, Zhouliang Chen, Zhan Deng, Michael Dore, David Dunstan, Jianmei Fan, Peter Fekkes, Brant Firestone, Michelle Fodor, Jorge Garcia-Fortanet, Pascal D. Fortin, Cary Fridrich, John Giraldes, Meir Glick, Denise Grunenfelder, Huia-Xiang Hao, Martin Hentemann, Samuel Ho, Andriana Jouk, Zhao B. Kang, Rajesh Karki, Mitsunori Kato, Nick Keen, Robert Koenig, Laura R. LaBonte, Jay Larrow, Gang Liu, Shumei Liu, Dyuti Majumdar, Simon Mathieu, Matthew J. Meyer, Morvarid Mohseni, Rukundo Ntaganda, Mark Palermo, Lawrence Perez, Minying Pu, Timothy Ramsey, John Reilly, Patrick Sarver, William R. Sellers, Martin Sendzik, Michael D. Shultz, Joanna Slisz, Kelly Slocum, Troy Smith, Stanley Spence, Travis Stams, Christopher Straub, Victoriano Tamez, Jr., Bakary-Barry Toure, Christopher Towler, Ping Wang, Hongyun Wang, Sarah L. Williams, Fan Yang, Bing Yu, Ji-Hu Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Suzanne Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of TNO155, an Allosteric SHP2 Inhibitor for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (22)
                                     , 13578-13594. <a href="https://doi.org/10.1021/acs.jmedchem.0c01170" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01170%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BTNO155%25252C%252Ban%252BAllosteric%252BSHP2%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DLaMarche%26aufirst%3DMatthew%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07072020%26date%3D24092020%26date%3D10092020%26volume%3D63%26issue%3D22%26spage%3D13578%26epage%3D13594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christina E. M. Schindler, Hannah Baumann, Andreas Blum, Dietrich Böse, Hans-Peter Buchstaller, Lars Burgdorf, Daniel Cappel, Eugene Chekler, Paul Czodrowski, Dieter Dorsch, Merveille K. I. Eguida, Bruce Follows, Thomas Fuchß, Ulrich Grädler, Jakub Gunera, Theresa Johnson, Catherine Jorand Lebrun, Srinivasa Karra, Markus Klein, Tim Knehans, Lisa Koetzner, Mireille Krier, Matthias Leiendecker, Birgitta Leuthner, Liwei Li, Igor Mochalkin, Djordje Musil, Constantin Neagu, Friedrich Rippmann, Kai Schiemann, Robert Schulz, Thomas Steinbrecher, Eva-Maria Tanzer, Andrea Unzue Lopez, Ariele Viacava Follis, Ansgar Wegener, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Kuhn</span>. </span><span class="cited-content_cbyCitation_article-title">Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (11)
                                     , 5457-5474. <a href="https://doi.org/10.1021/acs.jcim.0c00900" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00900%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DLarge-Scale%252BAssessment%252Bof%252BBinding%252BFree%252BEnergy%252BCalculations%252Bin%252BActive%252BDrug%252BDiscovery%252BProjects%26aulast%3DSchindler%26aufirst%3DChristina%2BE.%2BM.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D07082020%26date%3D03092020%26date%3D19082020%26volume%3D60%26issue%3D11%26spage%3D5457%26epage%3D5474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xinrui Yuan, Hong Bu, Jinpei Zhou, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Huibin Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of SHP2 Inhibitors in Cancer Therapy: Current Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (20)
                                     , 11368-11396. <a href="https://doi.org/10.1021/acs.jmedchem.0c00249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00249%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bof%252BSHP2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BCurrent%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D10062020%26date%3D27052020%26volume%3D63%26issue%3D20%26spage%3D11368%26epage%3D11396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bingsong Han, Francesco G. Salituro, <span class="NLM_string-name hlFld-ContribAuthor">Maria-Jesus Blanco</span>. </span><span class="cited-content_cbyCitation_article-title">Impact of Allosteric Modulation in Drug Discovery: Innovation in Emerging Chemical Modalities. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (10)
                                     , 1810-1819. <a href="https://doi.org/10.1021/acsmedchemlett.9b00655" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00655%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImpact%252Bof%252BAllosteric%252BModulation%252Bin%252BDrug%252BDiscovery%25253A%252BInnovation%252Bin%252BEmerging%252BChemical%252BModalities%26aulast%3DHan%26aufirst%3DBingsong%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D26122019%26date%3D10032020%26date%3D20032020%26date%3D10032020%26volume%3D11%26issue%3D10%26spage%3D1810%26epage%3D1819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mingliang Wang, Jianfeng Lu, Mi Wang, Chao-Yie Yang, <span class="NLM_string-name hlFld-ContribAuthor">Shaomeng Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of SHP2-D26 as a First, Potent, and Effective PROTAC Degrader of SHP2 Protein. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7510-7528. <a href="https://doi.org/10.1021/acs.jmedchem.0c00471" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00471</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00471%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSHP2-D26%252Bas%252Ba%252BFirst%25252C%252BPotent%25252C%252Band%252BEffective%252BPROTAC%252BDegrader%252Bof%252BSHP2%252BProtein%26aulast%3DWang%26aufirst%3DMingliang%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D20032020%26date%3D21052020%26volume%3D63%26issue%3D14%26spage%3D7510%26epage%3D7528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Maja Köhn</span>. </span><span class="cited-content_cbyCitation_article-title">Turn and Face the Strange: A New View on Phosphatases. </span><span class="cited-content_cbyCitation_journal-name">ACS Central Science</span><span> <strong>2020,</strong> <em>6 </em>
                                    (4)
                                     , 467-477. <a href="https://doi.org/10.1021/acscentsci.9b00909" title="DOI URL">https://doi.org/10.1021/acscentsci.9b00909</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscentsci.9b00909&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscentsci.9b00909%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Central%2520Science%26atitle%3DTurn%252Band%252BFace%252Bthe%252BStrange%25253A%252BA%252BNew%252BView%252Bon%252BPhosphatases%26aulast%3DK%25C3%25B6hn%26aufirst%3DMaja%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D09092019%26date%3D13032020%26volume%3D6%26issue%3D4%26spage%3D467%26epage%3D477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chul Soon Park, Kazuki Iwabata, Uma Sridhar, Michael Tsuei, Khushboo Singh, Young-Ki Kim, S. Thayumanavan, <span class="NLM_string-name hlFld-ContribAuthor">Nicholas L. Abbott</span>. </span><span class="cited-content_cbyCitation_article-title">A New Strategy for Reporting Specific Protein Binding Events at Aqueous–Liquid Crystal Interfaces in the Presence of Non-Specific Proteins. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2020,</strong> <em>12 </em>
                                    (7)
                                     , 7869-7878. <a href="https://doi.org/10.1021/acsami.9b16867" title="DOI URL">https://doi.org/10.1021/acsami.9b16867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.9b16867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.9b16867%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DA%252BNew%252BStrategy%252Bfor%252BReporting%252BSpecific%252BProtein%252BBinding%252BEvents%252Bat%252BAqueous%2525E2%252580%252593Liquid%252BCrystal%252BInterfaces%252Bin%252Bthe%252BPresence%252Bof%252BNon-Specific%252BProteins%26aulast%3DPark%26aufirst%3DChul%2BSoon%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D17092019%26date%3D11122019%26date%3D07022020%26date%3D11122019%26volume%3D12%26issue%3D7%26spage%3D7869%26epage%3D7878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jeffrey
T. Bagdanoff, Zhouliang Chen, Michael Acker, Ying-Nan Chen, Homan Chan, Michael Dore, Brant Firestone, Michelle Fodor, Jorge Fortanet, Murphy Hentemann, Mitsunori Kato, Robert Koenig, Laura R. LaBonte, Shumei Liu, Movarid Mohseni, Rukundo Ntaganda, Patrick Sarver, Troy Smith, Martin Sendzik, Travis Stams, Stan Spence, Christopher Towler, Hongyun Wang, Ping Wang, Sarah L. Williams, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. LaMarche</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of Fused Bicyclic Allosteric SHP2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1781-1792. <a href="https://doi.org/10.1021/acs.jmedchem.8b01725" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01725</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01725&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01725%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252BFused%252BBicyclic%252BAllosteric%252BSHP2%252BInhibitors%26aulast%3DBagdanoff%26aufirst%3DJeffrey%2BT.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D05112018%26date%3D08022019%26date%3D28012019%26volume%3D62%26issue%3D4%26spage%3D1781%26epage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Patrick Sarver, Michael Acker, Jeffrey T. Bagdanoff, Zhouliang Chen, Ying-Nan Chen, Homan Chan, Brant Firestone, Michelle Fodor, Jorge Fortanet, Huaixiang Hao, Murphy Hentemann, Mitsunori Kato, Robert Koenig, Laura R. LaBonte, Gang Liu, Shumei Liu, Chen Liu, Eric McNeill, Morvarid Mohseni, Martin Sendzik, Travis Stams, Stan Spence, Victoriano Tamez, Ritesh Tichkule, Christopher Towler, Hongyun Wang, Ping Wang, Sarah L. Williams, Bing Yu, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. LaMarche</span>. </span><span class="cited-content_cbyCitation_article-title">6-Amino-3-methylpyrimidinones as Potent, Selective, and Orally Efficacious SHP2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1793-1802. <a href="https://doi.org/10.1021/acs.jmedchem.8b01726" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01726</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01726&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01726%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Amino-3-methylpyrimidinones%252Bas%252BPotent%25252C%252BSelective%25252C%252Band%252BOrally%252BEfficacious%252BSHP2%252BInhibitors%26aulast%3DSarver%26aufirst%3DPatrick%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D05112018%26date%3D16022019%26date%3D28012019%26volume%3D62%26issue%3D4%26spage%3D1793%26epage%3D1802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xiaoqin Wu, Gang Xu, Xiaobo Li, Weiren Xu, Qianjin Li, Wei Liu, Karen A. Kirby, Mignon L. Loh, Jun Li, Stefan G. Sarafianos, <span class="NLM_string-name hlFld-ContribAuthor">Cheng-Kui Qu</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecule Inhibitor that Stabilizes the Autoinhibited Conformation of the Oncogenic Tyrosine Phosphatase SHP2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (3)
                                     , 1125-1137. <a href="https://doi.org/10.1021/acs.jmedchem.8b00513" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00513</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00513&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00513%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall%252BMolecule%252BInhibitor%252Bthat%252BStabilizes%252Bthe%252BAutoinhibited%252BConformation%252Bof%252Bthe%252BOncogenic%252BTyrosine%252BPhosphatase%252BSHP2%26aulast%3DWu%26aufirst%3DXiaoqin%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D01042018%26date%3D05122018%26date%3D20112018%26volume%3D62%26issue%3D3%26spage%3D1125%26epage%3D1137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michael
K. Hjortness, Laura Riccardi, Akarawin Hongdusit, Alex Ruppe, Mengxia Zhao, Edward Y. Kim, Peter H. Zwart, Banumathi Sankaran, Haribabu Arthanari, Marcelo C. Sousa, Marco De Vivo, <span class="NLM_string-name hlFld-ContribAuthor">Jerome M. Fox</span>. </span><span class="cited-content_cbyCitation_article-title">Abietane-Type Diterpenoids Inhibit Protein Tyrosine Phosphatases by Stabilizing an Inactive Enzyme Conformation. </span><span class="cited-content_cbyCitation_journal-name">Biochemistry</span><span> <strong>2018,</strong> <em>57 </em>
                                    (40)
                                     , 5886-5896. <a href="https://doi.org/10.1021/acs.biochem.8b00655" title="DOI URL">https://doi.org/10.1021/acs.biochem.8b00655</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.biochem.8b00655&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.biochem.8b00655%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemistry%26atitle%3DAbietane-Type%252BDiterpenoids%252BInhibit%252BProtein%252BTyrosine%252BPhosphatases%252Bby%252BStabilizing%252Ban%252BInactive%252BEnzyme%252BConformation%26aulast%3DHjortness%26aufirst%3DMichael%2BK.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15062018%26date%3D14082018%26date%3D14092018%26date%3D31082018%26volume%3D57%26issue%3D40%26spage%3D5886%26epage%3D5896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Michelle Fodor, Edmund Price, Ping Wang, Hengyu Lu, Andreea Argintaru, Zhouliang Chen, Meir Glick, Huai-Xiang Hao, Mitsunori Kato, Robert Koenig, Jonathan R. LaRochelle, Gang Liu, Eric McNeill, Dyuti Majumdar, Gisele A. Nishiguchi, Lawrence B. Perez, Gregory Paris, Christopher M. Quinn, Timothy Ramsey, Martin Sendzik, Michael David Shultz, Sarah L. Williams, Travis Stams, Stephen C. Blacklow, Michael G. Acker, <span class="NLM_string-name hlFld-ContribAuthor">Matthew J. LaMarche</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Allosteric Inhibition of SHP2 Phosphatase. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2018,</strong> <em>13 </em>
                                    (3)
                                     , 647-656. <a href="https://doi.org/10.1021/acschembio.7b00980" title="DOI URL">https://doi.org/10.1021/acschembio.7b00980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.7b00980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.7b00980%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDual%252BAllosteric%252BInhibition%252Bof%252BSHP2%252BPhosphatase%26aulast%3DFodor%26aufirst%3DMichelle%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D16112017%26date%3D05012018%26date%3D18012018%26date%3D05012018%26volume%3D13%26issue%3D3%26spage%3D647%26epage%3D656" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhi-Hong  Yu</span> and <span class="hlFld-ContribAuthor ">Zhong-Yin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2018,</strong> <em>118 </em>
                                    (3)
                                     , 1069-1091. <a href="https://doi.org/10.1021/acs.chemrev.7b00105" title="DOI URL">https://doi.org/10.1021/acs.chemrev.7b00105</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.7b00105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.7b00105%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRegulatory%252BMechanisms%252Band%252BNovel%252BTherapeutic%252BTargeting%252BStrategies%252Bfor%252BProtein%252BTyrosine%252BPhosphatases%26aulast%3DYu%26aufirst%3DZhi-Hong%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D23022017%26date%3D25052017%26date%3D14022018%26volume%3D118%26issue%3D3%26spage%3D1069%26epage%3D1091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingjing  Xie</span>, <span class="hlFld-ContribAuthor ">Xiaojia  Si</span>, <span class="hlFld-ContribAuthor ">Shoulai  Gu</span>, <span class="hlFld-ContribAuthor ">Mingliang  Wang</span>, <span class="hlFld-ContribAuthor ">Jian  Shen</span>, <span class="hlFld-ContribAuthor ">Haoyan  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Shen</span>, <span class="hlFld-ContribAuthor ">Dan  Li</span>, <span class="hlFld-ContribAuthor ">Yanjia  Fang</span>, <span class="hlFld-ContribAuthor ">Cong  Liu</span>, and <span class="hlFld-ContribAuthor ">Jidong  Zhu</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Inhibitors of SHP2 with Therapeutic Potential for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (24)
                                     , 10205-10219. <a href="https://doi.org/10.1021/acs.jmedchem.7b01520" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01520%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BInhibitors%252Bof%252BSHP2%252Bwith%252BTherapeutic%252BPotential%252Bfor%252BCancer%252BTreatment%26aulast%3DXie%26aufirst%3DJingjing%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11102017%26date%3D07122017%26date%3D28122017%26date%3D20112017%26volume%3D60%26issue%3D24%26spage%3D10205%26epage%3D10219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Fahs</span>, <span class="hlFld-ContribAuthor ">Pablo  Lujan</span>, and <span class="hlFld-ContribAuthor ">Maja  Köhn</span>  . </span><span class="cited-content_cbyCitation_article-title">Approaches to Study Phosphatases. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2016,</strong> <em>11 </em>
                                    (11)
                                     , 2944-2961. <a href="https://doi.org/10.1021/acschembio.6b00570" title="DOI URL">https://doi.org/10.1021/acschembio.6b00570</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.6b00570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.6b00570%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DApproaches%252Bto%252BStudy%252BPhosphatases%26aulast%3DFahs%26aufirst%3DSara%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01072016%26date%3D12092016%26date%3D04102016%26date%3D18112016%26volume%3D11%26issue%3D11%26spage%3D2944%26epage%3D2961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph M.  Salamoun</span> and <span class="hlFld-ContribAuthor ">Peter  Wipf</span>  . </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Phosphatase Activity May Redefine Therapeutic Value. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 7771-7772. <a href="https://doi.org/10.1021/acs.jmedchem.6b01210" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01210%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulation%252Bof%252BPhosphatase%252BActivity%252BMay%252BRedefine%252BTherapeutic%252BValue%26aulast%3DSalamoun%26aufirst%3DJoseph%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D10082016%26date%3D19082016%26date%3D08092016%26volume%3D59%26issue%3D17%26spage%3D7771%26epage%3D7772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Umair  Majeed</span>, <span class="hlFld-ContribAuthor ">Rami  Manochakian</span>, <span class="hlFld-ContribAuthor ">Yujie  Zhao</span>, <span class="hlFld-ContribAuthor ">Yanyan  Lou</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted therapy in advanced non-small cell lung cancer: current advances and future trends. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-021-01121-2" title="DOI URL">https://doi.org/10.1186/s13045-021-01121-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-021-01121-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-021-01121-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DTargeted%252Btherapy%252Bin%252Badvanced%252Bnon-small%252Bcell%252Blung%252Bcancer%25253A%252Bcurrent%252Badvances%252Band%252Bfuture%252Btrends%26aulast%3DMajeed%26aufirst%3DUmair%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroyuki  Tani</span>, <span class="hlFld-ContribAuthor ">Ryo  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Tomokazu  Nagashima</span>, <span class="hlFld-ContribAuthor ">Masaki  Michishita</span>, <span class="hlFld-ContribAuthor ">Kyoichi  Tamura</span>, <span class="hlFld-ContribAuthor ">Makoto  Bonkobara</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular characterization of canine
              SHP2
              mutants and anti‐tumor effect of
              SHP2
              inhibitor,
              SHP099
              , in a xenograft mouse model of canine histiocytic sarcoma. </span><span class="cited-content_cbyCitation_journal-name">Veterinary and Comparative Oncology</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1111/vco.12751" title="DOI URL">https://doi.org/10.1111/vco.12751</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/vco.12751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fvco.12751%26sid%3Dliteratum%253Aachs%26jtitle%3DVeterinary%2520and%2520Comparative%2520Oncology%26atitle%3DMolecular%252Bcharacterization%252Bof%252Bcanine%252BSHP2%252Bmutants%252Band%252Banti%2525E2%252580%252590tumor%252Beffect%252Bof%252BSHP2%252Binhibitor%25252C%252BSHP099%252B%25252C%252Bin%252Ba%252Bxenograft%252Bmouse%252Bmodel%252Bof%252Bcanine%252Bhistiocytic%252Bsarcoma%26aulast%3DTani%26aufirst%3DHiroyuki%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuyi  Wang</span>, <span class="hlFld-ContribAuthor ">Ombretta  Salvucci</span>, <span class="hlFld-ContribAuthor ">Hidetaka  Ohnuki</span>, <span class="hlFld-ContribAuthor ">Andy D  Tran</span>, <span class="hlFld-ContribAuthor ">Taekyu  Ha</span>, <span class="hlFld-ContribAuthor ">Jing‐Xin  Feng</span>, <span class="hlFld-ContribAuthor ">Michael  DiPrima</span>, <span class="hlFld-ContribAuthor ">Hyeongil  Kwak</span>, <span class="hlFld-ContribAuthor ">Dunrui  Wang</span>, <span class="hlFld-ContribAuthor ">Yanlin  Yu</span>, <span class="hlFld-ContribAuthor ">Michael  Kruhlak</span>, <span class="hlFld-ContribAuthor ">Giovanna  Tosato</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the SHP2 phosphatase promotes vascular damage and inhibition of tumor growth. </span><span class="cited-content_cbyCitation_journal-name">EMBO Molecular Medicine</span><span> <strong>2021,</strong> <em>13 </em>
                                    (7)
                                     <a href="https://doi.org/10.15252/emmm.202114089" title="DOI URL">https://doi.org/10.15252/emmm.202114089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15252/emmm.202114089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15252%2Femmm.202114089%26sid%3Dliteratum%253Aachs%26jtitle%3DEMBO%2520Molecular%2520Medicine%26atitle%3DTargeting%252Bthe%252BSHP2%252Bphosphatase%252Bpromotes%252Bvascular%252Bdamage%252Band%252Binhibition%252Bof%252Btumor%252Bgrowth%26aulast%3DWang%26aufirst%3DYuyi%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios  Chatzigoulas</span>, <span class="hlFld-ContribAuthor ">Zoe  Cournia</span>. </span><span class="cited-content_cbyCitation_article-title">Rational design of allosteric modulators: Challenges and successes. </span><span class="cited-content_cbyCitation_journal-name">WIREs Computational Molecular Science</span><span> <strong>2021,</strong> <em>17 </em><a href="https://doi.org/10.1002/wcms.1529" title="DOI URL">https://doi.org/10.1002/wcms.1529</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1529&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1529%26sid%3Dliteratum%253Aachs%26jtitle%3DWIREs%2520Computational%2520Molecular%2520Science%26atitle%3DRational%252Bdesign%252Bof%252Ballosteric%252Bmodulators%25253A%252BChallenges%252Band%252Bsuccesses%26aulast%3DChatzigoulas%26aufirst%3DAlexios%26date%3D2021%26date%3D2021%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Guo</span>, <span class="hlFld-ContribAuthor ">Yaping  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>, <span class="hlFld-ContribAuthor ">Jianjun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Cross the Undruggable Barrier, the Development of SHP2 Inhibitors: From Catalytic Site Inhibitors to Allosteric Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (22)
                                     , 5504-5523. <a href="https://doi.org/10.1002/slct.202100186" title="DOI URL">https://doi.org/10.1002/slct.202100186</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100186&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100186%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DCross%252Bthe%252BUndruggable%252BBarrier%25252C%252Bthe%252BDevelopment%252Bof%252BSHP2%252BInhibitors%25253A%252BFrom%252BCatalytic%252BSite%252BInhibitors%252Bto%252BAllosteric%252BInhibitors%26aulast%3DGuo%26aufirst%3DYu%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D22%26spage%3D5504%26epage%3D5523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyanki  Kalita</span>, <span class="hlFld-ContribAuthor ">Shashank Sekhar  Shukla</span>, <span class="hlFld-ContribAuthor ">Ranjan K.  Singh</span>, <span class="hlFld-ContribAuthor ">Ayon  Bhattacharjee</span>. </span><span class="cited-content_cbyCitation_article-title">Potential liquid crystal-based biosensor depending on the interaction between liquid crystals and proteins. </span><span class="cited-content_cbyCitation_journal-name">Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy</span><span> <strong>2021,</strong> <em>254 </em>, 119634. <a href="https://doi.org/10.1016/j.saa.2021.119634" title="DOI URL">https://doi.org/10.1016/j.saa.2021.119634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.saa.2021.119634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.saa.2021.119634%26sid%3Dliteratum%253Aachs%26jtitle%3DSpectrochimica%2520Acta%2520Part%2520A%253A%2520Molecular%2520and%2520Biomolecular%2520Spectroscopy%26atitle%3DPotential%252Bliquid%252Bcrystal-based%252Bbiosensor%252Bdepending%252Bon%252Bthe%252Binteraction%252Bbetween%252Bliquid%252Bcrystals%252Band%252Bproteins%26aulast%3DKalita%26aufirst%3DPriyanki%26date%3D2021%26volume%3D254%26spage%3D119634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D. Lucas  Kerr</span>, <span class="hlFld-ContribAuthor ">Franziska  Haderk</span>, <span class="hlFld-ContribAuthor ">Trever G.  Bivona</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric SHP2 inhibitors in cancer: Targeting the intersection of RAS, resistance, and the immune microenvironment. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Chemical Biology</span><span> <strong>2021,</strong> <em>62 </em>, 1-12. <a href="https://doi.org/10.1016/j.cbpa.2020.11.007" title="DOI URL">https://doi.org/10.1016/j.cbpa.2020.11.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cbpa.2020.11.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cbpa.2020.11.007%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Chemical%2520Biology%26atitle%3DAllosteric%252BSHP2%252Binhibitors%252Bin%252Bcancer%25253A%252BTargeting%252Bthe%252Bintersection%252Bof%252BRAS%25252C%252Bresistance%25252C%252Band%252Bthe%252Bimmune%252Bmicroenvironment%26aulast%3DKerr%26aufirst%3DD.%2BLucas%26date%3D2021%26volume%3D62%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiangbo  Yang</span>, <span class="hlFld-ContribAuthor ">Zhijia  Wang</span>, <span class="hlFld-ContribAuthor ">Yuan  Pei</span>, <span class="hlFld-ContribAuthor ">Ning  Song</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Bo  Feng</span>, <span class="hlFld-ContribAuthor ">Hanlin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaobei  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Qiu</span>, <span class="hlFld-ContribAuthor ">Huijin  Feng</span>, <span class="hlFld-ContribAuthor ">Yaxi  Yang</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113341. <a href="https://doi.org/10.1016/j.ejmech.2021.113341" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113341</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113341%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthalidomide-based%252BPROTAC%252Bsmall%252Bmolecules%252Bas%252Bthe%252Bhighly%252Befficient%252BSHP2%252Bdegraders%26aulast%3DYang%26aufirst%3DXiangbo%26date%3D2021%26volume%3D218%26spage%3D113341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Bingxue  Qu</span>, <span class="hlFld-ContribAuthor ">Haiyan  Yang</span>, <span class="hlFld-ContribAuthor ">Shengquan  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">If small molecules immunotherapy comes, can the prime be far behind?. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113356. <a href="https://doi.org/10.1016/j.ejmech.2021.113356" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113356%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIf%252Bsmall%252Bmolecules%252Bimmunotherapy%252Bcomes%25252C%252Bcan%252Bthe%252Bprime%252Bbe%252Bfar%252Bbehind%25253F%26aulast%3DZhang%26aufirst%3DJingyu%26date%3D2021%26volume%3D218%26spage%3D113356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erin  Sheffels</span>, <span class="hlFld-ContribAuthor ">Robert L.  Kortum</span>. </span><span class="cited-content_cbyCitation_article-title">The Role of Wild-Type RAS in Oncogenic RAS Transformation. </span><span class="cited-content_cbyCitation_journal-name">Genes</span><span> <strong>2021,</strong> <em>12 </em>
                                    (5)
                                     , 662. <a href="https://doi.org/10.3390/genes12050662" title="DOI URL">https://doi.org/10.3390/genes12050662</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/genes12050662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fgenes12050662%26sid%3Dliteratum%253Aachs%26jtitle%3DGenes%26atitle%3DThe%252BRole%252Bof%252BWild-Type%252BRAS%252Bin%252BOncogenic%252BRAS%252BTransformation%26aulast%3DSheffels%26aufirst%3DErin%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D5%26spage%3D662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qing  Nian</span>, <span class="hlFld-ContribAuthor ">Jinhao  Zeng</span>, <span class="hlFld-ContribAuthor ">Li  He</span>, <span class="hlFld-ContribAuthor ">Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Zhang</span>, <span class="hlFld-ContribAuthor ">Fernando  Rodrigues-Lima</span>, <span class="hlFld-ContribAuthor ">Liyun  Zhao</span>, <span class="hlFld-ContribAuthor ">Xuanlin  Feng</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">A small molecule inhibitor targeting SHP2 mutations for the lung carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2021,</strong> <em>32 </em>
                                    (5)
                                     , 1645-1652. <a href="https://doi.org/10.1016/j.cclet.2021.01.002" title="DOI URL">https://doi.org/10.1016/j.cclet.2021.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2021.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2021.01.002%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DA%252Bsmall%252Bmolecule%252Binhibitor%252Btargeting%252BSHP2%252Bmutations%252Bfor%252Bthe%252Blung%252Bcarcinoma%26aulast%3DNian%26aufirst%3DQing%26date%3D2021%26volume%3D32%26issue%3D5%26spage%3D1645%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew W.  Buesking</span>, <span class="hlFld-ContribAuthor ">Patrick A.  Mayes</span>, <span class="hlFld-ContribAuthor ">Andrew P.  Combs</span>. </span><span class="cited-content_cbyCitation_article-title">Immuno‐Oncology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-30. <a href="https://doi.org/10.1002/0471266949.bmc272" title="DOI URL">https://doi.org/10.1002/0471266949.bmc272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc272%26sid%3Dliteratum%253Aachs%26atitle%3DImmuno%2525E2%252580%252590Oncology%26aulast%3DBuesking%26aufirst%3DAndrew%2BW.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D30%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ziqiao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jihong  Guan</span>, <span class="hlFld-ContribAuthor ">Shuigeng  Zhou</span>, . </span><span class="cited-content_cbyCitation_article-title">FraGAT: a fragment-oriented multi-scale graph attention model for molecular property prediction. </span><span class="cited-content_cbyCitation_journal-name">Bioinformatics</span><span> <strong>2021,</strong> <em>57 </em><a href="https://doi.org/10.1093/bioinformatics/btab195" title="DOI URL">https://doi.org/10.1093/bioinformatics/btab195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bioinformatics/btab195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbioinformatics%2Fbtab195%26sid%3Dliteratum%253Aachs%26jtitle%3DBioinformatics%26atitle%3DFraGAT%25253A%252Ba%252Bfragment-oriented%252Bmulti-scale%252Bgraph%252Battention%252Bmodel%252Bfor%252Bmolecular%252Bproperty%252Bprediction%26aulast%3DZhang%26aufirst%3DZiqiao%26date%3D2021%26date%3D2021%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vidyasiri  Vemulapalli</span>, <span class="hlFld-ContribAuthor ">Lily A  Chylek</span>, <span class="hlFld-ContribAuthor ">Alison  Erickson</span>, <span class="hlFld-ContribAuthor ">Anamarija  Pfeiffer</span>, <span class="hlFld-ContribAuthor ">Khal-Hentz  Gabriel</span>, <span class="hlFld-ContribAuthor ">Jonathan  LaRochelle</span>, <span class="hlFld-ContribAuthor ">Kartik  Subramanian</span>, <span class="hlFld-ContribAuthor ">Ruili  Cao</span>, <span class="hlFld-ContribAuthor ">Kimberley  Stegmaier</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Matthew J  LaMarche</span>, <span class="hlFld-ContribAuthor ">Michael G  Acker</span>, <span class="hlFld-ContribAuthor ">Peter K  Sorger</span>, <span class="hlFld-ContribAuthor ">Steven P  Gygi</span>, <span class="hlFld-ContribAuthor ">Stephen C  Blacklow</span>. </span><span class="cited-content_cbyCitation_article-title">Time resolved phosphoproteomics reveals scaffolding and catalysis-responsive patterns of SHP2-dependent signaling. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.7554/eLife.64251" title="DOI URL">https://doi.org/10.7554/eLife.64251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.64251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.64251%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DTime%252Bresolved%252Bphosphoproteomics%252Breveals%252Bscaffolding%252Band%252Bcatalysis-responsive%252Bpatterns%252Bof%252BSHP2-dependent%252Bsignaling%26aulast%3DVemulapalli%26aufirst%3DVidyasiri%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Dong</span>, <span class="hlFld-ContribAuthor ">Da  Han</span>, <span class="hlFld-ContribAuthor ">Xinyi  Meng</span>, <span class="hlFld-ContribAuthor ">Mengchuan  Xu</span>, <span class="hlFld-ContribAuthor ">Chuwen  Zheng</span>, <span class="hlFld-ContribAuthor ">Qin  Xia</span>. </span><span class="cited-content_cbyCitation_article-title">Activating Mutation of SHP2 Establishes a Tumorigenic Phonotype Through Cell-Autonomous and Non-Cell-Autonomous Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cell and Developmental Biology</span><span> <strong>2021,</strong> <em>9 </em><a href="https://doi.org/10.3389/fcell.2021.630712" title="DOI URL">https://doi.org/10.3389/fcell.2021.630712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fcell.2021.630712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffcell.2021.630712%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cell%2520and%2520Developmental%2520Biology%26atitle%3DActivating%252BMutation%252Bof%252BSHP2%252BEstablishes%252Ba%252BTumorigenic%252BPhonotype%252BThrough%252BCell-Autonomous%252Band%252BNon-Cell-Autonomous%252BMechanisms%26aulast%3DDong%26aufirst%3DLei%26date%3D2021%26date%3D2021%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingwei  Wu</span>, <span class="hlFld-ContribAuthor ">Weiya  Li</span>, <span class="hlFld-ContribAuthor ">Zhihui  Zheng</span>, <span class="hlFld-ContribAuthor ">Xinhua  Lu</span>, <span class="hlFld-ContribAuthor ">Huan  Zhang</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Runling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation, common feature pharmacophore model and molecular dynamics simulation studies of ethyl 4-(phenoxymethyl)-2-phenylthiazole-5-carboxylate as Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (4)
                                     , 1174-1188. <a href="https://doi.org/10.1080/07391102.2020.1726817" title="DOI URL">https://doi.org/10.1080/07391102.2020.1726817</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1726817&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1726817%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Bcommon%252Bfeature%252Bpharmacophore%252Bmodel%252Band%252Bmolecular%252Bdynamics%252Bsimulation%252Bstudies%252Bof%252Bethyl%252B4-%252528phenoxymethyl%252529-2-phenylthiazole-5-carboxylate%252Bas%252BSrc%252Bhomology-2%252Bdomain%252Bcontaining%252Bprotein%252Btyrosine%252Bphosphatase-2%252B%252528SHP2%252529%252Binhibitors%26aulast%3DWu%26aufirst%3DJingwei%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D4%26spage%3D1174%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rangan  Mitra</span>, <span class="hlFld-ContribAuthor ">Senthil R.  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Small‐Molecule Inhibitors of Shp2 Phosphatase as Potential Chemotherapeutic Agents for Glioblastoma: A Minireview. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 777-787. <a href="https://doi.org/10.1002/cmdc.202000706" title="DOI URL">https://doi.org/10.1002/cmdc.202000706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000706%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSmall%2525E2%252580%252590Molecule%252BInhibitors%252Bof%252BShp2%252BPhosphatase%252Bas%252BPotential%252BChemotherapeutic%252BAgents%252Bfor%252BGlioblastoma%25253A%252BA%252BMinireview%26aulast%3DMitra%26aufirst%3DRangan%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D777%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Yong  Feng</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Zhao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing-Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Hua  Lu</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the mechanism of the potent allosteric inhibitor compound2 on SHP2 WT and SHP2F285S by molecular dynamics study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2021,</strong> <em>103 </em>, 107807. <a href="https://doi.org/10.1016/j.jmgm.2020.107807" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107807%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DExploring%252Bthe%252Bmechanism%252Bof%252Bthe%252Bpotent%252Ballosteric%252Binhibitor%252Bcompound2%252Bon%252BSHP2%252BWT%252Band%252BSHP2F285S%252Bby%252Bmolecular%252Bdynamics%252Bstudy%26aulast%3DZhou%26aufirst%3DLiang%26date%3D2021%26volume%3D103%26spage%3D107807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rati Kailash Prasad  Tripathi</span>, <span class="hlFld-ContribAuthor ">Senthil Raja  Ayyannan</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging chemical scaffolds with potential SHP2 phosphatase inhibitory capabilities – A comprehensive review. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2021,</strong> <em>97 </em>
                                    (3)
                                     , 721-773. <a href="https://doi.org/10.1111/cbdd.13807" title="DOI URL">https://doi.org/10.1111/cbdd.13807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.13807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.13807%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DEmerging%252Bchemical%252Bscaffolds%252Bwith%252Bpotential%252BSHP2%252Bphosphatase%252Binhibitory%252Bcapabilities%252B%2525E2%252580%252593%252BA%252Bcomprehensive%252Breview%26aulast%3DTripathi%26aufirst%3DRati%2BKailash%2BPrasad%26date%3D2021%26date%3D2020%26volume%3D97%26issue%3D3%26spage%3D721%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Liu</span>, <span class="hlFld-ContribAuthor ">Shan  Gao</span>, <span class="hlFld-ContribAuthor ">Reham M.  Elhassan</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies to overcome drug resistance using SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>27 </em><a href="https://doi.org/10.1016/j.apsb.2021.03.037" title="DOI URL">https://doi.org/10.1016/j.apsb.2021.03.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2021.03.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2021.03.037%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DStrategies%252Bto%252Bovercome%252Bdrug%252Bresistance%252Busing%252BSHP2%252Binhibitors%26aulast%3DLiu%26aufirst%3DMeng%26date%3D2021%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiaohe  Yang</span>, <span class="hlFld-ContribAuthor ">Yali  Wang</span>, <span class="hlFld-ContribAuthor ">Yueying  Yang</span>, <span class="hlFld-ContribAuthor ">Dejuan  Sun</span>, <span class="hlFld-ContribAuthor ">Hua  Li</span>, <span class="hlFld-ContribAuthor ">Lixia  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a therapeutic strategy for inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113264. <a href="https://doi.org/10.1016/j.ejmech.2021.113264" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113264</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113264%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Btherapeutic%252Bstrategy%252Bfor%252Binflammatory%252Bdiseases%26aulast%3DLiu%26aufirst%3DYang%26date%3D2021%26volume%3D214%26spage%3D113264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmine  Fedele</span>, <span class="hlFld-ContribAuthor ">Shuai  Li</span>, <span class="hlFld-ContribAuthor ">Kai Wen  Teng</span>, <span class="hlFld-ContribAuthor ">Connor J.R.  Foster</span>, <span class="hlFld-ContribAuthor ">David  Peng</span>, <span class="hlFld-ContribAuthor ">Hao  Ran</span>, <span class="hlFld-ContribAuthor ">Paolo  Mita</span>, <span class="hlFld-ContribAuthor ">Mitchell J.  Geer</span>, <span class="hlFld-ContribAuthor ">Takamitsu  Hattori</span>, <span class="hlFld-ContribAuthor ">Akiko  Koide</span>, <span class="hlFld-ContribAuthor ">Yubao  Wang</span>, <span class="hlFld-ContribAuthor ">Kwan Ho  Tang</span>, <span class="hlFld-ContribAuthor ">Joshua  Leinwand</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Brian  Diskin</span>, <span class="hlFld-ContribAuthor ">Jiehui  Deng</span>, <span class="hlFld-ContribAuthor ">Ting  Chen</span>, <span class="hlFld-ContribAuthor ">Igor  Dolgalev</span>, <span class="hlFld-ContribAuthor ">Ugur  Ozerdem</span>, <span class="hlFld-ContribAuthor ">George  Miller</span>, <span class="hlFld-ContribAuthor ">Shohei  Koide</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">Benjamin G.  Neel</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodeling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental Medicine</span><span> <strong>2021,</strong> <em>218 </em>
                                    (1)
                                     <a href="https://doi.org/10.1084/jem.20201414" title="DOI URL">https://doi.org/10.1084/jem.20201414</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1084/jem.20201414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1084%2Fjem.20201414%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520Medicine%26atitle%3DSHP2%252Binhibition%252Bdiminishes%252BKRASG12C%252Bcycling%252Band%252Bpromotes%252Btumor%252Bmicroenvironment%252Bremodeling%26aulast%3DFedele%26aufirst%3DCarmine%26date%3D2021%26date%3D2020%26volume%3D218%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Xin-hua  Lu</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Li-Peng  Li</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Jing-Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the dynamic mechanism of allosteric drug SHP099 inhibiting SHP2E69K. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>24 </em><a href="https://doi.org/10.1007/s11030-020-10179-y" title="DOI URL">https://doi.org/10.1007/s11030-020-10179-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-020-10179-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-020-10179-y%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DExploring%252Bthe%252Bdynamic%252Bmechanism%252Bof%252Ballosteric%252Bdrug%252BSHP099%252Binhibiting%252BSHP2E69K%26aulast%3DDu%26aufirst%3DShan%26date%3D2021%26date%3D2021%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhendong  Song</span>, <span class="hlFld-ContribAuthor ">Meijing  Wang</span>, <span class="hlFld-ContribAuthor ">Yang  Ge</span>, <span class="hlFld-ContribAuthor ">Xue-Ping  Chen</span>, <span class="hlFld-ContribAuthor ">Ziyang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao-Feng  Xiong</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     , 13-29. <a href="https://doi.org/10.1016/j.apsb.2020.07.010" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.07.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.07.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.07.010%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DTyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Bin%252Btumor-targeted%252Btherapies%26aulast%3DSong%26aufirst%3DZhendong%26date%3D2021%26volume%3D11%26issue%3D1%26spage%3D13%26epage%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Massimiliano  Anselmi</span>, <span class="hlFld-ContribAuthor ">Jochen S.  Hub</span>. </span><span class="cited-content_cbyCitation_article-title">An allosteric interaction controls the activation mechanism of SHP2 tyrosine phosphatase. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-020-75409-7" title="DOI URL">https://doi.org/10.1038/s41598-020-75409-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-020-75409-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-020-75409-7%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DAn%252Ballosteric%252Binteraction%252Bcontrols%252Bthe%252Bactivation%252Bmechanism%252Bof%252BSHP2%252Btyrosine%252Bphosphatase%26aulast%3DAnselmi%26aufirst%3DMassimiliano%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Quan  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Cheng  Zhao</span>, <span class="hlFld-ContribAuthor ">Xue-Qi  Fu</span>, <span class="hlFld-ContribAuthor ">Qing-Chuan  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.597495" title="DOI URL">https://doi.org/10.3389/fchem.2020.597495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.597495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.597495%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DExploring%252Bthe%252BAllosteric%252BMechanism%252Bof%252BSrc%252BHomology-2%252BDomain-Containing%252BProtein%252BTyrosine%252BPhosphatase%252B2%252B%252528SHP2%252529%252Bby%252BMolecular%252BDynamics%252BSimulations%26aulast%3DWang%26aufirst%3DQuan%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenjie  Guo</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphatase-independent functions of SHP2 and its regulation by small molecule compounds. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmacological Sciences</span><span> <strong>2020,</strong> <em>144 </em>
                                    (3)
                                     , 139-146. <a href="https://doi.org/10.1016/j.jphs.2020.06.002" title="DOI URL">https://doi.org/10.1016/j.jphs.2020.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jphs.2020.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jphs.2020.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmacological%2520Sciences%26atitle%3DPhosphatase-independent%252Bfunctions%252Bof%252BSHP2%252Band%252Bits%252Bregulation%252Bby%252Bsmall%252Bmolecule%252Bcompounds%26aulast%3DGuo%26aufirst%3DWenjie%26date%3D2020%26volume%3D144%26issue%3D3%26spage%3D139%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Tang</span>, <span class="hlFld-ContribAuthor ">Yao-Nan  Jia</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-Min  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112657. <a href="https://doi.org/10.1016/j.ejmech.2020.112657" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112657</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112657&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112657%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMedicinal%252Bchemistry%252Bstrategies%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bprotein%252Btyrosine%252Bphosphatase%252BSHP2%252Binhibitors%252Band%252BPROTAC%252Bdegraders%26aulast%3DTang%26aufirst%3DKai%26date%3D2020%26volume%3D204%26spage%3D112657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivette  Valencia-Sama</span>, <span class="hlFld-ContribAuthor ">Yagnesh  Ladumor</span>, <span class="hlFld-ContribAuthor ">Lynn  Kee</span>, <span class="hlFld-ContribAuthor ">Teresa  Adderley</span>, <span class="hlFld-ContribAuthor ">Gabriella  Christopher</span>, <span class="hlFld-ContribAuthor ">Claire M.  Robinson</span>, <span class="hlFld-ContribAuthor ">Yoshihito  Kano</span>, <span class="hlFld-ContribAuthor ">Michael  Ohh</span>, <span class="hlFld-ContribAuthor ">Meredith S.  Irwin</span>. </span><span class="cited-content_cbyCitation_article-title">NRAS
              Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS–MAPK Pathway in Neuroblastoma. </span><span class="cited-content_cbyCitation_journal-name">Cancer Research</span><span> <strong>2020,</strong> <em>80 </em>
                                    (16)
                                     , 3413-3423. <a href="https://doi.org/10.1158/0008-5472.CAN-19-3822" title="DOI URL">https://doi.org/10.1158/0008-5472.CAN-19-3822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/0008-5472.CAN-19-3822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F0008-5472.CAN-19-3822%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Research%26atitle%3DNRAS%252BStatus%252BDetermines%252BSensitivity%252Bto%252BSHP2%252BInhibitor%252BCombination%252BTherapies%252BTargeting%252Bthe%252BRAS%2525E2%252580%252593MAPK%252BPathway%252Bin%252BNeuroblastoma%26aulast%3DValencia-Sama%26aufirst%3DIvette%26date%3D2020%26date%3D2020%26volume%3D80%26issue%3D16%26spage%3D3413%26epage%3D3423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haonan  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhengquan  Gao</span>, <span class="hlFld-ContribAuthor ">Chunxiao  Meng</span>, <span class="hlFld-ContribAuthor ">Xiangqian  Li</span>, <span class="hlFld-ContribAuthor ">Dayong  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor Binding Sites in the Protein Tyrosine Phosphatase SHP-2. </span><span class="cited-content_cbyCitation_journal-name">Mini-Reviews in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (11)
                                     , 1017-1030. <a href="https://doi.org/10.2174/1389557520666200303130833" title="DOI URL">https://doi.org/10.2174/1389557520666200303130833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1389557520666200303130833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1389557520666200303130833%26sid%3Dliteratum%253Aachs%26jtitle%3DMini-Reviews%2520in%2520Medicinal%2520Chemistry%26atitle%3DInhibitor%252BBinding%252BSites%252Bin%252Bthe%252BProtein%252BTyrosine%252BPhosphatase%252BSHP-2%26aulast%3DZhang%26aufirst%3DHaonan%26date%3D2020%26volume%3D20%26issue%3D11%26spage%3D1017%26epage%3D1030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen Oi Ning  Leung</span>, <span class="hlFld-ContribAuthor ">Man  Tong</span>, <span class="hlFld-ContribAuthor ">Katherine Po Sin  Chung</span>, <span class="hlFld-ContribAuthor ">Lena  Zhou</span>, <span class="hlFld-ContribAuthor ">Noélia  Che</span>, <span class="hlFld-ContribAuthor ">Kwan Ho  Tang</span>, <span class="hlFld-ContribAuthor ">Jin  Ding</span>, <span class="hlFld-ContribAuthor ">Eunice Yuen Ting  Lau</span>, <span class="hlFld-ContribAuthor ">Irene Oi Lin  Ng</span>, <span class="hlFld-ContribAuthor ">Stephanie  Ma</span>, <span class="hlFld-ContribAuthor ">Terence Kin Wah  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Hepatology</span><span> <strong>2020,</strong> <em>72 </em>
                                    (1)
                                     , 155-168. <a href="https://doi.org/10.1002/hep.30989" title="DOI URL">https://doi.org/10.1002/hep.30989</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hep.30989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhep.30989%26sid%3Dliteratum%253Aachs%26jtitle%3DHepatology%26atitle%3DOverriding%252BAdaptive%252BResistance%252Bto%252BSorafenib%252BThrough%252BCombination%252BTherapy%252BWith%252BSrc%252BHomology%252B2%252BDomain%2525E2%252580%252593Containing%252BPhosphatase%252B2%252BBlockade%252Bin%252BHepatocellular%252BCarcinoma%26aulast%3DLeung%26aufirst%3DCarmen%2BOi%2BNing%26date%3D2020%26date%3D2020%26volume%3D72%26issue%3D1%26spage%3D155%26epage%3D168" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Bing  Yang</span>, <span class="hlFld-ContribAuthor ">Rui-Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Yang-Chun  Ma</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Shan  Du</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyridine derivatives as selective SHP2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>100 </em>, 103875. <a href="https://doi.org/10.1016/j.bioorg.2020.103875" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103875%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyridine%252Bderivatives%252Bas%252Bselective%252BSHP2%252Binhibitors%26aulast%3DLiu%26aufirst%3DWen-Shan%26date%3D2020%26volume%3D100%26spage%3D103875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen  Liu</span>, <span class="hlFld-ContribAuthor ">Ye  Yin</span>, <span class="hlFld-ContribAuthor ">Meijing  Wang</span>, <span class="hlFld-ContribAuthor ">Ting  Fan</span>, <span class="hlFld-ContribAuthor ">Yuyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Lihong  Shen</span>, <span class="hlFld-ContribAuthor ">Shuang  Peng</span>, <span class="hlFld-ContribAuthor ">Jian  Gao</span>, <span class="hlFld-ContribAuthor ">Guoliang  Deng</span>, <span class="hlFld-ContribAuthor ">Xiangbao  Meng</span>, <span class="hlFld-ContribAuthor ">Lingdong  Kong</span>, <span class="hlFld-ContribAuthor ">Gen-Sheng  Feng</span>, <span class="hlFld-ContribAuthor ">Wenjie  Guo</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Disrupting phosphatase SHP2 in macrophages protects mice from high-fat diet-induced hepatic steatosis and insulin resistance by elevating IL-18 levels. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2020,</strong> <em>295 </em>
                                    (31)
                                     , 10842-10856. <a href="https://doi.org/10.1074/jbc.RA119.011840" title="DOI URL">https://doi.org/10.1074/jbc.RA119.011840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA119.011840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA119.011840%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DDisrupting%252Bphosphatase%252BSHP2%252Bin%252Bmacrophages%252Bprotects%252Bmice%252Bfrom%252Bhigh-fat%252Bdiet-induced%252Bhepatic%252Bsteatosis%252Band%252Binsulin%252Bresistance%252Bby%252Belevating%252BIL-18%252Blevels%26aulast%3DLiu%26aufirst%3DWen%26date%3D2020%26volume%3D295%26issue%3D31%26spage%3D10842%26epage%3D10856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liyuan  Zhu</span>, <span class="hlFld-ContribAuthor ">Ruth  Roberts</span>, <span class="hlFld-ContribAuthor ">Ruili  Huang</span>, <span class="hlFld-ContribAuthor ">Jinghua  Zhao</span>, <span class="hlFld-ContribAuthor ">Menghang  Xia</span>, <span class="hlFld-ContribAuthor ">Brian  Delavan</span>, <span class="hlFld-ContribAuthor ">Mike  Mikailov</span>, <span class="hlFld-ContribAuthor ">Weida  Tong</span>, <span class="hlFld-ContribAuthor ">Zhichao  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphar.2020.00927" title="DOI URL">https://doi.org/10.3389/fphar.2020.00927</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2020.00927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2020.00927%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DDrug%252BRepositioning%252Bfor%252BNoonan%252Band%252BLEOPARD%252BSyndromes%252Bby%252BIntegrating%252BTranscriptomics%252BWith%252Ba%252BStructure-Based%252BApproach%26aulast%3DZhu%26aufirst%3DLiyuan%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-96. <a href="https://doi.org/10.1002/9781119607311.ch1" title="DOI URL">https://doi.org/10.1002/9781119607311.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BTargets%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D96%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Rui-Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Mei  Rong</span>, <span class="hlFld-ContribAuthor ">Chi-Lu  Liu</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Investigating the reason for loss-of-function of Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) caused by Y279C mutation through molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (9)
                                     , 2509-2520. <a href="https://doi.org/10.1080/07391102.2019.1634641" title="DOI URL">https://doi.org/10.1080/07391102.2019.1634641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1634641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1634641%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DInvestigating%252Bthe%252Breason%252Bfor%252Bloss-of-function%252Bof%252BSrc%252Bhomology%252B2%252Bdomain-containing%252Bprotein%252Btyrosine%252Bphosphatase%252B2%252B%252528SHP2%252529%252Bcaused%252Bby%252BY279C%252Bmutation%252Bthrough%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DLiu%26aufirst%3DWen-Shan%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D9%26spage%3D2509%26epage%3D2520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajendran  Satheeshkumar</span>, <span class="hlFld-ContribAuthor ">Rui  Zhu</span>, <span class="hlFld-ContribAuthor ">Bo  Feng</span>, <span class="hlFld-ContribAuthor ">Chao  Huang</span>, <span class="hlFld-ContribAuthor ">Ya  Gao</span>, <span class="hlFld-ContribAuthor ">Li-Xin  Gao</span>, <span class="hlFld-ContribAuthor ">Chao  Shen</span>, <span class="hlFld-ContribAuthor ">Ting-Jun  Hou</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yun-Long  Zhu</span>, <span class="hlFld-ContribAuthor ">Yu-Bo  Zhou</span>, <span class="hlFld-ContribAuthor ">Wen-Long  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of heterocyclic bis-aryl amides as novel Src homology 2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (11)
                                     , 127170. <a href="https://doi.org/10.1016/j.bmcl.2020.127170" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127170%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bheterocyclic%252Bbis-aryl%252Bamides%252Bas%252Bnovel%252BSrc%252Bhomology%252B2%252Bdomain%252Bcontaining%252Bprotein%252Btyrosine%252Bphosphatase-2%252B%252528SHP2%252529%252Binhibitors%26aulast%3DSatheeshkumar%26aufirst%3DRajendran%26date%3D2020%26volume%3D30%26issue%3D11%26spage%3D127170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David E.  Williams</span>, <span class="hlFld-ContribAuthor ">Raymond J.  Andersen</span>. </span><span class="cited-content_cbyCitation_article-title">Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2020,</strong> <em>37 </em>
                                    (5)
                                     , 617-633. <a href="https://doi.org/10.1039/C9NP00054B" title="DOI URL">https://doi.org/10.1039/C9NP00054B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9NP00054B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9NP00054B%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DBiologically%252Bactive%252Bmarine%252Bnatural%252Bproducts%252Band%252Btheir%252Bmolecular%252Btargets%252Bdiscovered%252Busing%252Ba%252Bchemical%252Bgenetics%252Bapproach%26aulast%3DWilliams%26aufirst%3DDavid%2BE.%26date%3D2020%26date%3D2020%26volume%3D37%26issue%3D5%26spage%3D617%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Soobin  Wang</span>, <span class="hlFld-ContribAuthor ">Alessia  Battigelli</span>, <span class="hlFld-ContribAuthor ">Dahlia  Alkekhia</span>, <span class="hlFld-ContribAuthor ">Alexis  Fairman</span>, <span class="hlFld-ContribAuthor ">Valentin  Antoci</span>, <span class="hlFld-ContribAuthor ">Wentian  Yang</span>, <span class="hlFld-ContribAuthor ">Douglas  Moore</span>, <span class="hlFld-ContribAuthor ">Anita  Shukla</span>. </span><span class="cited-content_cbyCitation_article-title">Controlled delivery of a protein tyrosine phosphatase inhibitor, SHP099, using cyclodextrin-mediated host–guest interactions in polyelectrolyte multilayer films for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (34)
                                     , 20073-20082. <a href="https://doi.org/10.1039/D0RA03864D" title="DOI URL">https://doi.org/10.1039/D0RA03864D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA03864D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA03864D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DControlled%252Bdelivery%252Bof%252Ba%252Bprotein%252Btyrosine%252Bphosphatase%252Binhibitor%25252C%252BSHP099%25252C%252Busing%252Bcyclodextrin-mediated%252Bhost%2525E2%252580%252593guest%252Binteractions%252Bin%252Bpolyelectrolyte%252Bmultilayer%252Bfilms%252Bfor%252Bcancer%252Btherapy%26aulast%3DWang%26aufirst%3DSoobin%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D34%26spage%3D20073%26epage%3D20082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yating  Chong</span>, <span class="hlFld-ContribAuthor ">Yun  Liu</span>, <span class="hlFld-ContribAuthor ">Sumin  Lu</span>, <span class="hlFld-ContribAuthor ">Baohuan  Cai</span>, <span class="hlFld-ContribAuthor ">Haiyan  Qin</span>, <span class="hlFld-ContribAuthor ">Chang‐Sheng  Chang</span>, <span class="hlFld-ContribAuthor ">Mingqiang  Ren</span>, <span class="hlFld-ContribAuthor ">John K.  Cowell</span>, <span class="hlFld-ContribAuthor ">Tianxiang  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Critical individual roles of the BCR and FGFR1 kinase domains in BCR‐FGFR1‐driven stem cell leukemia/lymphoma syndrome. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2020,</strong> <em>146 </em>
                                    (8)
                                     , 2243-2254. <a href="https://doi.org/10.1002/ijc.32665" title="DOI URL">https://doi.org/10.1002/ijc.32665</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.32665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.32665%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DCritical%252Bindividual%252Broles%252Bof%252Bthe%252BBCR%252Band%252BFGFR1%252Bkinase%252Bdomains%252Bin%252BBCR%2525E2%252580%252590FGFR1%2525E2%252580%252590driven%252Bstem%252Bcell%252Bleukemia%25252Flymphoma%252Bsyndrome%26aulast%3DChong%26aufirst%3DYating%26date%3D2020%26date%3D2019%26volume%3D146%26issue%3D8%26spage%3D2243%26epage%3D2254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui-Rui  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the acting mode and advantages of RMC-4550 as an Src-homology 2 domain-containing protein tyrosine phosphatase (SHP2) inhibitor at molecular level through molecular docking and molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (5)
                                     , 1525-1538. <a href="https://doi.org/10.1080/07391102.2019.1613266" title="DOI URL">https://doi.org/10.1080/07391102.2019.1613266</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1613266&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1613266%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DProbing%252Bthe%252Bacting%252Bmode%252Band%252Badvantages%252Bof%252BRMC-4550%252Bas%252Ban%252BSrc-homology%252B2%252Bdomain-containing%252Bprotein%252Btyrosine%252Bphosphatase%252B%252528SHP2%252529%252Binhibitor%252Bat%252Bmolecular%252Blevel%252Bthrough%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%26aulast%3DWang%26aufirst%3DRui-Rui%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D5%26spage%3D1525%26epage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dadong  Shen</span>, <span class="hlFld-ContribAuthor ">Wenxia  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlin  Zhu</span>, <span class="hlFld-ContribAuthor ">Guofeng  Wu</span>, <span class="hlFld-ContribAuthor ">Runpu  Shen</span>, <span class="hlFld-ContribAuthor ">Meiyang  Xi</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic potential of targeting SHP2 in human developmental disorders and cancers. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>190 </em>, 112117. <a href="https://doi.org/10.1016/j.ejmech.2020.112117" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112117</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112117%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTherapeutic%252Bpotential%252Bof%252Btargeting%252BSHP2%252Bin%252Bhuman%252Bdevelopmental%252Bdisorders%252Band%252Bcancers%26aulast%3DShen%26aufirst%3DDadong%26date%3D2020%26volume%3D190%26spage%3D112117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiong  Yue</span>, <span class="hlFld-ContribAuthor ">Chao  Liang</span>, <span class="hlFld-ContribAuthor ">Kefu  Wu</span>, <span class="hlFld-ContribAuthor ">Zhi  Hou</span>, <span class="hlFld-ContribAuthor ">Lukang  Wang</span>, <span class="hlFld-ContribAuthor ">Chunqing  Zhang</span>, <span class="hlFld-ContribAuthor ">Shiyong  Liu</span>, <span class="hlFld-ContribAuthor ">Hui  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Upregulated SHP‐2 expression in the epileptogenic zone of temporal lobe epilepsy and various effects of SHP099 treatment on a pilocarpine model. </span><span class="cited-content_cbyCitation_journal-name">Brain Pathology</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 373-385. <a href="https://doi.org/10.1111/bpa.12777" title="DOI URL">https://doi.org/10.1111/bpa.12777</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bpa.12777&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbpa.12777%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Pathology%26atitle%3DUpregulated%252BSHP%2525E2%252580%2525902%252Bexpression%252Bin%252Bthe%252Bepileptogenic%252Bzone%252Bof%252Btemporal%252Blobe%252Bepilepsy%252Band%252Bvarious%252Beffects%252Bof%252BSHP099%252Btreatment%252Bon%252Ba%252Bpilocarpine%252Bmodel%26aulast%3DYue%26aufirst%3DJiong%26date%3D2020%26date%3D2019%26volume%3D30%26issue%3D2%26spage%3D373%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianqian  Liu</span>, <span class="hlFld-ContribAuthor ">Jiao  Qu</span>, <span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting SHP2 as a promising strategy for cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>152 </em>, 104595. <a href="https://doi.org/10.1016/j.phrs.2019.104595" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.104595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.104595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.104595%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DTargeting%252BSHP2%252Bas%252Ba%252Bpromising%252Bstrategy%252Bfor%252Bcancer%252Bimmunotherapy%26aulast%3DLiu%26aufirst%3DQianqian%26date%3D2020%26volume%3D152%26spage%3D104595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tonći  Šuštić</span>, <span class="hlFld-ContribAuthor ">Evert  Bosdriesz</span>, <span class="hlFld-ContribAuthor ">Sake  van Wageningen</span>, <span class="hlFld-ContribAuthor ">Lodewyk F.A.  Wessels</span>, <span class="hlFld-ContribAuthor ">René  Bernards</span>. </span><span class="cited-content_cbyCitation_article-title">RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS-mutant colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">Translational Oncology</span><span> <strong>2020,</strong> <em>13 </em>
                                    (2)
                                     , 201-211. <a href="https://doi.org/10.1016/j.tranon.2019.10.006" title="DOI URL">https://doi.org/10.1016/j.tranon.2019.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tranon.2019.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tranon.2019.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Oncology%26atitle%3DRUNX2%25252FCBFB%252Bmodulates%252Bthe%252Bresponse%252Bto%252BMEK%252Binhibitors%252Bthrough%252Bactivation%252Bof%252Breceptor%252Btyrosine%252Bkinases%252Bin%252BKRAS-mutant%252Bcolorectal%252Bcancer%26aulast%3D%25C5%25A0u%25C5%25A1ti%25C4%2587%26aufirst%3DTon%25C4%2587i%26date%3D2020%26volume%3D13%26issue%3D2%26spage%3D201%26epage%3D211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anjali  Cremer</span>, <span class="hlFld-ContribAuthor ">Jana M.  Ellegast</span>, <span class="hlFld-ContribAuthor ">Gabriela  Alexe</span>, <span class="hlFld-ContribAuthor ">Elizabeth S.  Frank</span>, <span class="hlFld-ContribAuthor ">Linda  Ross</span>, <span class="hlFld-ContribAuthor ">S. Haihua  Chu</span>, <span class="hlFld-ContribAuthor ">Yana  Pikman</span>, <span class="hlFld-ContribAuthor ">Amanda  Robichaud</span>, <span class="hlFld-ContribAuthor ">Amy  Goodale</span>, <span class="hlFld-ContribAuthor ">Björn  Häupl</span>, <span class="hlFld-ContribAuthor ">Sebastian  Mohr</span>, <span class="hlFld-ContribAuthor ">Arati V.  Rao</span>, <span class="hlFld-ContribAuthor ">Alison R.  Walker</span>, <span class="hlFld-ContribAuthor ">James S.  Blachly</span>, <span class="hlFld-ContribAuthor ">Federica  Piccioni</span>, <span class="hlFld-ContribAuthor ">Scott A.  Armstrong</span>, <span class="hlFld-ContribAuthor ">John C.  Byrd</span>, <span class="hlFld-ContribAuthor ">Thomas  Oellerich</span>, <span class="hlFld-ContribAuthor ">Kimberly  Stegmaier</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance Mechanisms to SYK Inhibition in Acute Myeloid Leukemia. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 214-231. <a href="https://doi.org/10.1158/2159-8290.CD-19-0209" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-19-0209</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-19-0209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-19-0209%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DResistance%252BMechanisms%252Bto%252BSYK%252BInhibition%252Bin%252BAcute%252BMyeloid%252BLeukemia%26aulast%3DCremer%26aufirst%3DAnjali%26date%3D2020%26date%3D2019%26volume%3D10%26issue%3D2%26spage%3D214%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Celeste  Romero</span>, <span class="hlFld-ContribAuthor ">Lester J.  Lambert</span>, <span class="hlFld-ContribAuthor ">Douglas J.  Sheffler</span>, <span class="hlFld-ContribAuthor ">Laurent J.S.  De Backer</span>, <span class="hlFld-ContribAuthor ">Dhanya  Raveendra-Panickar</span>, <span class="hlFld-ContribAuthor ">Maria  Celeridad</span>, <span class="hlFld-ContribAuthor ">Stefan  Grotegut</span>, <span class="hlFld-ContribAuthor ">Socorro  Rodiles</span>, <span class="hlFld-ContribAuthor ">John  Holleran</span>, <span class="hlFld-ContribAuthor ">Eduard  Sergienko</span>, <span class="hlFld-ContribAuthor ">Elena B.  Pasquale</span>, <span class="hlFld-ContribAuthor ">Nicholas D.P.  Cosford</span>, <span class="hlFld-ContribAuthor ">Lutz  Tautz</span>. </span><span class="cited-content_cbyCitation_article-title">A cellular target engagement assay for the characterization of SHP2 (PTPN11) phosphatase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2020,</strong> <em>295 </em>
                                    (9)
                                     , 2601-2613. <a href="https://doi.org/10.1074/jbc.RA119.010838" title="DOI URL">https://doi.org/10.1074/jbc.RA119.010838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA119.010838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA119.010838%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DA%252Bcellular%252Btarget%252Bengagement%252Bassay%252Bfor%252Bthe%252Bcharacterization%252Bof%252BSHP2%252B%252528PTPN11%252529%252Bphosphatase%252Binhibitors%26aulast%3DRomero%26aufirst%3DCeleste%26date%3D2020%26volume%3D295%26issue%3D9%26spage%3D2601%26epage%3D2613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Chen  Liu</span>, <span class="hlFld-ContribAuthor ">Hung  Huynh</span>, <span class="hlFld-ContribAuthor ">Thi Bich Uyen  Le</span>, <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>, <span class="hlFld-ContribAuthor ">Giordano  Caponigro</span>, <span class="hlFld-ContribAuthor ">Huai-Xiang  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance to allosteric SHP2 inhibition in FGFR-driven cancers through rapid feedback activation of FGFR. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 265-281. <a href="https://doi.org/10.18632/oncotarget.27435" title="DOI URL">https://doi.org/10.18632/oncotarget.27435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.27435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.27435%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DResistance%252Bto%252Ballosteric%252BSHP2%252Binhibition%252Bin%252BFGFR-driven%252Bcancers%252Bthrough%252Brapid%252Bfeedback%252Bactivation%252Bof%252BFGFR%26aulast%3DLu%26aufirst%3DHengyu%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D3%26spage%3D265%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Matthew  Rhett</span>, <span class="hlFld-ContribAuthor ">Imran  Khan</span>, <span class="hlFld-ContribAuthor ">John P.  O’Bryan</span>. </span><span class="cited-content_cbyCitation_article-title">Biology, pathology, and therapeutic targeting of RAS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 69-146. <a href="https://doi.org/10.1016/bs.acr.2020.05.002" title="DOI URL">https://doi.org/10.1016/bs.acr.2020.05.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.acr.2020.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.acr.2020.05.002%26sid%3Dliteratum%253Aachs%26atitle%3DBiology%25252C%252Bpathology%25252C%252Band%252Btherapeutic%252Btargeting%252Bof%252BRAS%26aulast%3DRhett%26aufirst%3DJ.%2BMatthew%26date%3D2020%26spage%3D69%26epage%3D146%26pub%3DElsevier%26date%3D2020%26volume%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bohee  Kim</span>, <span class="hlFld-ContribAuthor ">Seungjin  Jo</span>, <span class="hlFld-ContribAuthor ">Sung Bum  Park</span>, <span class="hlFld-ContribAuthor ">Chong Hak  Chae</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>, <span class="hlFld-ContribAuthor ">Byumseok  Koh</span>, <span class="hlFld-ContribAuthor ">Inji  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and structure-activity relationship study of SHP2 inhibitor containing 3,4,6-trihydroxy-5-oxo-5H-benzo[7]annulene. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (1)
                                     , 126756. <a href="https://doi.org/10.1016/j.bmcl.2019.126756" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126756%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Band%252Bstructure-activity%252Brelationship%252Bstudy%252Bof%252BSHP2%252Binhibitor%252Bcontaining%252B3%25252C4%25252C6-trihydroxy-5-oxo-5H-benzo%25255B7%25255Dannulene%26aulast%3DKim%26aufirst%3DBohee%26date%3D2020%26volume%3D30%26issue%3D1%26spage%3D126756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huai-Xiang  Hao</span>, <span class="hlFld-ContribAuthor ">Hongyun  Wang</span>, <span class="hlFld-ContribAuthor ">Chen  Liu</span>, <span class="hlFld-ContribAuthor ">Steven  Kovats</span>, <span class="hlFld-ContribAuthor ">Roberto  Velazquez</span>, <span class="hlFld-ContribAuthor ">Hengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Bhavesh  Pant</span>, <span class="hlFld-ContribAuthor ">Matthew  Shirley</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Meyer</span>, <span class="hlFld-ContribAuthor ">Minying  Pu</span>, <span class="hlFld-ContribAuthor ">Joanne  Lim</span>, <span class="hlFld-ContribAuthor ">Michael  Fleming</span>, <span class="hlFld-ContribAuthor ">LeighAnn  Alexander</span>, <span class="hlFld-ContribAuthor ">Ali  Farsidjani</span>, <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>, <span class="hlFld-ContribAuthor ">Susan  Moody</span>, <span class="hlFld-ContribAuthor ">Serena J.  Silver</span>, <span class="hlFld-ContribAuthor ">Giordano  Caponigro</span>, <span class="hlFld-ContribAuthor ">Darrin D.  Stuart</span>, <span class="hlFld-ContribAuthor ">Tinya J.  Abrams</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>, <span class="hlFld-ContribAuthor ">Juliet  Williams</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>, <span class="hlFld-ContribAuthor ">Silvia  Goldoni</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor Intrinsic Efficacy by SHP2 and RTK Inhibitors in KRAS-Mutant Cancers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (12)
                                     , 2368-2380. <a href="https://doi.org/10.1158/1535-7163.MCT-19-0170" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-0170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-0170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-0170%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTumor%252BIntrinsic%252BEfficacy%252Bby%252BSHP2%252Band%252BRTK%252BInhibitors%252Bin%252BKRAS-Mutant%252BCancers%26aulast%3DHao%26aufirst%3DHuai-Xiang%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D12%26spage%3D2368%26epage%3D2380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panagiotis  Parsonidis</span>, <span class="hlFld-ContribAuthor ">Mahammad  Shaik</span>, <span class="hlFld-ContribAuthor ">Athanasia Panagiota  Serafeim</span>, <span class="hlFld-ContribAuthor ">Ioanna  Vlachou</span>, <span class="hlFld-ContribAuthor ">Vasiliki  Daikopoulou</span>, <span class="hlFld-ContribAuthor ">Ioannis  Papasotiriou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and In Vitro Activity of Pyrazine Compounds. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (23)
                                     , 4389. <a href="https://doi.org/10.3390/molecules24234389" title="DOI URL">https://doi.org/10.3390/molecules24234389</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24234389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24234389%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BIn%252BVitro%252BActivity%252Bof%252BPyrazine%252BCompounds%26aulast%3DParsonidis%26aufirst%3DPanagiotis%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D23%26spage%3D4389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youzhou  Sang</span>, <span class="hlFld-ContribAuthor ">Yanli  Hou</span>, <span class="hlFld-ContribAuthor ">Rongrong  Cheng</span>, <span class="hlFld-ContribAuthor ">Liang  Zheng</span>, <span class="hlFld-ContribAuthor ">Angel A  Alvarez</span>, <span class="hlFld-ContribAuthor ">Bo  Hu</span>, <span class="hlFld-ContribAuthor ">Shi-Yuan  Cheng</span>, <span class="hlFld-ContribAuthor ">Weiwei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanxin  Li</span>, <span class="hlFld-ContribAuthor ">Haizhong  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2–mediated signaling. </span><span class="cited-content_cbyCitation_journal-name">Neuro-Oncology</span><span> <strong>2019,</strong> <em>21 </em>
                                    (11)
                                     , 1423-1435. <a href="https://doi.org/10.1093/neuonc/noz107" title="DOI URL">https://doi.org/10.1093/neuonc/noz107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/neuonc/noz107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fneuonc%2Fnoz107%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuro-Oncology%26atitle%3DTargeting%252BPDGFR%2525CE%2525B1-activated%252Bglioblastoma%252Bthrough%252Bspecific%252Binhibition%252Bof%252BSHP-2%2525E2%252580%252593mediated%252Bsignaling%26aulast%3DSang%26aufirst%3DYouzhou%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D11%26spage%3D1423%26epage%3D1435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">CongBao  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">19
              F-NMR in Target-based Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2019,</strong> <em>26 </em>
                                    (26)
                                     , 4964-4983. <a href="https://doi.org/10.2174/0929867326666190610160534" title="DOI URL">https://doi.org/10.2174/0929867326666190610160534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867326666190610160534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867326666190610160534%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3D19%252BF-NMR%252Bin%252BTarget-based%252BDrug%252BDiscovery%26aulast%3DKang%26aufirst%3DCongBao%26date%3D2019%26volume%3D26%26issue%3D26%26spage%3D4964%26epage%3D4983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cun  Wang</span>, <span class="hlFld-ContribAuthor ">Serena  Vegna</span>, <span class="hlFld-ContribAuthor ">Haojie  Jin</span>, <span class="hlFld-ContribAuthor ">Bente  Benedict</span>, <span class="hlFld-ContribAuthor ">Cor  Lieftink</span>, <span class="hlFld-ContribAuthor ">Christel  Ramirez</span>, <span class="hlFld-ContribAuthor ">Rodrigo Leite  de Oliveira</span>, <span class="hlFld-ContribAuthor ">Ben  Morris</span>, <span class="hlFld-ContribAuthor ">Jules  Gadiot</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Aimée  du Chatinier</span>, <span class="hlFld-ContribAuthor ">Liqin  Wang</span>, <span class="hlFld-ContribAuthor ">Dongmei  Gao</span>, <span class="hlFld-ContribAuthor ">Bastiaan  Evers</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Jin</span>, <span class="hlFld-ContribAuthor ">Zheng  Xue</span>, <span class="hlFld-ContribAuthor ">Arnout  Schepers</span>, <span class="hlFld-ContribAuthor ">Fleur  Jochems</span>, <span class="hlFld-ContribAuthor ">Antonio Mulero  Sanchez</span>, <span class="hlFld-ContribAuthor ">Sara  Mainardi</span>, <span class="hlFld-ContribAuthor ">Hein  te Riele</span>, <span class="hlFld-ContribAuthor ">Roderick L.  Beijersbergen</span>, <span class="hlFld-ContribAuthor ">Wenxin  Qin</span>, <span class="hlFld-ContribAuthor ">Leila  Akkari</span>, <span class="hlFld-ContribAuthor ">René  Bernards</span>. </span><span class="cited-content_cbyCitation_article-title">Inducing and exploiting vulnerabilities for the treatment of liver cancer. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2019,</strong> <em>574 </em>
                                    (7777)
                                     , 268-272. <a href="https://doi.org/10.1038/s41586-019-1607-3" title="DOI URL">https://doi.org/10.1038/s41586-019-1607-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-019-1607-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-019-1607-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DInducing%252Band%252Bexploiting%252Bvulnerabilities%252Bfor%252Bthe%252Btreatment%252Bof%252Bliver%252Bcancer%26aulast%3DWang%26aufirst%3DCun%26date%3D2019%26date%3D2019%26volume%3D574%26issue%3D7777%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Shan  Liu</span>, <span class="hlFld-ContribAuthor ">Wen-Yan  Jin</span>, <span class="hlFld-ContribAuthor ">Liang  Zhou</span>, <span class="hlFld-ContribAuthor ">Xing-Hua  Lu</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure based design of selective SHP2 inhibitors by De novo design, synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2019,</strong> <em>33 </em>
                                    (8)
                                     , 759-774. <a href="https://doi.org/10.1007/s10822-019-00213-z" title="DOI URL">https://doi.org/10.1007/s10822-019-00213-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-019-00213-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-019-00213-z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DStructure%252Bbased%252Bdesign%252Bof%252Bselective%252BSHP2%252Binhibitors%252Bby%252BDe%252Bnovo%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DLiu%26aufirst%3DWen-Shan%26date%3D2019%26date%3D2019%26volume%3D33%26issue%3D8%26spage%3D759%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hengyu  Lu</span>, <span class="hlFld-ContribAuthor ">Chen  Liu</span>, <span class="hlFld-ContribAuthor ">Roberto  Velazquez</span>, <span class="hlFld-ContribAuthor ">Hongyun  Wang</span>, <span class="hlFld-ContribAuthor ">Lukas Manuel  Dunkl</span>, <span class="hlFld-ContribAuthor ">Malika  Kazic-Legueux</span>, <span class="hlFld-ContribAuthor ">Anne  Haberkorn</span>, <span class="hlFld-ContribAuthor ">Eric  Billy</span>, <span class="hlFld-ContribAuthor ">Eusebio  Manchado</span>, <span class="hlFld-ContribAuthor ">Saskia M.  Brachmann</span>, <span class="hlFld-ContribAuthor ">Susan E.  Moody</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Engelman</span>, <span class="hlFld-ContribAuthor ">Peter S.  Hammerman</span>, <span class="hlFld-ContribAuthor ">Giordano  Caponigro</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Huai-Xiang  Hao</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 Inhibition Overcomes RTK-Mediated Pathway Reactivation in KRAS-Mutant Tumors Treated with MEK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (7)
                                     , 1323-1334. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0852" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0852%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSHP2%252BInhibition%252BOvercomes%252BRTK-Mediated%252BPathway%252BReactivation%252Bin%252BKRAS-Mutant%252BTumors%252BTreated%252Bwith%252BMEK%252BInhibitors%26aulast%3DLu%26aufirst%3DHengyu%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D7%26spage%3D1323%26epage%3D1334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Shiliang  Li</span>, <span class="hlFld-ContribAuthor ">Honglin  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Design of “Undruggable” Targets. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2019,</strong> <em>37 </em>
                                    (5)
                                     , 501-512. <a href="https://doi.org/10.1002/cjoc.201800552" title="DOI URL">https://doi.org/10.1002/cjoc.201800552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201800552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201800552%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DDrug%252BDesign%252Bof%252B%2525E2%252580%25259CUndruggable%2525E2%252580%25259D%252BTargets%26aulast%3DWang%26aufirst%3DJie%26date%3D2019%26date%3D2019%26volume%3D37%26issue%3D5%26spage%3D501%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdolkarim  Farrokhzadeh</span>, <span class="hlFld-ContribAuthor ">Farideh Badichi  Akher</span>, <span class="hlFld-ContribAuthor ">Mahmoud E. S.  Soliman</span>. </span><span class="cited-content_cbyCitation_article-title">Probing the Dynamic Mechanism of Uncommon Allosteric Inhibitors Optimized to Enhance Drug Selectivity of SHP2 with Therapeutic Potential for Cancer Treatment. </span><span class="cited-content_cbyCitation_journal-name">Applied Biochemistry and Biotechnology</span><span> <strong>2019,</strong> <em>188 </em>
                                    (1)
                                     , 260-281. <a href="https://doi.org/10.1007/s12010-018-2914-0" title="DOI URL">https://doi.org/10.1007/s12010-018-2914-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12010-018-2914-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12010-018-2914-0%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Biochemistry%2520and%2520Biotechnology%26atitle%3DProbing%252Bthe%252BDynamic%252BMechanism%252Bof%252BUncommon%252BAllosteric%252BInhibitors%252BOptimized%252Bto%252BEnhance%252BDrug%252BSelectivity%252Bof%252BSHP2%252Bwith%252BTherapeutic%252BPotential%252Bfor%252BCancer%252BTreatment%26aulast%3DFarrokhzadeh%26aufirst%3DAbdolkarim%26date%3D2019%26date%3D2018%26volume%3D188%26issue%3D1%26spage%3D260%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kangshuai  Li</span>, <span class="hlFld-ContribAuthor ">Xuben  Hou</span>, <span class="hlFld-ContribAuthor ">Ruirui  Li</span>, <span class="hlFld-ContribAuthor ">Wenxiang  Bi</span>, <span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Xu  Chen</span>, <span class="hlFld-ContribAuthor ">Peng  Xiao</span>, <span class="hlFld-ContribAuthor ">Tiantian  Liu</span>, <span class="hlFld-ContribAuthor ">Tiange  Lu</span>, <span class="hlFld-ContribAuthor ">Yuan  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhaomei  Tian</span>, <span class="hlFld-ContribAuthor ">Yuemao  Shen</span>, <span class="hlFld-ContribAuthor ">Yingkai  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiangyun  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>, <span class="hlFld-ContribAuthor ">Jinpeng  Sun</span>, <span class="hlFld-ContribAuthor ">Xiao  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification and structure–function analyses of an allosteric inhibitor of the tyrosine phosphatase PTPN22. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2019,</strong> <em>294 </em>
                                    (21)
                                     , 8653-8663. <a href="https://doi.org/10.1074/jbc.RA118.007129" title="DOI URL">https://doi.org/10.1074/jbc.RA118.007129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.RA118.007129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.RA118.007129%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DIdentification%252Band%252Bstructure%2525E2%252580%252593function%252Banalyses%252Bof%252Ban%252Ballosteric%252Binhibitor%252Bof%252Bthe%252Btyrosine%252Bphosphatase%252BPTPN22%26aulast%3DLi%26aufirst%3DKangshuai%26date%3D2019%26volume%3D294%26issue%3D21%26spage%3D8653%26epage%3D8663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuncang  Yuan</span>, <span class="hlFld-ContribAuthor ">Guoxiang  Qi</span>, <span class="hlFld-ContribAuthor ">Hao  Shen</span>, <span class="hlFld-ContribAuthor ">Aizhen  Guo</span>, <span class="hlFld-ContribAuthor ">Fuao  Cao</span>, <span class="hlFld-ContribAuthor ">Yan  Zhu</span>, <span class="hlFld-ContribAuthor ">Chunjie  Xiao</span>, <span class="hlFld-ContribAuthor ">Wenjun  Chang</span>, <span class="hlFld-ContribAuthor ">Shangyong  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical significance and biological function of WD repeat domain 54 as an oncogene in colorectal cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2019,</strong> <em>144 </em>
                                    (7)
                                     , 1584-1595. <a href="https://doi.org/10.1002/ijc.31736" title="DOI URL">https://doi.org/10.1002/ijc.31736</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.31736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.31736%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DClinical%252Bsignificance%252Band%252Bbiological%252Bfunction%252Bof%252BWD%252Brepeat%252Bdomain%252B54%252Bas%252Ban%252Boncogene%252Bin%252Bcolorectal%252Bcancer%26aulast%3DYuan%26aufirst%3DYuncang%26date%3D2019%26date%3D2018%26volume%3D144%26issue%3D7%26spage%3D1584%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingxia  Zhao</span>, <span class="hlFld-ContribAuthor ">Wenjie  Guo</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Wu</span>, <span class="hlFld-ContribAuthor ">Chenxi  Yang</span>, <span class="hlFld-ContribAuthor ">Liang  Zhong</span>, <span class="hlFld-ContribAuthor ">Guoliang  Deng</span>, <span class="hlFld-ContribAuthor ">Yuyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Wen  Liu</span>, <span class="hlFld-ContribAuthor ">Yanhong  Gu</span>, <span class="hlFld-ContribAuthor ">Yin  Lu</span>, <span class="hlFld-ContribAuthor ">Lingdong  Kong</span>, <span class="hlFld-ContribAuthor ">Xiangbao  Meng</span>, <span class="hlFld-ContribAuthor ">Qiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 inhibition triggers anti-tumor immunity and synergizes with PD-1 blockade. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2019,</strong> <em>9 </em>
                                    (2)
                                     , 304-315. <a href="https://doi.org/10.1016/j.apsb.2018.08.009" title="DOI URL">https://doi.org/10.1016/j.apsb.2018.08.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2018.08.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2018.08.009%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DSHP2%252Binhibition%252Btriggers%252Banti-tumor%252Bimmunity%252Band%252Bsynergizes%252Bwith%252BPD-1%252Bblockade%26aulast%3DZhao%26aufirst%3DMingxia%26date%3D2019%26volume%3D9%26issue%3D2%26spage%3D304%26epage%3D315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamer A.  Ahmed</span>, <span class="hlFld-ContribAuthor ">Christos  Adamopoulos</span>, <span class="hlFld-ContribAuthor ">Zoi  Karoulia</span>, <span class="hlFld-ContribAuthor ">Xuewei  Wu</span>, <span class="hlFld-ContribAuthor ">Ravi  Sachidanandam</span>, <span class="hlFld-ContribAuthor ">Stuart A.  Aaronson</span>, <span class="hlFld-ContribAuthor ">Poulikos I.  Poulikakos</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-Dependent Tumors. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2019,</strong> <em>26 </em>
                                    (1)
                                     , 65-78.e5. <a href="https://doi.org/10.1016/j.celrep.2018.12.013" title="DOI URL">https://doi.org/10.1016/j.celrep.2018.12.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2018.12.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2018.12.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DSHP2%252BDrives%252BAdaptive%252BResistance%252Bto%252BERK%252BSignaling%252BInhibition%252Bin%252BMolecularly%252BDefined%252BSubsets%252Bof%252BERK-Dependent%252BTumors%26aulast%3DAhmed%26aufirst%3DTamer%2BA.%26date%3D2019%26volume%3D26%26issue%3D1%26spage%3D65%26epage%3D78.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ricardo A. P.  Pádua</span>, <span class="hlFld-ContribAuthor ">Yizhi  Sun</span>, <span class="hlFld-ContribAuthor ">Ingrid  Marko</span>, <span class="hlFld-ContribAuthor ">Warintra  Pitsawong</span>, <span class="hlFld-ContribAuthor ">John B.  Stiller</span>, <span class="hlFld-ContribAuthor ">Renee  Otten</span>, <span class="hlFld-ContribAuthor ">Dorothee  Kern</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-06814-w" title="DOI URL">https://doi.org/10.1038/s41467-018-06814-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-06814-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-06814-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DMechanism%252Bof%252Bactivating%252Bmutations%252Band%252Ballosteric%252Bdrug%252Binhibition%252Bof%252Bthe%252Bphosphatase%252BSHP2%26aulast%3DP%25C3%25A1dua%26aufirst%3DRicardo%2BA.%2BP.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan R.  LaRochelle</span>, <span class="hlFld-ContribAuthor ">Michelle  Fodor</span>, <span class="hlFld-ContribAuthor ">Vidyasiri  Vemulapalli</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Ping  Wang</span>, <span class="hlFld-ContribAuthor ">Travis  Stams</span>, <span class="hlFld-ContribAuthor ">Matthew J.  LaMarche</span>, <span class="hlFld-ContribAuthor ">Rajiv  Chopra</span>, <span class="hlFld-ContribAuthor ">Michael G.  Acker</span>, <span class="hlFld-ContribAuthor ">Stephen C.  Blacklow</span>. </span><span class="cited-content_cbyCitation_article-title">Structural reorganization of SHP2 by oncogenic mutations and implications for oncoprotein resistance to allosteric inhibition. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2018,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-018-06823-9" title="DOI URL">https://doi.org/10.1038/s41467-018-06823-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-018-06823-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-018-06823-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DStructural%252Breorganization%252Bof%252BSHP2%252Bby%252Boncogenic%252Bmutations%252Band%252Bimplications%252Bfor%252Boncoprotein%252Bresistance%252Bto%252Ballosteric%252Binhibition%26aulast%3DLaRochelle%26aufirst%3DJonathan%2BR.%26date%3D2018%26date%3D2018%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Huang</span>, <span class="hlFld-ContribAuthor ">Ling  Qin</span>, <span class="hlFld-ContribAuthor ">Samir Z.  Zard</span>. </span><span class="cited-content_cbyCitation_article-title">Xanthate-mediated intermolecular alkylation of pyrazines. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (40)
                                     , 5804-5817. <a href="https://doi.org/10.1016/j.tet.2018.08.040" title="DOI URL">https://doi.org/10.1016/j.tet.2018.08.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.08.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.08.040%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DXanthate-mediated%252Bintermolecular%252Balkylation%252Bof%252Bpyrazines%26aulast%3DHuang%26aufirst%3DQi%26date%3D2018%26volume%3D74%26issue%3D40%26spage%3D5804%26epage%3D5817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmine  Fedele</span>, <span class="hlFld-ContribAuthor ">Hao  Ran</span>, <span class="hlFld-ContribAuthor ">Brian  Diskin</span>, <span class="hlFld-ContribAuthor ">Wei  Wei</span>, <span class="hlFld-ContribAuthor ">Jayu  Jen</span>, <span class="hlFld-ContribAuthor ">Mitchell J.  Geer</span>, <span class="hlFld-ContribAuthor ">Kiyomi  Araki</span>, <span class="hlFld-ContribAuthor ">Ugur  Ozerdem</span>, <span class="hlFld-ContribAuthor ">Diane M.  Simeone</span>, <span class="hlFld-ContribAuthor ">George  Miller</span>, <span class="hlFld-ContribAuthor ">Benjamin G.  Neel</span>, <span class="hlFld-ContribAuthor ">Kwan Ho  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 Inhibition Prevents Adaptive Resistance to MEK Inhibitors in Multiple Cancer Models. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2018,</strong> <em>8 </em>
                                    (10)
                                     , 1237-1249. <a href="https://doi.org/10.1158/2159-8290.CD-18-0444" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-18-0444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-18-0444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-18-0444%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DSHP2%252BInhibition%252BPrevents%252BAdaptive%252BResistance%252Bto%252BMEK%252BInhibitors%252Bin%252BMultiple%252BCancer%252BModels%26aulast%3DFedele%26aufirst%3DCarmine%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D10%26spage%3D1237%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert J.  Nichols</span>, <span class="hlFld-ContribAuthor ">Franziska  Haderk</span>, <span class="hlFld-ContribAuthor ">Carlos  Stahlhut</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schulze</span>, <span class="hlFld-ContribAuthor ">Golzar  Hemmati</span>, <span class="hlFld-ContribAuthor ">David  Wildes</span>, <span class="hlFld-ContribAuthor ">Christos  Tzitzilonis</span>, <span class="hlFld-ContribAuthor ">Kasia  Mordec</span>, <span class="hlFld-ContribAuthor ">Abby  Marquez</span>, <span class="hlFld-ContribAuthor ">Jason  Romero</span>, <span class="hlFld-ContribAuthor ">Tientien  Hsieh</span>, <span class="hlFld-ContribAuthor ">Aubhishek  Zaman</span>, <span class="hlFld-ContribAuthor ">Victor  Olivas</span>, <span class="hlFld-ContribAuthor ">Caroline  McCoach</span>, <span class="hlFld-ContribAuthor ">Collin M.  Blakely</span>, <span class="hlFld-ContribAuthor ">Zhengping  Wang</span>, <span class="hlFld-ContribAuthor ">Gert  Kiss</span>, <span class="hlFld-ContribAuthor ">Elena S.  Koltun</span>, <span class="hlFld-ContribAuthor ">Adrian L.  Gill</span>, <span class="hlFld-ContribAuthor ">Mallika  Singh</span>, <span class="hlFld-ContribAuthor ">Mark A.  Goldsmith</span>, <span class="hlFld-ContribAuthor ">Jacqueline A. M.  Smith</span>, <span class="hlFld-ContribAuthor ">Trever G.  Bivona</span>. </span><span class="cited-content_cbyCitation_article-title">RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers. </span><span class="cited-content_cbyCitation_journal-name">Nature Cell Biology</span><span> <strong>2018,</strong> <em>20 </em>
                                    (9)
                                     , 1064-1073. <a href="https://doi.org/10.1038/s41556-018-0169-1" title="DOI URL">https://doi.org/10.1038/s41556-018-0169-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41556-018-0169-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41556-018-0169-1%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Cell%2520Biology%26atitle%3DRAS%252Bnucleotide%252Bcycling%252Bunderlies%252Bthe%252BSHP2%252Bphosphatase%252Bdependence%252Bof%252Bmutant%252BBRAF-%25252C%252BNF1-%252Band%252BRAS-driven%252Bcancers%26aulast%3DNichols%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26volume%3D20%26issue%3D9%26spage%3D1064%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chelsea  Jenkins</span>, <span class="hlFld-ContribAuthor ">Samuel B.  Luty</span>, <span class="hlFld-ContribAuthor ">Julia E.  Maxson</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Eide</span>, <span class="hlFld-ContribAuthor ">Melissa L.  Abel</span>, <span class="hlFld-ContribAuthor ">Corinne  Togiai</span>, <span class="hlFld-ContribAuthor ">Eneida R.  Nemecek</span>, <span class="hlFld-ContribAuthor ">Daniel  Bottomly</span>, <span class="hlFld-ContribAuthor ">Shannon K.  McWeeney</span>, <span class="hlFld-ContribAuthor ">Beth  Wilmot</span>, <span class="hlFld-ContribAuthor ">Marc  Loriaux</span>, <span class="hlFld-ContribAuthor ">Bill H.  Chang</span>, <span class="hlFld-ContribAuthor ">Jeffrey W.  Tyner</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia. </span><span class="cited-content_cbyCitation_journal-name">Science Signaling</span><span> <strong>2018,</strong> <em>11 </em>
                                    (539)
                                     , eaao5617. <a href="https://doi.org/10.1126/scisignal.aao5617" title="DOI URL">https://doi.org/10.1126/scisignal.aao5617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scisignal.aao5617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscisignal.aao5617%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Signaling%26atitle%3DSynthetic%252Blethality%252Bof%252BTNK2%252Binhibition%252Bin%252BPTPN11-mutant%252Bleukemia%26aulast%3DJenkins%26aufirst%3DChelsea%26date%3D2018%26date%3D2018%26volume%3D11%26issue%3D539%26spage%3Deaao5617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gabrielle S.  Wong</span>, <span class="hlFld-ContribAuthor ">Jin  Zhou</span>, <span class="hlFld-ContribAuthor ">Jie Bin  Liu</span>, <span class="hlFld-ContribAuthor ">Zhong  Wu</span>, <span class="hlFld-ContribAuthor ">Xinsen  Xu</span>, <span class="hlFld-ContribAuthor ">Tianxia  Li</span>, <span class="hlFld-ContribAuthor ">David  Xu</span>, <span class="hlFld-ContribAuthor ">Steven E.  Schumacher</span>, <span class="hlFld-ContribAuthor ">Jens  Puschhof</span>, <span class="hlFld-ContribAuthor ">James  McFarland</span>, <span class="hlFld-ContribAuthor ">Charles  Zou</span>, <span class="hlFld-ContribAuthor ">Austin  Dulak</span>, <span class="hlFld-ContribAuthor ">Les  Henderson</span>, <span class="hlFld-ContribAuthor ">Peng  Xu</span>, <span class="hlFld-ContribAuthor ">Emily  O’Day</span>, <span class="hlFld-ContribAuthor ">Rachel  Rendak</span>, <span class="hlFld-ContribAuthor ">Wei-li  Liao</span>, <span class="hlFld-ContribAuthor ">Fabiola  Cecchi</span>, <span class="hlFld-ContribAuthor ">Todd  Hembrough</span>, <span class="hlFld-ContribAuthor ">Sarit  Schwartz</span>, <span class="hlFld-ContribAuthor ">Christopher  Szeto</span>, <span class="hlFld-ContribAuthor ">Anil K.  Rustgi</span>, <span class="hlFld-ContribAuthor ">Kwok-Kin  Wong</span>, <span class="hlFld-ContribAuthor ">J. Alan  Diehl</span>, <span class="hlFld-ContribAuthor ">Karin  Jensen</span>, <span class="hlFld-ContribAuthor ">Francesco  Graziano</span>, <span class="hlFld-ContribAuthor ">Annamaria  Ruzzo</span>, <span class="hlFld-ContribAuthor ">Shaunt  Fereshetian</span>, <span class="hlFld-ContribAuthor ">Philipp  Mertins</span>, <span class="hlFld-ContribAuthor ">Steven A.  Carr</span>, <span class="hlFld-ContribAuthor ">Rameen  Beroukhim</span>, <span class="hlFld-ContribAuthor ">Kenichi  Nakamura</span>, <span class="hlFld-ContribAuthor ">Eiji  Oki</span>, <span class="hlFld-ContribAuthor ">Masayuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Hideo  Baba</span>, <span class="hlFld-ContribAuthor ">Yu  Imamura</span>, <span class="hlFld-ContribAuthor ">Daniel  Catenacci</span>, <span class="hlFld-ContribAuthor ">Adam J.  Bass</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2018,</strong> <em>24 </em>
                                    (7)
                                     , 968-977. <a href="https://doi.org/10.1038/s41591-018-0022-x" title="DOI URL">https://doi.org/10.1038/s41591-018-0022-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41591-018-0022-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41591-018-0022-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DTargeting%252Bwild-type%252BKRAS-amplified%252Bgastroesophageal%252Bcancer%252Bthrough%252Bcombined%252BMEK%252Band%252BSHP2%252Binhibition%26aulast%3DWong%26aufirst%3DGabrielle%2BS.%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D7%26spage%3D968%26epage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Mainardi</span>, <span class="hlFld-ContribAuthor ">Antonio  Mulero-Sánchez</span>, <span class="hlFld-ContribAuthor ">Anirudh  Prahallad</span>, <span class="hlFld-ContribAuthor ">Giovanni  Germano</span>, <span class="hlFld-ContribAuthor ">Astrid  Bosma</span>, <span class="hlFld-ContribAuthor ">Paul  Krimpenfort</span>, <span class="hlFld-ContribAuthor ">Cor  Lieftink</span>, <span class="hlFld-ContribAuthor ">Jeffrey D.  Steinberg</span>, <span class="hlFld-ContribAuthor ">Niels  de Wit</span>, <span class="hlFld-ContribAuthor ">Samuel  Gonçalves-Ribeiro</span>, <span class="hlFld-ContribAuthor ">Ernest  Nadal</span>, <span class="hlFld-ContribAuthor ">Alberto  Bardelli</span>, <span class="hlFld-ContribAuthor ">Alberto  Villanueva</span>, <span class="hlFld-ContribAuthor ">Rene  Bernards</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2018,</strong> <em>24 </em>
                                    (7)
                                     , 961-967. <a href="https://doi.org/10.1038/s41591-018-0023-9" title="DOI URL">https://doi.org/10.1038/s41591-018-0023-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41591-018-0023-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41591-018-0023-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DSHP2%252Bis%252Brequired%252Bfor%252Bgrowth%252Bof%252BKRAS-mutant%252Bnon-small-cell%252Blung%252Bcancer%252Bin%252Bvivo%26aulast%3DMainardi%26aufirst%3DSara%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D7%26spage%3D961%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dietrich A.  Ruess</span>, <span class="hlFld-ContribAuthor ">Guus J.  Heynen</span>, <span class="hlFld-ContribAuthor ">Katrin J.  Ciecielski</span>, <span class="hlFld-ContribAuthor ">Jiaoyu  Ai</span>, <span class="hlFld-ContribAuthor ">Alexandra  Berninger</span>, <span class="hlFld-ContribAuthor ">Derya  Kabacaoglu</span>, <span class="hlFld-ContribAuthor ">Kivanc  Görgülü</span>, <span class="hlFld-ContribAuthor ">Zahra  Dantes</span>, <span class="hlFld-ContribAuthor ">Sonja M.  Wörmann</span>, <span class="hlFld-ContribAuthor ">Kalliope N.  Diakopoulos</span>, <span class="hlFld-ContribAuthor ">Angeliki F.  Karpathaki</span>, <span class="hlFld-ContribAuthor ">Marlena  Kowalska</span>, <span class="hlFld-ContribAuthor ">Ezgi  Kaya-Aksoy</span>, <span class="hlFld-ContribAuthor ">Liang  Song</span>, <span class="hlFld-ContribAuthor ">Eveline A. Zeeuw  van der Laan</span>, <span class="hlFld-ContribAuthor ">María P.  López-Alberca</span>, <span class="hlFld-ContribAuthor ">Marc  Nazaré</span>, <span class="hlFld-ContribAuthor ">Maximilian  Reichert</span>, <span class="hlFld-ContribAuthor ">Dieter  Saur</span>, <span class="hlFld-ContribAuthor ">Mert M.  Erkan</span>, <span class="hlFld-ContribAuthor ">Ulrich T.  Hopt</span>, <span class="hlFld-ContribAuthor ">Bruno  Sainz</span>, <span class="hlFld-ContribAuthor ">Walter  Birchmeier</span>, <span class="hlFld-ContribAuthor ">Roland M.  Schmid</span>, <span class="hlFld-ContribAuthor ">Marina  Lesina</span>, <span class="hlFld-ContribAuthor ">Hana  Algül</span>. </span><span class="cited-content_cbyCitation_article-title">Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2018,</strong> <em>24 </em>
                                    (7)
                                     , 954-960. <a href="https://doi.org/10.1038/s41591-018-0024-8" title="DOI URL">https://doi.org/10.1038/s41591-018-0024-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41591-018-0024-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41591-018-0024-8%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DMutant%252BKRAS-driven%252Bcancers%252Bdepend%252Bon%252BPTPN11%25252FSHP2%252Bphosphatase%26aulast%3DRuess%26aufirst%3DDietrich%2BA.%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D7%26spage%3D954%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Garrett R.  Casey</span>, <span class="hlFld-ContribAuthor ">Cliff I.  Stains</span>. </span><span class="cited-content_cbyCitation_article-title">Interrogating Protein Phosphatases with Chemical Activity Probes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry - A European Journal</span><span> <strong>2018,</strong> <em>24 </em>
                                    (31)
                                     , 7810-7824. <a href="https://doi.org/10.1002/chem.201705194" title="DOI URL">https://doi.org/10.1002/chem.201705194</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201705194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201705194%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520-%2520A%2520European%2520Journal%26atitle%3DInterrogating%252BProtein%252BPhosphatases%252Bwith%252BChemical%252BActivity%252BProbes%26aulast%3DCasey%26aufirst%3DGarrett%2BR.%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D31%26spage%3D7810%26epage%3D7824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">X  Sun</span>, <span class="hlFld-ContribAuthor ">Y  Ren</span>, <span class="hlFld-ContribAuthor ">S  Gunawan</span>, <span class="hlFld-ContribAuthor ">P  Teng</span>, <span class="hlFld-ContribAuthor ">Z  Chen</span>, <span class="hlFld-ContribAuthor ">HR  Lawrence</span>, <span class="hlFld-ContribAuthor ">J  Cai</span>, <span class="hlFld-ContribAuthor ">NJ  Lawrence</span>, <span class="hlFld-ContribAuthor ">J  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition of leukemia-associated SHP2E69K mutant by the allosteric SHP2 inhibitor SHP099. </span><span class="cited-content_cbyCitation_journal-name">Leukemia</span><span> <strong>2018,</strong> <em>32 </em>
                                    (5)
                                     , 1246-1249. <a href="https://doi.org/10.1038/s41375-018-0020-5" title="DOI URL">https://doi.org/10.1038/s41375-018-0020-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41375-018-0020-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41375-018-0020-5%26sid%3Dliteratum%253Aachs%26jtitle%3DLeukemia%26atitle%3DSelective%252Binhibition%252Bof%252Bleukemia-associated%252BSHP2E69K%252Bmutant%252Bby%252Bthe%252Ballosteric%252BSHP2%252Binhibitor%252BSHP099%26aulast%3DSun%26aufirst%3DX%26date%3D2018%26date%3D2018%26volume%3D32%26issue%3D5%26spage%3D1246%26epage%3D1249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Yan  Jin</span>, <span class="hlFld-ContribAuthor ">Ying  Ma</span>, <span class="hlFld-ContribAuthor ">Wei-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Hong-Lian  Li</span>, <span class="hlFld-ContribAuthor ">Run-Ling  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Scaffold-based novel SHP2 allosteric inhibitors design using Receptor-Ligand pharmacophore model, virtual screening and molecular dynamics. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2018,</strong> <em>73 </em>, 179-188. <a href="https://doi.org/10.1016/j.compbiolchem.2018.02.004" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2018.02.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2018.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2018.02.004%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DScaffold-based%252Bnovel%252BSHP2%252Ballosteric%252Binhibitors%252Bdesign%252Busing%252BReceptor-Ligand%252Bpharmacophore%252Bmodel%25252C%252Bvirtual%252Bscreening%252Band%252Bmolecular%252Bdynamics%26aulast%3DJin%26aufirst%3DWen-Yan%26date%3D2018%26volume%3D73%26spage%3D179%26epage%3D188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leila  Dardaei</span>, <span class="hlFld-ContribAuthor ">Hui Qin  Wang</span>, <span class="hlFld-ContribAuthor ">Manrose  Singh</span>, <span class="hlFld-ContribAuthor ">Paul  Fordjour</span>, <span class="hlFld-ContribAuthor ">Katherine X  Shaw</span>, <span class="hlFld-ContribAuthor ">Satoshi  Yoda</span>, <span class="hlFld-ContribAuthor ">Grainne  Kerr</span>, <span class="hlFld-ContribAuthor ">Kristine  Yu</span>, <span class="hlFld-ContribAuthor ">Jinsheng  Liang</span>, <span class="hlFld-ContribAuthor ">Yichen  Cao</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Michael S  Lawrence</span>, <span class="hlFld-ContribAuthor ">Adam  Langenbucher</span>, <span class="hlFld-ContribAuthor ">Justin F  Gainor</span>, <span class="hlFld-ContribAuthor ">Luc  Friboulet</span>, <span class="hlFld-ContribAuthor ">Ibiayi  Dagogo-Jack</span>, <span class="hlFld-ContribAuthor ">David T  Myers</span>, <span class="hlFld-ContribAuthor ">Emma  Labrot</span>, <span class="hlFld-ContribAuthor ">David  Ruddy</span>, <span class="hlFld-ContribAuthor ">Melissa  Parks</span>, <span class="hlFld-ContribAuthor ">Dana  Lee</span>, <span class="hlFld-ContribAuthor ">Richard H  DiCecca</span>, <span class="hlFld-ContribAuthor ">Susan  Moody</span>, <span class="hlFld-ContribAuthor ">Huaixiang  Hao</span>, <span class="hlFld-ContribAuthor ">Morvarid  Mohseni</span>, <span class="hlFld-ContribAuthor ">Matthew  LaMarche</span>, <span class="hlFld-ContribAuthor ">Juliet  Williams</span>, <span class="hlFld-ContribAuthor ">Keith  Hoffmaster</span>, <span class="hlFld-ContribAuthor ">Giordano  Caponigro</span>, <span class="hlFld-ContribAuthor ">Alice T  Shaw</span>, <span class="hlFld-ContribAuthor ">Aaron N  Hata</span>, <span class="hlFld-ContribAuthor ">Cyril H  Benes</span>, <span class="hlFld-ContribAuthor ">Fang  Li</span>, <span class="hlFld-ContribAuthor ">Jeffrey A  Engelman</span>. </span><span class="cited-content_cbyCitation_article-title">SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Nature Medicine</span><span> <strong>2018,</strong> <em>24 </em>
                                    (4)
                                     , 512-517. <a href="https://doi.org/10.1038/nm.4497" title="DOI URL">https://doi.org/10.1038/nm.4497</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nm.4497&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnm.4497%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Medicine%26atitle%3DSHP2%252Binhibition%252Brestores%252Bsensitivity%252Bin%252BALK-rearranged%252Bnon-small-cell%252Blung%252Bcancer%252Bresistant%252Bto%252BALK%252Binhibitors%26aulast%3DDardaei%26aufirst%3DLeila%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D4%26spage%3D512%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John S.  Lazo</span>, <span class="hlFld-ContribAuthor ">Kelley E.  McQueeney</span>, <span class="hlFld-ContribAuthor ">James C.  Burnett</span>, <span class="hlFld-ContribAuthor ">Peter  Wipf</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Sharlow</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule targeting of PTPs in cancer. </span><span class="cited-content_cbyCitation_journal-name">The International Journal of Biochemistry & Cell Biology</span><span> <strong>2018,</strong> <em>96 </em>, 171-181. <a href="https://doi.org/10.1016/j.biocel.2017.09.011" title="DOI URL">https://doi.org/10.1016/j.biocel.2017.09.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biocel.2017.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biocel.2017.09.011%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520International%2520Journal%2520of%2520Biochemistry%2520%2526%2520Cell%2520Biology%26atitle%3DSmall%252Bmolecule%252Btargeting%252Bof%252BPTPs%252Bin%252Bcancer%26aulast%3DLazo%26aufirst%3DJohn%2BS.%26date%3D2018%26volume%3D96%26spage%3D171%26epage%3D181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wiljan  Hendriks</span>, <span class="hlFld-ContribAuthor ">Annika  Bourgonje</span>, <span class="hlFld-ContribAuthor ">William  Leenders</span>, <span class="hlFld-ContribAuthor ">Rafael  Pulido</span>. </span><span class="cited-content_cbyCitation_article-title">Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (2)
                                     , 395. <a href="https://doi.org/10.3390/molecules23020395" title="DOI URL">https://doi.org/10.3390/molecules23020395</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23020395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23020395%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DProteinaceous%252BRegulators%252Band%252BInhibitors%252Bof%252BProtein%252BTyrosine%252BPhosphatases%26aulast%3DHendriks%26aufirst%3DWiljan%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D2%26spage%3D395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tiancen  Hu</span>, <span class="hlFld-ContribAuthor ">Elizabeth R.  Sprague</span>, <span class="hlFld-ContribAuthor ">Michelle  Fodor</span>, <span class="hlFld-ContribAuthor ">Travis  Stams</span>, <span class="hlFld-ContribAuthor ">Kirk L.  Clark</span>, <span class="hlFld-ContribAuthor ">Sandra W.  Cowan-Jacob</span>. </span><span class="cited-content_cbyCitation_article-title">The impact of structural biology in medicine illustrated with four case studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Medicine</span><span> <strong>2018,</strong> <em>96 </em>
                                    (1)
                                     , 9-19. <a href="https://doi.org/10.1007/s00109-017-1565-x" title="DOI URL">https://doi.org/10.1007/s00109-017-1565-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00109-017-1565-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00109-017-1565-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Medicine%26atitle%3DThe%252Bimpact%252Bof%252Bstructural%252Bbiology%252Bin%252Bmedicine%252Billustrated%252Bwith%252Bfour%252Bcase%252Bstudies%26aulast%3DHu%26aufirst%3DTiancen%26date%3D2018%26date%3D2017%26volume%3D96%26issue%3D1%26spage%3D9%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Long  Wang</span>, <span class="hlFld-ContribAuthor ">Xiao-Yu  Chen</span>, <span class="hlFld-ContribAuthor ">Ya  Gao</span>, <span class="hlFld-ContribAuthor ">Li-Xin  Gao</span>, <span class="hlFld-ContribAuthor ">Li  Sheng</span>, <span class="hlFld-ContribAuthor ">Jingyu  Zhu</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Zhen-Zhong  Ding</span>, <span class="hlFld-ContribAuthor ">Chao  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing-Ya  Li</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yu-Bo  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Benzo[ c ][1,2,5]thiadiazole derivatives: A new class of potent Src homology-2 domain containing protein tyrosine phosphatase-2 (SHP2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (23)
                                     , 5154-5157. <a href="https://doi.org/10.1016/j.bmcl.2017.10.059" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.10.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.10.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.10.059%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBenzo%25255B%252Bc%252B%25255D%25255B1%25252C2%25252C5%25255Dthiadiazole%252Bderivatives%25253A%252BA%252Bnew%252Bclass%252Bof%252Bpotent%252BSrc%252Bhomology-2%252Bdomain%252Bcontaining%252Bprotein%252Btyrosine%252Bphosphatase-2%252B%252528SHP2%252529%252Binhibitors%26aulast%3DWang%26aufirst%3DWen-Long%26date%3D2017%26volume%3D27%26issue%3D23%26spage%3D5154%26epage%3D5157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leanne G.  Ahronian</span>, <span class="hlFld-ContribAuthor ">Ryan B.  Corcoran</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Genome Medicine</span><span> <strong>2017,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13073-017-0431-3" title="DOI URL">https://doi.org/10.1186/s13073-017-0431-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13073-017-0431-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13073-017-0431-3%26sid%3Dliteratum%253Aachs%26jtitle%3DGenome%2520Medicine%26atitle%3DStrategies%252Bfor%252Bmonitoring%252Band%252Bcombating%252Bresistance%252Bto%252Bcombination%252Bkinase%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DAhronian%26aufirst%3DLeanne%2BG.%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit  Bhattacharyya</span>, <span class="hlFld-ContribAuthor ">Leo  Feferman</span>, <span class="hlFld-ContribAuthor ">Joanne K.  Tobacman</span>. </span><span class="cited-content_cbyCitation_article-title">Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3). </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (59)
                                     , 100242-100260. <a href="https://doi.org/10.18632/oncotarget.22152" title="DOI URL">https://doi.org/10.18632/oncotarget.22152</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.22152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.22152%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DChondroitin%252Bsulfatases%252Bdifferentially%252Bregulate%252BWnt%252Bsignaling%252Bin%252Bprostate%252Bstem%252Bcells%252Bthrough%252Beffects%252Bon%252BSHP2%25252C%252Bphospho-ERK1%25252F2%25252C%252Band%252BDickkopf%252BWnt%252Bsignaling%252Bpathway%252Binhibitor%252B%252528DKK3%252529%26aulast%3DBhattacharyya%26aufirst%3DSumit%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D59%26spage%3D100242%26epage%3D100260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katherine A.  Kelley</span>, <span class="hlFld-ContribAuthor ">Rebecca A.  Ruhl</span>, <span class="hlFld-ContribAuthor ">Shushan R.  Rana</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Dewey</span>, <span class="hlFld-ContribAuthor ">Cristina  Espinosa</span>, <span class="hlFld-ContribAuthor ">Charles R.  Thomas</span>, <span class="hlFld-ContribAuthor ">Robert G.  Martindale</span>, <span class="hlFld-ContribAuthor ">Sudarshan  Anand</span>, <span class="hlFld-ContribAuthor ">Vassiliki L.  Tsikitis</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding and Resetting Radiation Sensitivity in Rectal Cancer. </span><span class="cited-content_cbyCitation_journal-name">Annals of Surgery</span><span> <strong>2017,</strong> <em>266 </em>
                                    (4)
                                     , 610-616. <a href="https://doi.org/10.1097/SLA.0000000000002409" title="DOI URL">https://doi.org/10.1097/SLA.0000000000002409</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/SLA.0000000000002409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FSLA.0000000000002409%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnals%2520of%2520Surgery%26atitle%3DUnderstanding%252Band%252BResetting%252BRadiation%252BSensitivity%252Bin%252BRectal%252BCancer%26aulast%3DKelley%26aufirst%3DKatherine%2BA.%26date%3D2017%26volume%3D266%26issue%3D4%26spage%3D610%26epage%3D616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Facs.jmedchem.6b00680&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00680&amp;citedByCount=105&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Representative SHP2 inhibitors reported in the literature possessing ionizable functional groups.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Equilibrium of SHP2 in closed (blocked active site) and open (free active site) states via a diphosphotyrosyl peptide.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> (B) DIFMUP assay measuring phosphatase activity.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Pyrimidine HTS hit, <b>2</b>. (B) X-ray of <b>2</b> with SHP2, 1.85 Å, in the closed, inactive conformation; inset, allosteric binding pocket at the junction of three domains. (C) Binding mode of <b>2</b>, showing protein interactions (e.g., Glu250).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>1</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) PdCl<sub>2</sub>(dppf), K<sub>3</sub>PO<sub>4</sub>, MeCN/H<sub>2</sub>O, 120 °C, 4 h, 74%; (b) K<sub>3</sub>PO<sub>4</sub>, NMP, 140 °C, 36 h, 55%; (c) HCl, THF/H<sub>2</sub>O, 60 °C, 2 h, 95%.</p></p></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray structure of <b>1</b> and SHP2, 1.70 Å. (A) Arg111 cationic π stacking interaction. (B) Phe113 interaction with 4-aminopiperidine motif of <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/medium/jm-2016-00680y_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Dose-dependent exposure and p-ERK modulation of <b>1</b> in KYSE-520 tumor bearing nude mouse. (B) Dose-dependent efficacy of <b>1</b> in KYSE-520 tumor bearing nude mouse.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-17/acs.jmedchem.6b00680/20160901/images/large/jm-2016-00680y_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b00680&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i35">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hof, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pluskey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dhe-Paganon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eck, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Crystal structure of the tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">92</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">450</span><span class="refDoi"> DOI: 10.1016/S0092-8674(00)80938-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS0092-8674%2800%2980938-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=9491886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1998&pages=441-450&author=P.+Hofauthor=S.+Pluskeyauthor=S.+Dhe-Paganonauthor=M.+J.+Eckauthor=S.+E.+Shoelson&title=Crystal+structure+of+the+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0092-8674%2800%2980938-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of the tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Hof, Peter; Pluskey, Scott; Dhe-Paganon, Sirano; Eck, Michael J.; Shoelson, Steven E.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">441-450</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The structure of the SHP-2 tyrosine phosphatase, detd. at 2.0 Å resoln., shows how its catalytic activity is regulated by its two SH2 domains.  In the absence of a tyrosine-phosphorylated binding partner, the N-terminal SH2 domain binds the phosphatase domain and directly blocks its active site.  This interaction alters the structure of the N-SH2 domain, disrupting its phosphopeptide-binding cleft.  Conversely, interaction of the N-SH2 domain with phosphopeptide disrupts its phosphatase recognition surface.  Thus, the N-SH2 domain is a conformational switch; it either binds and inhibits the phosphatase, or it binds phosphoproteins and activates the enzyme.  Recognition of bisphosphorylated ligands by the tandem SH2 domains is an integral element of this switch; the C-terminal SH2 domain contributes binding energy and specificity, but it does not have a direct role in activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcAryHYl6D5bVg90H21EOLACvtfcHk0liOxAzanzUVfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhsVKnsLc%253D&md5=ea99b7adb90b5db07754c0be75a63c66</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2800%2980938-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252800%252980938-1%26sid%3Dliteratum%253Aachs%26aulast%3DHof%26aufirst%3DP.%26aulast%3DPluskey%26aufirst%3DS.%26aulast%3DDhe-Paganon%26aufirst%3DS.%26aulast%3DEck%26aufirst%3DM.%2BJ.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DCrystal%2520structure%2520of%2520the%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DCell%26date%3D1998%26volume%3D92%26spage%3D441%26epage%3D450%26doi%3D10.1016%2FS0092-8674%2800%2980938-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Barford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/S0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+mechanisms+for+SH2+domain+mediated+regulation+of+the+protein+tyrosine+phosphatase+SHP-2&doi=10.1016%2FS0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0liOxAzanzUVfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520mechanisms%2520for%2520SH2%2520domain%2520mediated%2520regulation%2520of%2520the%2520protein%2520tyrosine%2520phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254%26doi%3D10.1016%2FS0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Plusky, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wandless, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoelson, S. E.</span><span> </span><span class="NLM_article-title">Potent Stimulation of SH-PTP2 Phosphatase Activity by Simultaneous Occupancy of Both SH2 Domains</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">270</span><span class="NLM_x">, </span> <span class="NLM_fpage">2897</span><span class="NLM_x">–</span> <span class="NLM_lpage">2900</span><span class="refDoi"> DOI: 10.1074/jbc.270.7.2897</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1074%2Fjbc.270.7.2897" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=270&publication_year=1995&pages=2897-2900&author=S.+Pluskyauthor=T.+J.+Wandlessauthor=C.+T.+Walshauthor=S.+E.+Shoelson&title=Potent+Stimulation+of+SH-PTP2+Phosphatase+Activity+by+Simultaneous+Occupancy+of+Both+SH2+Domains&doi=10.1074%2Fjbc.270.7.2897"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1074%2Fjbc.270.7.2897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.270.7.2897%26sid%3Dliteratum%253Aachs%26aulast%3DPlusky%26aufirst%3DS.%26aulast%3DWandless%26aufirst%3DT.%2BJ.%26aulast%3DWalsh%26aufirst%3DC.%2BT.%26aulast%3DShoelson%26aufirst%3DS.%2BE.%26atitle%3DPotent%2520Stimulation%2520of%2520SH-PTP2%2520Phosphatase%2520Activity%2520by%2520Simultaneous%2520Occupancy%2520of%2520Both%2520SH2%2520Domains%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1995%26volume%3D270%26spage%3D2897%26epage%3D2900%26doi%3D10.1074%2Fjbc.270.7.2897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Prahallad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heynen, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Germano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willems, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evers, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vecchione, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambino, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieftink, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beijersbergen, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Nicolantonio, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bardelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernards, R.</span><span> </span><span class="NLM_article-title">PTPN11 Is a Central Node in Intrinsic and Aquired Resistance to Targeted Cancer Drugs</span> <span class="citation_source-journal">Cell Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1978</span><span class="refDoi"> DOI: 10.1016/j.celrep.2015.08.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.celrep.2015.08.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=26365186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsV2ls7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2015&pages=1978&author=A.+Prahalladauthor=G.+J.+Heynenauthor=G.+Germanoauthor=S.+M.+Willemsauthor=B.+Eversauthor=L.+Vecchioneauthor=V.+Gambinoauthor=C.+Lieftinkauthor=R.+L.+Beijersbergenauthor=F.+Di+Nicolantonioauthor=A.+Bardelliauthor=R.+Bernards&title=PTPN11+Is+a+Central+Node+in+Intrinsic+and+Aquired+Resistance+to+Targeted+Cancer+Drugs&doi=10.1016%2Fj.celrep.2015.08.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 Is a Central Node in Intrinsic and Acquired Resistance to Targeted Cancer Drugs</span></div><div class="casAuthors">Prahallad, Anirudh; Heynen, Guus J. J. E.; Germano, Giovanni; Willems, Stefan M.; Evers, Bastiaan; Vecchione, Loredana; Gambino, Valentina; Lieftink, Cor; Beijersbergen, Roderick L.; Di Nicolantonio, Federica; Bardelli, Alberto; Bernards, Rene</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1978-1985</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Most BRAF (V600E) mutant melanomas are sensitive to selective BRAF inhibitors, but BRAF mutant colon cancers are intrinsically resistant to these drugs because of feedback activation of EGFR.  We performed an RNA-interference-based genetic screen in BRAF mutant colon cancer cells to search for phosphatases whose knockdown induces sensitivity to BRAF inhibition.  We found that suppression of protein tyrosine phosphatase non-receptor type 11 (PTPN11) confers sensitivity to BRAF inhibitors in colon cancer.  Mechanistically, we found that inhibition of PTPN11 blocks signaling from receptor tyrosine kinases (RTKs) to the RAS-MEK-ERK pathway.  PTPN11 suppression is lethal to cells that are driven by activated RTKs and prevents acquired resistance to targeted cancer drugs that results from RTK activation.  Our findings identify PTPN11 as a drug target to combat both intrinsic and acquired resistance to several targeted cancer drugs.  Moreover, activated PTPN11 can serve as a biomarker of drug resistance resulting from RTK activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2cE8g_Ejr7Vg90H21EOLACvtfcHk0liAbM9sPIBcZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsV2ls7fN&md5=521d9847bba4c7c6529ad355da097787</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2015.08.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2015.08.037%26sid%3Dliteratum%253Aachs%26aulast%3DPrahallad%26aufirst%3DA.%26aulast%3DHeynen%26aufirst%3DG.%2BJ.%26aulast%3DGermano%26aufirst%3DG.%26aulast%3DWillems%26aufirst%3DS.%2BM.%26aulast%3DEvers%26aufirst%3DB.%26aulast%3DVecchione%26aufirst%3DL.%26aulast%3DGambino%26aufirst%3DV.%26aulast%3DLieftink%26aufirst%3DC.%26aulast%3DBeijersbergen%26aufirst%3DR.%2BL.%26aulast%3DDi%2BNicolantonio%26aufirst%3DF.%26aulast%3DBardelli%26aufirst%3DA.%26aulast%3DBernards%26aufirst%3DR.%26atitle%3DPTPN11%2520Is%2520a%2520Central%2520Node%2520in%2520Intrinsic%2520and%2520Aquired%2520Resistance%2520to%2520Targeted%2520Cancer%2520Drugs%26jtitle%3DCell%2520Rep.%26date%3D2015%26volume%3D12%26spage%3D1978%26doi%3D10.1016%2Fj.celrep.2015.08.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiang, H.</span><span> </span><span class="NLM_article-title">Src Homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">442</span><span class="refDoi"> DOI: 10.1186/1471-2407-14-442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1186%2F1471-2407-14-442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=24931737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVymtrfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=442&author=H.+Wangauthor=W.+Chiangauthor=H.+Huangauthor=Y.+Shenauthor=H.+Chiang&title=Src+Homology+2+domain-containing+tyrosine+phosphatase+2+promotes+oral+cancer+invasion+and+metastasis&doi=10.1186%2F1471-2407-14-442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Src-homology 2 domain-containing tyrosine phosphatase 2 promotes oral cancer invasion and metastasis</span></div><div class="casAuthors">Wang, Hsueh-Chun; Chiang, Wei-Fan; Huang, Hsin-Hsiu; Shen, Ying-Ying; Chiang, Hung-Che</div><div class="citationInfo"><span class="NLM_cas:title">BMC Cancer</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">442/1-442/13</span>CODEN:
                <span class="NLM_cas:coden">BCMACL</span>;
        ISSN:<span class="NLM_cas:issn">1471-2407</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Tumor invasion and metastasis represent a major unsolved problem in cancer pathogenesis.  Recent studies have indicated the involvement of Src-homol. 2 domain-contg. tyrosine phosphatase 2 (SHP2) in multiple malignancies; however, the role of SHP2 in oral cancer progression has yet to be elucidated.  We propose that SHP2 is involved in the progression of oral cancer toward metastasis.  Methods: SHP2 expression was evaluated in paired oral cancer tissues by using immunohistochem. staining and real-time reverse transcription polymerase chain reaction.  Isogenic highly invasive oral cancer cell lines from their resp. low invasive parental lines were established using a Boyden chamber assay, and changes in the hallmarks of the epithelial-mesenchymal transition (EMT) were assessed to evaluate SHP2 function.  SHP2 activity in oral cancer cells was reduced using si-RNA knockdown or enforced expression of a catalytically deficient mutant to analyze migratory and invasive ability in vitro and metastasis toward the lung in mice in vivo.  Results: We obsd. the significant upregulation of SHP2 in oral cancer tissues and cell lines.  Following SHP2 knockdown, the oral cancer cells markedly attenuated migratory and invasion ability.  We obsd. similar results in phosphatase-dead SHP2 C459S mutant expressing cells.  Enhanced invasiveness was assocd. with significant upregulation of E-cadherin, vimentin, Snail/Twist1, and matrix metalloproteinase-2 in the highly invasive clones.  In addn., we detd. that SHP2 activity is required for the downregulation of phosphorylated ERK1/2, which modulates the downstream effectors, Snail and Twist1 at a transcript level.  In lung tissue sections of mice, we obsd. that HSC3 tumors with SHP2 deletion exhibited significantly reduced metastatic capacity, compared with tumors administered control si-RNA.  Conclusions: Our data suggest that SHP2 promotes the invasion and metastasis of oral cancer cells.  These results provide a rationale for further investigating the effects of small-mol. SHP2 inhibitors on the progression of oral cancer, and indicate a previously unrecognized SHP2-ERK1/2-Snail/Twist1 pathway that is likely to play a crucial role in oral cancer invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4fInuWtOHl7Vg90H21EOLACvtfcHk0ljUJlfcsk713g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVymtrfM&md5=b1dd0157d70ac01327bbdbc473dab8ee</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-14-442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-14-442%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DChiang%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DChiang%26aufirst%3DH.%26atitle%3DSrc%2520Homology%25202%2520domain-containing%2520tyrosine%2520phosphatase%25202%2520promotes%2520oral%2520cancer%2520invasion%2520and%2520metastasis%26jtitle%3DBMC%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D442%26doi%3D10.1186%2F1471-2407-14-442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Neel, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pao, L.</span><span> </span><span class="NLM_article-title">The ‘Shp’ing News: SH2 Domain-Containing Tyrosine Phosphatases in Cell Signaling</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span><span class="refDoi"> DOI: 10.1016/S0968-0004(03)00091-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS0968-0004%2803%2900091-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=12826400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=284-293&author=B.+G.+Neelauthor=H.+Guauthor=L.+Pao&title=The+%E2%80%98Shp%E2%80%99ing+News%3A+SH2+Domain-Containing+Tyrosine+Phosphatases+in+Cell+Signaling&doi=10.1016%2FS0968-0004%2803%2900091-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">The Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling</span></div><div class="casAuthors">Neel, Benjamin G.; Gu, Haihua; Pao, Lily</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Biochemical Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">284-293</span>CODEN:
                <span class="NLM_cas:coden">TBSCDB</span>;
        ISSN:<span class="NLM_cas:issn">0968-0004</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Src homol.-2 (SH2) domain-contg. phosphatases (Shps) are a small, highly conserved subfamily of protein tyrosine phosphatases, members of which are present in both vertebrates and invertebrates.  The mechanism of regulation of Shps by ligand binding is now well understood.  Much is also known about the normal signaling pathways regulated by each Shp and the consequences of Shp deficiency.  Recent studies have identified mutations in human Shp2 as the cause of the inherited disorder, Noonan syndrome.  Shp2 mutations might also contribute to the pathogenesis of some leukemias.  In addn., Shp2 might be a key virulence determinant for the important human pathogen, Helicobacter pylori.  Despite these efforts, however, the key targets of each Shp have remained elusive.  Identifying these substrates remains a major challenge for future research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7zIEChntK0rVg90H21EOLACvtfcHk0ljUJlfcsk713g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXkvVCnu7k%253D&md5=bce9fc3db0a41b29ba605251dc46c64f</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2FS0968-0004%2803%2900091-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0968-0004%252803%252900091-4%26sid%3Dliteratum%253Aachs%26aulast%3DNeel%26aufirst%3DB.%2BG.%26aulast%3DGu%26aufirst%3DH.%26aulast%3DPao%26aufirst%3DL.%26atitle%3DThe%2520%25E2%2580%2598Shp%25E2%2580%2599ing%2520News%253A%2520SH2%2520Domain-Containing%2520Tyrosine%2520Phosphatases%2520in%2520Cell%2520Signaling%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2003%26volume%3D28%26spage%3D284%26epage%3D293%26doi%3D10.1016%2FS0968-0004%2803%2900091-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, G. S.</span><span> </span><span class="NLM_article-title">PTPN11 is the First Identified Proto-Oncogene That Encodes a Tyrosine Phosphatase</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">862</span><span class="NLM_x">–</span> <span class="NLM_lpage">867</span><span class="refDoi"> DOI: 10.1182/blood-2006-07-028829</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1182%2Fblood-2006-07-028829" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=17053061" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2007&pages=862-867&author=R.+J.+Chanauthor=G.+S.+Feng&title=PTPN11+is+the+First+Identified+Proto-Oncogene+That+Encodes+a+Tyrosine+Phosphatase&doi=10.1182%2Fblood-2006-07-028829"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase</span></div><div class="casAuthors">Chan, Rebecca J.; Feng, Gen-Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">862-867</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-4971</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">A review.  Elucidation of the mol. mechanisms underlying carcinogenesis has benefited tremendously from the identification and characterization of oncogenes and tumor suppressor genes.  One new advance in this field is the identification of PTPN11 as the first proto-oncogene that encodes a cytoplasmic tyrosine phosphatase with 2 Src-homol. 2 (SH2) domains (Shp2).  This tyrosine phosphatase was previously shown to play an essential role in normal hematopoiesis.  More recently, somatic missense PTPN11 gain-of-function mutations were detected in leukemias and rarely in solid tumors, and were found to induce aberrant hyperactivation of the Ras-Erk pathway.  This progress represents another milestone in the leukemia/cancer research field and provides a fresh view on the mol. mechanisms underlying cell transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqsuOora-d37Vg90H21EOLACvtfcHk0ljUJlfcsk713g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtFersLg%253D&md5=8c5760a6ac385635f9794acbf5b64a03</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1182%2Fblood-2006-07-028829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2006-07-028829%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DFeng%26aufirst%3DG.%2BS.%26atitle%3DPTPN11%2520is%2520the%2520First%2520Identified%2520Proto-Oncogene%2520That%2520Encodes%2520a%2520Tyrosine%2520Phosphatase%26jtitle%3DBlood%26date%3D2007%26volume%3D109%26spage%3D862%26epage%3D867%26doi%3D10.1182%2Fblood-2006-07-028829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tiganis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, A. M.</span><span> </span><span class="NLM_article-title">Protein Tyrosine Phosphatase Function: the Substrated Perspective</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">402</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span><span class="refDoi"> DOI: 10.1042/BJ20061548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1042%2FBJ20061548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=17238862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD2sXosFOisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=402&publication_year=2007&pages=1-15&author=T.+Tiganisauthor=A.+M.+Bennett&title=Protein+Tyrosine+Phosphatase+Function%3A+the+Substrated+Perspective&doi=10.1042%2FBJ20061548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">Protein tyrosine phosphatase function: the substrate perspective</span></div><div class="casAuthors">Tiganis, Tony; Bennett, Anton M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">402</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-15</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  It is now well established that the members of the protein tyrosine phosphatase (PTP) superfamily play crit. roles in fundamental biol. processes.  Although there has been much progress in defining the function of PTPs, the task of identifying substrates for these enzymes still presents a challenge.  Many PTPs have yet to have their physiol. substrates identified.  The focus of this review is on the current state of knowledge of PTP substrates and the approaches used to identify them.  The authors propose exptl. criteria that should be satisfied in order to rigorously assign PTP substrates as bona fide.  Finally, the progress that has been made in defining the biol. roles of PTPs through the identification of their substrates is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGod89zW3LtOs7Vg90H21EOLACvtfcHk0lg0hJNReANCvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXosFOisQ%253D%253D&md5=e0b404da50fc57e25efe140026d6cd53</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.1042%2FBJ20061548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20061548%26sid%3Dliteratum%253Aachs%26aulast%3DTiganis%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DA.%2BM.%26atitle%3DProtein%2520Tyrosine%2520Phosphatase%2520Function%253A%2520the%2520Substrated%2520Perspective%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D402%26spage%3D1%26epage%3D15%26doi%3D10.1042%2FBJ20061548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bunda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heir, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alamsahebpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raught, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadeh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohh, M.</span><span> </span><span class="NLM_article-title">Inhibition of SHP2-Mediated Dephosphorylation of Ras Suppresses Oncogenesis</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8859</span><span class="refDoi"> DOI: 10.1038/ncomms9859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fncomms9859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=26617336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=8859&author=S.+Bundaauthor=K.+Burrellauthor=P.+Heirauthor=L.+Zengauthor=A.+Alamsahebpourauthor=Y.+Kanoauthor=B.+Raughtauthor=Z.-Y.+Zhangauthor=G.+Zadehauthor=M.+Ohh&title=Inhibition+of+SHP2-Mediated+Dephosphorylation+of+Ras+Suppresses+Oncogenesis&doi=10.1038%2Fncomms9859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis</span></div><div class="casAuthors">Bunda, Severa; Burrell, Kelly; Heir, Pardeep; Zeng, Lifan; Alamsahebpour, Amir; Kano, Yoshihito; Raught, Brian; Zhang, Zhong-Yin; Zadeh, Gelareh; Ohh, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8859</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ras is phosphorylated on a conserved tyrosine at position 32 within the switch I region via Src kinase.  This phosphorylation inhibits the binding of effector Raf while promoting the engagement of GTPase-activating protein (GAP) and GTP hydrolysis.  Here we identify SHP2 as the ubiquitously expressed tyrosine phosphatase that preferentially binds to and dephosphorylates Ras to increase its assocn. with Raf and activate downstream proliferative Ras/ERK/MAPK signalling.  In comparison to normal astrocytes, SHP2 activity is elevated in astrocytes isolated from glioblastoma multiforme (GBM)-prone H-Ras(12V) knock-in mice as well as in glioma cell lines and patient-derived GBM specimens exhibiting hyperactive Ras.  Pharmacol. inhibition of SHP2 activity attenuates cell proliferation, soft-agar colony formation and orthotopic GBM growth in NOD/SCID mice and decelerates the progression of low-grade astrocytoma to GBM in a spontaneous transgenic glioma mouse model.  These results identify SHP2 as a direct activator of Ras and a potential therapeutic target for cancers driven by a previously 'undruggable' oncogenic or hyperactive Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhWi25AJiphrVg90H21EOLACvtfcHk0lg0hJNReANCvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP&md5=8524ad9cc6f2e85abaff6b07c698f464</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fncomms9859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9859%26sid%3Dliteratum%253Aachs%26aulast%3DBunda%26aufirst%3DS.%26aulast%3DBurrell%26aufirst%3DK.%26aulast%3DHeir%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAlamsahebpour%26aufirst%3DA.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26aulast%3DZadeh%26aufirst%3DG.%26aulast%3DOhh%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520SHP2-Mediated%2520Dephosphorylation%2520of%2520Ras%2520Suppresses%2520Oncogenesis%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8859%26doi%3D10.1038%2Fncomms9859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mehler, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zampino, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kremer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Burgt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ion, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeffery, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalidas, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kucherlapati, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Mutations in PTPN11, Encoding the Protein Tyrosine Phosphatase SHP-2, Cause Noonan syndrome</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">465</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1038/ng772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fng772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=11704759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2001&pages=465-468&author=M.+Tartagliaauthor=E.+L.+Mehlerauthor=R.+Goldbergauthor=G.+Zampinoauthor=H.+G.+Brunnerauthor=H.+Kremerauthor=I.+Van+Der+Burgtauthor=A.+H.+Crosbyauthor=A.+Ionauthor=S.+Jefferyauthor=K.+Kalidasauthor=J.+A.+Pattonauthor=R.+S.+Kucherlapatiauthor=B.+D.+Gelb&title=Mutations+in+PTPN11%2C+Encoding+the+Protein+Tyrosine+Phosphatase+SHP-2%2C+Cause+Noonan+syndrome&doi=10.1038%2Fng772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome</span></div><div class="casAuthors">Tartaglia, Marco; Mehler, Ernest L.; Goldberg, Rosalie; Zampino, Giuseppe; Brunner, Han G.; Kremer, Hannie; van der Burgt, Ineke; Crosby, Andrew H.; Ion, Andra; Jeffery, Steve; Kalidas, Kamini; Patton, Michael A.; Kucherlapati, Raju S.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">465-468</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Noonan syndrome (MIM 163950) is an autosomal dominant disorder characterized by dysmorphic facial features, proportionate short stature and heart disease (most commonly pulmonic stenosis and hypertrophic cardiomyopathy).  Webbed neck, chest deformity, cryptorchidism, mental retardation and bleeding diathesis also are frequently assocd. with this disease.  This syndrome is relatively common, with an estd. incidence of 1 in 1000-2500 live births.  It has been mapped to a 5-cM region (N-SH2) on chromosome 12q24.1, and genetic heterogeneity has also been documented.  Here we show that missense mutations in PTPN11 (MIM 176876)-a gene encoding the nonreceptor protein tyrosine phosphatase SHP-2, which contains two Src homol. 2 (SH2) domains-cause Noonan syndrome and account for more than 50% of the cases that we examd.  All PTPN11 missense mutations cluster in interacting portions of the amino N-SH2 domain and the phosphotyrosine phosphatase domains, which are involved in switching the protein between its inactive and active conformations.  An energetics-based structural anal. of two N-SH2 mutants indicates that in these mutants there may be a significant shift of the equil. favoring the active conformation.  This implies that they are gain-of-function changes and that the pathogenesis of Noonan syndrome arises from excessive SHP-2 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKg7QISHW0bbVg90H21EOLACvtfcHk0lg0hJNReANCvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXovFGjt7w%253D&md5=c8225c08340f9446cd58c249de42e515</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fng772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng772%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DMehler%26aufirst%3DE.%2BL.%26aulast%3DGoldberg%26aufirst%3DR.%26aulast%3DZampino%26aufirst%3DG.%26aulast%3DBrunner%26aufirst%3DH.%2BG.%26aulast%3DKremer%26aufirst%3DH.%26aulast%3DVan%2BDer%2BBurgt%26aufirst%3DI.%26aulast%3DCrosby%26aufirst%3DA.%2BH.%26aulast%3DIon%26aufirst%3DA.%26aulast%3DJeffery%26aufirst%3DS.%26aulast%3DKalidas%26aufirst%3DK.%26aulast%3DPatton%26aufirst%3DJ.%2BA.%26aulast%3DKucherlapati%26aufirst%3DR.%2BS.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DMutations%2520in%2520PTPN11%252C%2520Encoding%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%252C%2520Cause%2520Noonan%2520syndrome%26jtitle%3DNat.%2520Genet.%26date%3D2001%26volume%3D29%26spage%3D465%26epage%3D468%26doi%3D10.1038%2Fng772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Tartaglia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niemeyer, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fragale, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buechner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hählen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasle, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelb, B. D.</span><span> </span><span class="NLM_article-title">Somatic Mutations in PTPN11 in Juvenile Myelomonocytic Leukemia, Myelodysplactic Syndromes and Acute Myeloid Leukemia</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span><span class="refDoi"> DOI: 10.1038/ng1156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fng1156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=12717436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2003&pages=148-150&author=M.+Tartagliaauthor=C.+M.+Niemeyerauthor=A.+Fragaleauthor=X.+Songauthor=J.+Buechnerauthor=A.+Jungauthor=K.+H%C3%A4hlenauthor=H.+Hasleauthor=J.+D.+Lichtauthor=B.+D.+Gelb&title=Somatic+Mutations+in+PTPN11+in+Juvenile+Myelomonocytic+Leukemia%2C+Myelodysplactic+Syndromes+and+Acute+Myeloid+Leukemia&doi=10.1038%2Fng1156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia</span></div><div class="casAuthors">Tartaglia, Marco; Niemeyer, Charlotte M.; Fragale, Alessandra; Song, Xiaoling; Buechner, Jochen; Jung, Andreas; Haehlen, Karel; Hasle, Henrik; Licht, Jonathan D.; Gelb, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">148-150</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We report here that individuals with Noonan syndrome and juvenile myelomonocytic leukemia (JMML) have germline mutations in PTPN11 and that somatic mutations in PTPN11 account for 34% of non-syndromic JMML.  Furthermore, we found mutations in PTPN11 in a small percentage of individuals with myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML).  Functional analyses documented that the two most common mutations in PTPN11 assocd. with JMML caused a gain of function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCwFhlUQDJQLVg90H21EOLACvtfcHk0lguF_BD4HhF5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktFSltrY%253D&md5=67d6900b46520ee461330bed95cbc890</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fng1156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1156%26sid%3Dliteratum%253Aachs%26aulast%3DTartaglia%26aufirst%3DM.%26aulast%3DNiemeyer%26aufirst%3DC.%2BM.%26aulast%3DFragale%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DX.%26aulast%3DBuechner%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DA.%26aulast%3DH%25C3%25A4hlen%26aufirst%3DK.%26aulast%3DHasle%26aufirst%3DH.%26aulast%3DLicht%26aufirst%3DJ.%2BD.%26aulast%3DGelb%26aufirst%3DB.%2BD.%26atitle%3DSomatic%2520Mutations%2520in%2520PTPN11%2520in%2520Juvenile%2520Myelomonocytic%2520Leukemia%252C%2520Myelodysplactic%2520Syndromes%2520and%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D34%26spage%3D148%26epage%3D150%26doi%3D10.1038%2Fng1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The Tyrosine Phosphoatase Shp2 (<i>PTPN11</i>) in Cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span><span class="refDoi"> DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-192&author=G.+Chanauthor=D.+Kalaitzidisauthor=B.+G.+Neel&title=The+Tyrosine+Phosphoatase+Shp2+%28PTPN11%29+in+Cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0lguF_BD4HhF5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520Tyrosine%2520Phosphoatase%2520Shp2%2520%2528PTPN11%2529%2520in%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D192%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Miyamoto, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yomogita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kondo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatakeyama, M.</span><span> </span><span class="NLM_article-title">Isolation of a Distinct Class of Gain-of-Function SHP-2 mutants with Oncogenic RAS-like Transforming Activity From Solid Tumors</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">3508</span><span class="NLM_x">–</span> <span class="NLM_lpage">3515</span><span class="refDoi"> DOI: 10.1038/sj.onc.1211019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fsj.onc.1211019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=18223690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=3508-3515&author=D.+Miyamotoauthor=M.+Miyamotoauthor=A.+Takahashiauthor=Y.+Yomogitaauthor=H.+Higashiauthor=S.+Kondoauthor=M.+Hatakeyama&title=Isolation+of+a+Distinct+Class+of+Gain-of-Function+SHP-2+mutants+with+Oncogenic+RAS-like+Transforming+Activity+From+Solid+Tumors&doi=10.1038%2Fsj.onc.1211019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors</span></div><div class="casAuthors">Miyamoto, D.; Miyamoto, M.; Takahashi, A.; Yomogita, Y.; Higashi, H.; Kondo, S.; Hatakeyama, M.</div><div class="citationInfo"><span class="NLM_cas:title">Oncogene</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">3508-3515</span>CODEN:
                <span class="NLM_cas:coden">ONCNES</span>;
        ISSN:<span class="NLM_cas:issn">0950-9232</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">SHP-2 protein tyrosine phosphatase plays an important role in activation of the RAS-dependent signaling.  Gain-of-function mutations in the PTPN11 gene, which encodes SHP-2, have been found in the leukemia-prone developmental disorder Noonan syndrome as well as sporadic childhood leukemias, indicating that SHP-2 is a bona fide human oncoprotein.  However, the role of SHP-2 mutations in non-hematol. malignancies remains obscure.  Here, we screened for PTPN11 mutations in primary solid tumors and identified a 1520C>A mutation that causes threonine-507 to lysine (T507K) substitution in the phosphatase domain of SHP-2 in a case of hepatocellular carcinoma.  T507K SHP-2 exhibited altered substrate specificity with slightly elevated basal phosphatase activity.  Upon expression in NIH3T3 cells, T507K SHP-2 induced transformed foci, which was not obsd. with wild type, Noonan-specific or leukemia-specific SHP-2.  Furthermore, NIH3T3 cells transformed by T507K SHP-2 showed anchorage-independent growth and developed tumors in nude mice.  These results indicate that quant. and/or qual. alteration in phosphatase activity dets. the transforming potential as well as target cell/tissue spectrum of individual SHP-2 mutants as oncoproteins.  Although rare in solid tumors, the identified T507K SHP-2 represents a distinct class of SHP-2 mutants with oncogenic RAS-like transforming activity, which could contribute to the development of solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwOMpOPEfD0rVg90H21EOLACvtfcHk0lguF_BD4HhF5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmslWmurY%253D&md5=e0a0e2df71b6998a92b40bbba05ffef8</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1038%2Fsj.onc.1211019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.onc.1211019%26sid%3Dliteratum%253Aachs%26aulast%3DMiyamoto%26aufirst%3DD.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DA.%26aulast%3DYomogita%26aufirst%3DY.%26aulast%3DHigashi%26aufirst%3DH.%26aulast%3DKondo%26aufirst%3DS.%26aulast%3DHatakeyama%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520Distinct%2520Class%2520of%2520Gain-of-Function%2520SHP-2%2520mutants%2520with%2520Oncogenic%2520RAS-like%2520Transforming%2520Activity%2520From%2520Solid%2520Tumors%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D3508%26epage%3D3515%26doi%3D10.1038%2Fsj.onc.1211019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jie, H.-B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gildener-Leapman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, S.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">508</span><span class="NLM_x">–</span> <span class="NLM_lpage">518</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-14-1215</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1158%2F0008-5472.CAN-14-1215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=25480946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVenurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2015&pages=508-518&author=J.+Liauthor=H.-B.+Jieauthor=Y.+Leiauthor=N.+Gildener-Leapmanauthor=S.+Trivedi&title=PD-1%2FSHP-2+Inhibits+Tc1%2FTh1+Phenotypic+Responses+and+the+Activation+of+T+Cells+in+the+Tumor+Microenvironment&doi=10.1158%2F0008-5472.CAN-14-1215"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">PD-1/SHP-2 Inhibits Tc1/Th1 Phenotypic Responses and the Activation of T Cells in the Tumor Microenvironment</span></div><div class="casAuthors">Li, Jing; Jie, Hyun-Bae; Lei, Yu; Gildener-Leapman, Neil; Trivedi, Sumita; Green, Tony; Kane, Lawrence P.; Ferris, Robert L.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">508-518</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">This study addresses the mechanisms through which PD-1 antibody therapy restores the ability of the immune system to recognize and attack tumors by skewing intratumoral T cells toward a more potent activation phenotype that is assocd. with enhanced signaling and a reversal of their immunosuppressed phenotype.  Immune rejection of tumors is mediated by IFNγ prodn. and T-cell cytolytic activity.  These processes are impeded by PD-1, a coinhibitory mol. expressed on T cells that is elevated in tumor-infiltrating lymphocytes (TIL).  PD-1 elevation may reflect T-cell exhaustion marked by decreased proliferation, prodn. of type I cytokines, and poor cytolytic activity.  Although anti-PD-1 antibodies enhance IFNγ secretion after stimulation of the T-cell receptor (TCR), the mechanistic link between PD-1 and its effects on T-cell help (Tc1/Th1 skewing) remains unclear.  In prospectively collected cancer tissues, we found that TIL exhibited dampened Tc1/Th1 skewing and activation compared with peripheral blood lymphocytes (PBL).  When PD-1 bound its ligand PD-L1, we obsd. a marked suppression of crit. TCR target genes and Th1 cytokines.  Conversely, PD-1 blockade reversed these suppressive effects of PD-1:PD-L1 ligation.  We also found that the TCR-regulated phosphatase SHP-2 was expressed higher in TIL than in PBL, tightly correlating with PD-1 expression and neg. regulation of TCR target genes.  Overall, these results defined a PD-1/SHP-2/STAT1/T-bet signaling axis mediating the suppressive effects of PD-1 on Th1 immunity at tumor sites.  Our findings argue that PD-1 or SHP-2 blockade will be sufficient to restore robust Th1 immunity and T-cell activation and thereby reverse immunosuppression in the tumor microenvironment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqe6jAWHNatvLVg90H21EOLACvtfcHk0ljTP45rPfw56Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVenurY%253D&md5=695007f0715b5eee2b7e47deaf87ae23</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-14-1215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-14-1215%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJie%26aufirst%3DH.-B.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DGildener-Leapman%26aufirst%3DN.%26aulast%3DTrivedi%26aufirst%3DS.%26atitle%3DPD-1%252FSHP-2%2520Inhibits%2520Tc1%252FTh1%2520Phenotypic%2520Responses%2520and%2520the%2520Activation%2520of%2520T%2520Cells%2520in%2520the%2520Tumor%2520Microenvironment%26jtitle%3DCancer%2520Res.%26date%3D2015%26volume%3D75%26spage%3D508%26epage%3D518%26doi%3D10.1158%2F0008-5472.CAN-14-1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Topalian, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodi, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brahmer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gettinger, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powderly, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carvajal, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atkins, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leming, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spigel, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonia, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drake, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardoll, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharfman, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anders, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taube, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMiller, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korman, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jure-Kunkel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDonald, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollia, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigginton, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sznol, M.</span><span> </span><span class="NLM_article-title">Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">366</span><span class="NLM_x">, </span> <span class="NLM_fpage">2443</span><span class="NLM_x">–</span> <span class="NLM_lpage">2454</span><span class="refDoi"> DOI: 10.1056/NEJMoa1200690</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1056%2FNEJMoa1200690" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=22658127" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2rs7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=366&publication_year=2012&pages=2443-2454&author=S.+L.+Topalianauthor=F.+S.+Hodiauthor=J.+R.+Brahmerauthor=S.+N.+Gettingerauthor=D.+C.+Smithauthor=D.+F.+McDermottauthor=J.+D.+Powderlyauthor=R.+D.+Carvajalauthor=J.+A.+Sosmanauthor=M.+B.+Atkinsauthor=P.+D.+Lemingauthor=D.+R.+Spigelauthor=S.+J.+Antoniaauthor=L.+Hornauthor=C.+G.+Drakeauthor=D.+M.+Pardollauthor=L.+Chenauthor=W.+H.+Sharfmanauthor=R.+A.+Andersauthor=J.+M.+Taubeauthor=T.+L.+McMillerauthor=H.+Xuauthor=A.+J.+Kormanauthor=M.+Jure-Kunkelauthor=S.+Agrawalauthor=D.+McDonaldauthor=G.+D.+Kolliaauthor=A.+Guptaauthor=J.+M.+Wiggintonauthor=M.+Sznol&title=Safety%2C+Activity%2C+and+Immune+Correlates+of+Anti-PD-1+Antibody+in+Cancer&doi=10.1056%2FNEJMoa1200690"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, activity, and immune correlates of anti-PD-1 antibody in cancer</span></div><div class="casAuthors">Topalian, Suzanne L.; Hodi, F. Stephen; Brahmer, Julie R.; Gettinger, Scott N.; Smith, David C.; McDermott, David F.; Powderly, John D.; Carvajal, Richard D.; Sosman, Jeffrey A.; Atkins, Michael B.; Leming, Philip D.; Spigel, David R.; Antonia, Scott J.; Horn, Leora; Drake, Charles G.; Pardoll, Drew M.; Chen, Lieping; Sharfman, William H.; Anders, Robert A.; Taube, Janis M.; McMiller, Tracee L.; Xu, Haiying; Korman, Alan J.; Jure-Kunkel, Maria; Agrawal, Shruti; McDonald, Daniel; Kollia, Georgia D.; Gupta, Ashok; Wigginton, Jon M.; Sznol, Mario</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">366</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2443-2454</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Blockade of programmed death 1 (PD-1), an inhibitory receptor expressed by T cells, can overcome immune resistance.  We assessed the antitumor activity and safety of BMS-936558, an antibody that specifically blocks PD-1.  Methods: We enrolled patients with advanced melanoma, non-small-cell lung cancer, castration-resistant prostate cancer, or renal-cell or colorectal cancer to receive anti-PD-1 antibody at a dose of 0.1 to 10.0 mg per kg of body wt. every 2 wk.  Response was assessed after each 8-wk treatment cycle.  Patients received up to 12 cycles until disease progression or a complete response occurred.  Results: A total of 296 patients received treatment through Feb. 24, 2012.  Grade 3 or 4 drug-related adverse events occurred in 14% of patients; there were three deaths from pulmonary toxicity.  No max. tolerated dose was defined.  Adverse events consistent with immune-related causes were obsd.  Among 236 patients in whom response could be evaluated, objective responses (complete or partial responses) were obsd. in those with non-small-cell lung cancer, melanoma, or renal-cell cancer.  Cumulative response rates (all doses) were 18% among patients with non-small-cell lung cancer (14 of 76 patients), 28% among patients with melanoma (26 of 94 patients), and 27% among patients with renal-cell cancer (9 of 33 patients).  Responses were durable; 20 of 31 responses lasted 1 yr or more in patients with 1 yr or more of follow-up.  To assess the role of intratumoral PD-1 ligand (PD-L1) expression in the modulation of the PD-1-PD-L1 pathway, immunohistochem. anal. was performed on pretreatment tumor specimens obtained from 42 patients.  Of 17 patients with PD-L1-neg. tumors, none had an objective response; 9 of 25 patients (36%) with PD-L1-pos. tumors had an objective response (P = 0.006).  Conclusions: Anti-PD-1 antibody produced objective responses in approx. one in four to one in five patients with non-small-cell lung cancer, melanoma, or renal-cell cancer; the adverse-event profile does not appear to preclude its use.  Preliminary data suggest a relationship between PD-L1 expression on tumor cells and objective response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLOPvHybmlvbVg90H21EOLACvtfcHk0ljTP45rPfw56Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2rs7fN&md5=7c13f228ef92b6089982fc878d3a394b</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1200690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1200690%26sid%3Dliteratum%253Aachs%26aulast%3DTopalian%26aufirst%3DS.%2BL.%26aulast%3DHodi%26aufirst%3DF.%2BS.%26aulast%3DBrahmer%26aufirst%3DJ.%2BR.%26aulast%3DGettinger%26aufirst%3DS.%2BN.%26aulast%3DSmith%26aufirst%3DD.%2BC.%26aulast%3DMcDermott%26aufirst%3DD.%2BF.%26aulast%3DPowderly%26aufirst%3DJ.%2BD.%26aulast%3DCarvajal%26aufirst%3DR.%2BD.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DAtkins%26aufirst%3DM.%2BB.%26aulast%3DLeming%26aufirst%3DP.%2BD.%26aulast%3DSpigel%26aufirst%3DD.%2BR.%26aulast%3DAntonia%26aufirst%3DS.%2BJ.%26aulast%3DHorn%26aufirst%3DL.%26aulast%3DDrake%26aufirst%3DC.%2BG.%26aulast%3DPardoll%26aufirst%3DD.%2BM.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSharfman%26aufirst%3DW.%2BH.%26aulast%3DAnders%26aufirst%3DR.%2BA.%26aulast%3DTaube%26aufirst%3DJ.%2BM.%26aulast%3DMcMiller%26aufirst%3DT.%2BL.%26aulast%3DXu%26aufirst%3DH.%26aulast%3DKorman%26aufirst%3DA.%2BJ.%26aulast%3DJure-Kunkel%26aufirst%3DM.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DMcDonald%26aufirst%3DD.%26aulast%3DKollia%26aufirst%3DG.%2BD.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DWigginton%26aufirst%3DJ.%2BM.%26aulast%3DSznol%26aufirst%3DM.%26atitle%3DSafety%252C%2520Activity%252C%2520and%2520Immune%2520Correlates%2520of%2520Anti-PD-1%2520Antibody%2520in%2520Cancer%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2012%26volume%3D366%26spage%3D2443%26epage%3D2454%26doi%3D10.1056%2FNEJMoa1200690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ohigashi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamada, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsurui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoriki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kashizuka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yane, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsushima, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otsuki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagita, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Azuma, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakajima, Y.</span><span> </span><span class="NLM_article-title">Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2947</span><span class="NLM_x">–</span> <span class="NLM_lpage">2953</span><span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-1469</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1158%2F1078-0432.CCR-04-1469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=15837746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlejt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=2947-2953&author=Y.+Ohigashiauthor=M.+Shoauthor=Y.+Yamadaauthor=Y.+Tsuruiauthor=K.+Hamadaauthor=N.+Ikedaauthor=T.+Mizunoauthor=R.+Yorikiauthor=H.+Kashizukaauthor=K.+Yaneauthor=F.+Tsushimaauthor=N.+Otsukiauthor=H.+Yagitaauthor=M.+Azumaauthor=Y.+Nakajima&title=Clinical+Significance+of+Programmed+Death-1+Ligand-1+and+Programmed+Death-1+Ligand-2+Expression+in+Human+Esophageal+Cancer&doi=10.1158%2F1078-0432.CCR-04-1469"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical Significance of Programmed Death-1 Ligand-1 and Programmed Death-1 Ligand-2 Expression in Human Esophageal Cancer</span></div><div class="casAuthors">Ohigashi, Yuichiro; Sho, Masayuki; Yamada, Yukishige; Tsurui, Yoshikazu; Hamada, Kaoru; Ikeda, Naoya; Mizuno, Takashi; Yoriki, Ryo; Kashizuka, Hisanori; Yane, Katsunari; Tsushima, Fumihiko; Otsuki, Noriko; Yagita, Hideo; Azuma, Miyuki; Nakajima, Yoshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2947-2953</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: The neg. regulatory programmed death-1/programmed death-1 ligand (PD-1/PD-L) pathway in T-cell activation has been suggested to play an important role in tumor evasion from host immunity.  In this study, we investigated the expression of PD-L1 and PD-L2 in human esophageal cancer to define their clin. significance in patients' prognosis after surgery.  Exptl. Design: PD-L1 and PD-L2 gene expression was evaluated in 41 esophagectomy patients by real-time quant. PCR.  The protein expression was also evaluated with newly generated monoclonal antibodies that recognize human PD-L1 (MIH1) and PD-L2 (MIH18).  Results: The protein and the mRNA levels of detn. by immunohistochem. and real-time quant. PCR were closely correlated.  PD-L-pos. patients had a significantly poorer prognosis than the neg. patients.  This was more pronounced in the advanced stage of tumor than in the early stage.  Furthermore, multivariate anal. indicated that PD-L status was an independent prognostic factor.  Although there was no significant correlation between PD-L1 expression and tumor-infiltrating T lymphocytes, PD-L2 expression was inversely correlated with tumor-infiltrating CD8+ T cells.  Conclusions: These data suggest that PD-L1 and PD-L2 status may be a new predictor of prognosis for patients with esophageal cancer and provide the rationale for developing novel immunotherapy of targeting PD-1/PD-L pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIMQiC4R0LD7Vg90H21EOLACvtfcHk0liu3_rdBAsRRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlejt7k%253D&md5=1dd37b483171a10070310ccd559c9e35</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-1469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-1469%26sid%3Dliteratum%253Aachs%26aulast%3DOhigashi%26aufirst%3DY.%26aulast%3DSho%26aufirst%3DM.%26aulast%3DYamada%26aufirst%3DY.%26aulast%3DTsurui%26aufirst%3DY.%26aulast%3DHamada%26aufirst%3DK.%26aulast%3DIkeda%26aufirst%3DN.%26aulast%3DMizuno%26aufirst%3DT.%26aulast%3DYoriki%26aufirst%3DR.%26aulast%3DKashizuka%26aufirst%3DH.%26aulast%3DYane%26aufirst%3DK.%26aulast%3DTsushima%26aufirst%3DF.%26aulast%3DOtsuki%26aufirst%3DN.%26aulast%3DYagita%26aufirst%3DH.%26aulast%3DAzuma%26aufirst%3DM.%26aulast%3DNakajima%26aufirst%3DY.%26atitle%3DClinical%2520Significance%2520of%2520Programmed%2520Death-1%2520Ligand-1%2520and%2520Programmed%2520Death-1%2520Ligand-2%2520Expression%2520in%2520Human%2520Esophageal%2520Cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D2947%26epage%3D2953%26doi%3D10.1158%2F1078-0432.CCR-04-1469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Butterworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overduin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, A. J.</span><span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatase SHP2 for Therapeutic Intervention</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+Protein+Tyrosine+Phosphatase+SHP2+for+Therapeutic+Intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0liu3_rdBAsRRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520for%2520Therapeutic%2520Intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Scott, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebti, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrence, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">1843</span><span class="NLM_x">–</span> <span class="NLM_lpage">1862</span><span class="refDoi"> DOI: 10.2174/138161210791209027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.2174%2F138161210791209027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=20337577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot1ClsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1843-1862&author=L.+M.+Scottauthor=H.+R.+Lawrenceauthor=S.+M.+Sebtiauthor=N.+J.+Lawrenceauthor=J.+Wu&title=Targeting+Protein+Tyrosine+Phosphatases+for+Anticancer+Drug+Discovery&doi=10.2174%2F138161210791209027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatases for anticancer drug discovery</span></div><div class="casAuthors">Scott, Latanya M.; Lawrence, Harshani R.; Sebti, Said M.; Lawrence, Nicholas J.; Wu, Jie</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1843-1862</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases (PTPs) are a diverse family of enzymes encoded by 107 genes in the human genome.  Together with protein tyrosine kinases (PTKs), PTPs regulate various cellular activities essential for the initiation and maintenance of malignant phenotypes.  While PTK inhibitors are now used routinely for cancer treatment, the PTP inhibitor development field is still in the discovery phase.  In this article, the suitability of targeting PTPs for novel anticancer drug discovery is discussed.  Examples are presented for PTPs that have been targeted for anticancer drug discovery as well as potential new PTP targets for novel anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHuBrNeSP0n7Vg90H21EOLACvtfcHk0liu3_rdBAsRRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot1ClsLY%253D&md5=17813d1fba0225fd5e54692b1159bc4a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F138161210791209027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161210791209027%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DL.%2BM.%26aulast%3DLawrence%26aufirst%3DH.%2BR.%26aulast%3DSebti%26aufirst%3DS.%2BM.%26aulast%3DLawrence%26aufirst%3DN.%2BJ.%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatases%2520for%2520Anticancer%2520Drug%2520Discovery%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2010%26volume%3D16%26spage%3D1843%26epage%3D1862%26doi%3D10.2174%2F138161210791209027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">He, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z.-Y.</span><span> </span><span class="NLM_article-title">Small Molecule Tools for Functional Interrogation of Protein Tyrosine Phosphatases</span> <span class="citation_source-journal">FEBS J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">731</span><span class="NLM_x">–</span> <span class="NLM_lpage">750</span><span class="refDoi"> DOI: 10.1111/j.1742-4658.2012.08718.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1111%2Fj.1742-4658.2012.08718.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=22816879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2013&pages=731-750&author=R.+Heauthor=L.-F.+Zengauthor=Y.+Heauthor=S.+Zhangauthor=Z.-Y.+Zhang&title=Small+Molecule+Tools+for+Functional+Interrogation+of+Protein+Tyrosine+Phosphatases&doi=10.1111%2Fj.1742-4658.2012.08718.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Small molecule tools for functional interrogation of protein tyrosine phosphatases</span></div><div class="casAuthors">He, Rongjun; Zeng, Li-Fan; He, Yantao; Zhang, Sheng; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">FEBS Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">731-750</span>CODEN:
                <span class="NLM_cas:coden">FJEOAC</span>;
        ISSN:<span class="NLM_cas:issn">1742-464X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The importance of protein tyrosine phosphatases (PTPs) in the regulation of cellular signalling is well established.  Malfunction of PTP activity is also known to be assocd. with cancer, metabolic syndromes and autoimmune disorders, as well as neurodegenerative and infectious diseases.  However, a detailed understanding of the roles played by the PTPs in normal physiol. and in pathogenic conditions has been hampered by the absence of PTP-specific small mol. agents.  In addn., the therapeutic benefits of modulating this target class are underexplored as a result of a lack of suitable chem. probes.  Potent and specific PTP inhibitors could significantly facilitate functional anal. of the PTPs in complex cellular signal transduction pathways and may constitute valuable therapeutics in the treatment of several human diseases.  We highlight the current challenges to and opportunities for developing PTP-specific small mol. agents.  We also review available selective small mol. inhibitors developed for a no. of PTPs, including PTP1B, TC-PTP, SHP2, lymphoid-specific tyrosine phosphatase, hematopoietic protein tyrosine phosphatase, CD45, PTPβ, PTPγ, PTPRO, Vaccinia H1-related phosphatase, mitogen-activated protein kinase phosphatase-1, mitogen-activated protein kinase phosphatase-3, Cdc25, YopH, mPTPA and mPTPB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokl-YBrjLX1bVg90H21EOLACvtfcHk0lh75_Y93OjJlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFCls7Y%253D&md5=a30f63b9e20bcff3b00bf61e77a95bce</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2012.08718.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2012.08718.x%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DR.%26aulast%3DZeng%26aufirst%3DL.-F.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DZ.-Y.%26atitle%3DSmall%2520Molecule%2520Tools%2520for%2520Functional%2520Interrogation%2520of%2520Protein%2520Tyrosine%2520Phosphatases%26jtitle%3DFEBS%2520J.%26date%3D2013%26volume%3D280%26spage%3D731%26epage%3D750%26doi%3D10.1111%2Fj.1742-4658.2012.08718.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Z. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nabinger, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrsosine Phosphatase-2 (SHP2)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2482</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span><span class="refDoi"> DOI: 10.1021/jm901645u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901645u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2482-2493&author=X.+Zhangauthor=Y.+Heauthor=S.+Liuauthor=Z.+Yuauthor=Z.+X.+Jiangauthor=Z.+Yangauthor=Y.+Dongauthor=S.+C.+Nabingerauthor=L.+Wuauthor=A.+M.+Gunawanauthor=L.+Wangauthor=R.+J.+Chanauthor=Z.+Y.+Zhang&title=Salicylic+Acid+Based+Small+Molecule+Inhibitor+for+the+Oncogenic+Src+Homology-2+Domain+Containing+Protein+Tyrsosine+Phosphatase-2+%28SHP2%29&doi=10.1021%2Fjm901645u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">Salicylic Acid Based Small Molecule Inhibitor for the Oncogenic Src Homology-2 Domain Containing Protein Tyrosine Phosphatase-2 (SHP2)</span></div><div class="casAuthors">Zhang, Xian; He, Yantao; Liu, Sijiu; Yu, Zhihong; Jiang, Zhong-Xing; Yang, Zhenyun; Dong, Yuanshu; Nabinger, Sarah C.; Wu, Li; Gunawan, Andrea M.; Wang, Lina; Chan, Rebecca J.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2482-2493</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol.-2 domain contg. protein tyrosine phosphatase-2 (SHP2) plays a pivotal role in growth factor and cytokine signaling.  Gain-of-function SHP2 mutations are assocd. with Noonan syndrome, various kinds of leukemias, and solid tumors.  Thus, there is considerable interest in SHP2 as a potential target for anticancer and antileukemia therapy.  We report a salicylic acid based combinatorial library approach aimed at binding both active site and unique nearby subpockets for enhanced affinity and selectivity.  Screening of the library led to the identification of a SHP2 inhibitor II-B08 (compd. 9) with highly efficacious cellular activity.  Compd. 9 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation, providing supporting evidence that chem. inhibition of SHP2 may be therapeutically useful for anticancer and antileukemia treatment.  X-ray crystallog. anal. of the structure of SHP2 in complex with 9 reveals mol. determinants that can be exploited for the acquisition of more potent and selective SHP2 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrC82T5JpCRArVg90H21EOLACvtfcHk0lh75_Y93OjJlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitFyhs7k%253D&md5=6f87897eda38ea485dc08e189f1b5ca8</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fjm901645u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901645u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DZ.%2BX.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DNabinger%26aufirst%3DS.%2BC.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DSalicylic%2520Acid%2520Based%2520Small%2520Molecule%2520Inhibitor%2520for%2520the%2520Oncogenic%2520Src%2520Homology-2%2520Domain%2520Containing%2520Protein%2520Tyrsosine%2520Phosphatase-2%2520%2528SHP2%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2482%26epage%3D2493%26doi%3D10.1021%2Fjm901645u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Zeng, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, Z. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mali, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span> </span><span class="NLM_article-title">Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">6594</span><span class="NLM_x">–</span> <span class="NLM_lpage">6609</span><span class="refDoi"> DOI: 10.1021/jm5006176</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5006176" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFajtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=6594-6609&author=L.+F.+Zengauthor=R.+Y.+Zhangauthor=Z.+H.+Yuauthor=S.+Liauthor=L.+Wuauthor=A.+M.+Gunawanauthor=B.+S.+Laneauthor=R.+S.+Maliauthor=X.+Liauthor=R.+J.+Chanauthor=R.+Kapurauthor=C.+D.+Wellsauthor=Z.+Y.+Zhang&title=Therapeutic+Potential+of+Targeting+the+Oncogenic+SHP2+Phosphatase&doi=10.1021%2Fjm5006176"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase</span></div><div class="casAuthors">Zeng, Li-Fan; Zhang, Ruo-Yu; Yu, Zhi-Hong; Li, Sijiu; Wu, Li; Gunawan, Andrea M.; Lane, Brandon S.; Mali, Raghuveer S.; Li, Xingjun; Chan, Rebecca J.; Kapur, Reuben; Wells, Clark D.; Zhang, Zhong-Yin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6594-6609</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Src homol. 2 domain contg. protein tyrosine phosphatase-2 (SHP2) is an oncogenic phosphatase assocd. with various kinds of leukemia and solid tumors.  Thus, there is substantial interest in developing SHP2 inhibitors as potential anticancer and antileukemia agents.  Using a structure-guided and fragment-based library approach, we identified a novel hydroxyindole carboxylic acid-based SHP2 inhibitor (I), with an IC50 value of 200 nM and greater than 5-fold selectivity against 20 mammalian PTPs.  Structural and modeling studies reveal that the hydroxyindole carboxylic acid anchors the inhibitor to the SHP2 active site, while interactions of the oxalamide linker and the phenylthiophene tail with residues in the β5-β6 loop contribute to I's binding potency and selectivity.  Evidence suggests that I specifically attenuates the SHP2-dependent signaling inside the cell.  Moreover, I blocks growth factor mediated Erk1/2 and Akt activation and exhibits excellent antiproliferative activity in lung cancer and breast cancer as well as leukemia cell lines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3ko-q4-PSXbVg90H21EOLACvtfcHk0lh75_Y93OjJlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFajtrvO&md5=ac8e5359387e614782c95c02f32fd97d</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1021%2Fjm5006176&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5006176%26sid%3Dliteratum%253Aachs%26aulast%3DZeng%26aufirst%3DL.%2BF.%26aulast%3DZhang%26aufirst%3DR.%2BY.%26aulast%3DYu%26aufirst%3DZ.%2BH.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DGunawan%26aufirst%3DA.%2BM.%26aulast%3DLane%26aufirst%3DB.%2BS.%26aulast%3DMali%26aufirst%3DR.%2BS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DChan%26aufirst%3DR.%2BJ.%26aulast%3DKapur%26aufirst%3DR.%26aulast%3DWells%26aufirst%3DC.%2BD.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26atitle%3DTherapeutic%2520Potential%2520of%2520Targeting%2520the%2520Oncogenic%2520SHP2%2520Phosphatase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D6594%26epage%3D6609%26doi%3D10.1021%2Fjm5006176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bunda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burrell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heir, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alamsahebpour, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raught, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zadeh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohh, M.</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">8859</span><span class="refDoi"> DOI: 10.1038/ncomms9859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fncomms9859" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=26617336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bunda%2C+S.%3B+Burrell%2C+K.%3B+Heir%2C+P.%3B+Zeng%2C+L.%3B+Alamsahebpour%2C+A.%3B+Kano%2C+Y.%3B+Raught%2C+B.%3B+Zhang%2C+Z.+Y.%3B+Zadeh%2C+G.%3B+Ohh%2C+M.Nat.+Commun.+2015%2C+6%2C+8859+10.1038%2Fncomms9859"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14cR"><div class="casContent"><span class="casTitleNuber">14c</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis</span></div><div class="casAuthors">Bunda, Severa; Burrell, Kelly; Heir, Pardeep; Zeng, Lifan; Alamsahebpour, Amir; Kano, Yoshihito; Raught, Brian; Zhang, Zhong-Yin; Zadeh, Gelareh; Ohh, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8859</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Ras is phosphorylated on a conserved tyrosine at position 32 within the switch I region via Src kinase.  This phosphorylation inhibits the binding of effector Raf while promoting the engagement of GTPase-activating protein (GAP) and GTP hydrolysis.  Here we identify SHP2 as the ubiquitously expressed tyrosine phosphatase that preferentially binds to and dephosphorylates Ras to increase its assocn. with Raf and activate downstream proliferative Ras/ERK/MAPK signalling.  In comparison to normal astrocytes, SHP2 activity is elevated in astrocytes isolated from glioblastoma multiforme (GBM)-prone H-Ras(12V) knock-in mice as well as in glioma cell lines and patient-derived GBM specimens exhibiting hyperactive Ras.  Pharmacol. inhibition of SHP2 activity attenuates cell proliferation, soft-agar colony formation and orthotopic GBM growth in NOD/SCID mice and decelerates the progression of low-grade astrocytoma to GBM in a spontaneous transgenic glioma mouse model.  These results identify SHP2 as a direct activator of Ras and a potential therapeutic target for cancers driven by a previously 'undruggable' oncogenic or hyperactive Ras.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhWi25AJiphrVg90H21EOLACvtfcHk0liirTqn1y1WFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWksLbP&md5=8524ad9cc6f2e85abaff6b07c698f464</span></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1038%2Fncomms9859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms9859%26sid%3Dliteratum%253Aachs%26aulast%3DBunda%26aufirst%3DS.%26aulast%3DBurrell%26aufirst%3DK.%26aulast%3DHeir%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DL.%26aulast%3DAlamsahebpour%26aufirst%3DA.%26aulast%3DKano%26aufirst%3DY.%26aulast%3DRaught%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26aulast%3DZadeh%26aufirst%3DG.%26aulast%3DOhh%26aufirst%3DM.%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D8859%26doi%3D10.1038%2Fncomms9859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gilmartin, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faitg, T. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seefeld, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darcy, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federowicz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthorn, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaworski, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaber, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martens, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNulty, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinnamon, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkpatrick, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heerding, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, R.</span><span> </span><span class="NLM_article-title">Allosteric WIP1 Phosphatase Inhibition Through Flap-Subdomain Interaction</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">181</span><span class="NLM_x">–</span> <span class="NLM_lpage">187</span><span class="refDoi"> DOI: 10.1038/nchembio.1427</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fnchembio.1427" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=24390428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=181-187&author=A.+G.+Gilmartinauthor=T.+H.+Faitgauthor=M.+Richterauthor=A.+Groyauthor=M.+A.+Seefeldauthor=M.+G.+Darcyauthor=X.+Pengauthor=K.+Federowiczauthor=J.+Yangauthor=S.+Y.+Zhangauthor=E.+Minthornauthor=J.+P.+Jaworskiauthor=M.+Schaberauthor=S.+Martensauthor=D.+E.+McNultyauthor=R.+H.+Sinnamonauthor=H.+Zhangauthor=R.+B.+Kirkpatrickauthor=N.+Nevinsauthor=G.+Cuiauthor=B.+Pietrakauthor=E.+Diazauthor=A.+Jonesauthor=M.+Brandtauthor=B.+Schwartzauthor=D.+A.+Heerdingauthor=R.+Kumar&title=Allosteric+WIP1+Phosphatase+Inhibition+Through+Flap-Subdomain+Interaction&doi=10.1038%2Fnchembio.1427"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15aR"><div class="casContent"><span class="casTitleNuber">15a</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction</span></div><div class="casAuthors">Gilmartin, Aidan G.; Faitg, Thomas H.; Richter, Mark; Groy, Arthur; Seefeld, Mark A.; Darcy, Michael G.; Peng, Xin; Federowicz, Kelly; Yang, Jingsong; Zhang, Shu-Yun; Minthorn, Elisabeth; Jaworski, Jon-Paul; Schaber, Michael; Martens, Stan; McNulty, Dean E.; Sinnamon, Robert H.; Zhang, Hong; Kirkpatrick, Robert B.; Nevins, Neysa; Cui, Guanglei; Pietrak, Beth; Diaz, Elsie; Jones, Amber; Brandt, Martin; Schwartz, Benjamin; Heerding, Dirk A.; Kumar, Rakesh</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">181-187</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Although therapeutic interventions of signal-transduction cascades with targeted kinase inhibitors are a well-established strategy, drug-discovery efforts to identify targeted phosphatase inhibitors have proven challenging.  Herein we report a series of allosteric, small-mol. inhibitors of wild-type p53-induced phosphatase (Wip1), an oncogenic phosphatase common to multiple cancers.  Compd. binding to Wip1 is dependent on a 'flap' subdomain located near the Wip1 catalytic site that renders Wip1 structurally divergent from other members of the protein phosphatase 2C (PP2C) family and that thereby confers selectivity for Wip1 over other phosphatases.  Treatment of tumor cells with the inhibitor GSK2830371 increases phosphorylation of Wip1 substrates and causes growth inhibition in both hematopoietic tumor cell lines and Wip1-amplified breast tumor cells harboring wild-type TP53.  Oral administration of Wip1 inhibitors in mice results in expected pharmacodynamic effects and causes inhibition of lymphoma xenograft growth.  To our knowledge, GSK2830371 is the first orally active, allosteric inhibitor of Wip1 phosphatase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-jXZXKTKTL7Vg90H21EOLACvtfcHk0liirTqn1y1WFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1egsA%253D%253D&md5=47524caa70df233fb152a2d683417e7d</span></div><a href="/servlet/linkout?suffix=cit15a&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1427%26sid%3Dliteratum%253Aachs%26aulast%3DGilmartin%26aufirst%3DA.%2BG.%26aulast%3DFaitg%26aufirst%3DT.%2BH.%26aulast%3DRichter%26aufirst%3DM.%26aulast%3DGroy%26aufirst%3DA.%26aulast%3DSeefeld%26aufirst%3DM.%2BA.%26aulast%3DDarcy%26aufirst%3DM.%2BG.%26aulast%3DPeng%26aufirst%3DX.%26aulast%3DFederowicz%26aufirst%3DK.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DS.%2BY.%26aulast%3DMinthorn%26aufirst%3DE.%26aulast%3DJaworski%26aufirst%3DJ.%2BP.%26aulast%3DSchaber%26aufirst%3DM.%26aulast%3DMartens%26aufirst%3DS.%26aulast%3DMcNulty%26aufirst%3DD.%2BE.%26aulast%3DSinnamon%26aufirst%3DR.%2BH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKirkpatrick%26aufirst%3DR.%2BB.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DCui%26aufirst%3DG.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DDiaz%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DA.%26aulast%3DBrandt%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DHeerding%26aufirst%3DD.%2BA.%26aulast%3DKumar%26aufirst%3DR.%26atitle%3DAllosteric%2520WIP1%2520Phosphatase%2520Inhibition%2520Through%2520Flap-Subdomain%2520Interaction%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2014%26volume%3D10%26spage%3D181%26epage%3D187%26doi%3D10.1038%2Fnchembio.1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chio, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bishop, A. C.</span><span> </span><span class="NLM_article-title">Rational Design of Allosteric-Inhibition Sites in Classical Protein Tyrosine Phosphatases</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">2828</span><span class="NLM_x">–</span> <span class="NLM_lpage">2838</span><span class="refDoi"> DOI: 10.1016/j.bmc.2015.03.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.bmc.2015.03.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=25828055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2MXkvVWhs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=2828-2838&author=C.+M.+Chioauthor=X.+Yuauthor=A.+C.+Bishop&title=Rational+Design+of+Allosteric-Inhibition+Sites+in+Classical+Protein+Tyrosine+Phosphatases&doi=10.1016%2Fj.bmc.2015.03.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15bR"><div class="casContent"><span class="casTitleNuber">15b</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of allosteric-inhibition sites in classical protein tyrosine phosphatases</span></div><div class="casAuthors">Chio, Cynthia M.; Yu, Xiaoling; Bishop, Anthony C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2828-2838</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Protein tyrosine phosphatases (PTPs), which catalyze the dephosphorylation of phosphotyrosine in protein substrates, are crit. regulators of metazoan cell signaling and have emerged as potential drug targets for a range of human diseases.  Strategies for chem. targeting the function of individual PTPs selectively could serve to elucidate the signaling roles of these enzymes and would potentially expedite validation of the therapeutic promise of PTP inhibitors.  Here we report a novel strategy for the design of non-natural allosteric-inhibition sites in PTPs; these sites, which can be introduced into target PTPs through protein engineering, serve to sensitize target PTPs to potent and selective inhibition by a biarsenical small mol.  Building on the recent discovery of a naturally occurring cryptic allosteric site in wild-type Src-homol.-2 domain contg. PTP (Shp2) that can be targeted by biarsenical compds., we hypothesized that Shp2's unusual sensitivity to biarsenicals could be strengthened through rational design and that the Shp2-specific site could serve as a blueprint for the introduction of non-natural inhibitor sensitivity in other PTPs.  Indeed, we show here that the strategic introduction of a cysteine residue at a position removed from the Shp2 active site can serve to increase the potency and selectivity of the interaction between Shp2's allosteric site and the biarsenical inhibitor.  Moreover, we find that 'Shp2-like' allosteric sites can be installed de novo in PTP enzymes that do not possess naturally occurring sensitivity to biarsenical compds.  Using primary-sequence alignments to guide our enzyme engineering, we have successfully introduced allosteric-inhibition sites in four classical PTPs-PTP1B, PTPH-1, FAP-1, and HePTP-from four different PTP subfamilies, suggesting that our sensitization approach can likely be applied widely across the classical PTP family to generate biarsenical-responsive PTPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwDXbkv2RdC7Vg90H21EOLACvtfcHk0liirTqn1y1WFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXkvVWhs7s%253D&md5=14a48e70c722a586a2e3ccb3fa9006ae</span></div><a href="/servlet/linkout?suffix=cit15b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2015.03.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2015.03.027%26sid%3Dliteratum%253Aachs%26aulast%3DChio%26aufirst%3DC.%2BM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DBishop%26aufirst%3DA.%2BC.%26atitle%3DRational%2520Design%2520of%2520Allosteric-Inhibition%2520Sites%2520in%2520Classical%2520Protein%2520Tyrosine%2520Phosphatases%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2015%26volume%3D23%26spage%3D2828%26epage%3D2838%26doi%3D10.1016%2Fj.bmc.2015.03.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit15c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Schneider, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beumer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grutter, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauh, D.</span><span> </span><span class="NLM_article-title">Selective Detection of Allosteric Phosphatase Inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">135</span><span class="NLM_x">, </span> <span class="NLM_fpage">6838</span><span class="NLM_x">–</span> <span class="NLM_lpage">6841</span><span class="refDoi"> DOI: 10.1021/ja4030484</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja4030484" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlWhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=6838-6841&author=R.+Schneiderauthor=C.+Beumerauthor=J.+R.+Simardauthor=C.+Grutterauthor=D.+Rauh&title=Selective+Detection+of+Allosteric+Phosphatase+Inhibitors&doi=10.1021%2Fja4030484"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15cR"><div class="casContent"><span class="casTitleNuber">15c</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Detection of Allosteric Phosphatase Inhibitors</span></div><div class="casAuthors">Schneider, Ralf; Beumer, Claudia; Simard, Jeffrey R.; Gruetter, Christian; Rauh, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">6838-6841</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Normal cellular function, such as signal transduction, is largely controlled by the reversible phosphorylation of cellular proteins catalyzed by two major classes of enzymes, kinases and phosphatases.  A misbalance in this complex and dynamic interplay leads to a variety of severe diseases, such as cancer, inflammation, or autoimmune diseases.  This makes kinases as well as phosphatases equally attractive targets for therapeutic manipulation by small mols.  While the development of kinase inhibitors has resulted in several blockbuster drugs, such as imatinib, with remarkable success in the clinic and sales of many billions of U.S. dollars per yr, not a single phosphatase inhibitor has yet been approved for clin. use.  Similar to the kinase world, substrate-competitive phosphatase inhibitors have been developed but were not suitable for further development into clin. candidates due to their charge and limited selectivity.  Research efforts, therefore, have shifted to the exploitation of allosteric sites that can regulate phosphatase activity and may enable the discovery of novel modulators of phosphatase activity with much improved pharmacol. properties.  However, assay systems, which enable the straightforward discovery of these inhibitor types, are missing.  Here, we present a novel binding assay capable of detecting ligands of an allosteric pocket of the protein tyrosine phosphatase 1B.  This assay is suitable for high-throughput screening and selectively detects ligands which bind to this unique site with a clear discrimination from substrate-competitive ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMMpcm8RfGWrVg90H21EOLACvtfcHk0lhvEpLncDR77Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlWhtbk%253D&md5=49a980ad7f749718803f1afe1d8d1a04</span></div><a href="/servlet/linkout?suffix=cit15c&amp;dbid=16384&amp;doi=10.1021%2Fja4030484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja4030484%26sid%3Dliteratum%253Aachs%26aulast%3DSchneider%26aufirst%3DR.%26aulast%3DBeumer%26aufirst%3DC.%26aulast%3DSimard%26aufirst%3DJ.%2BR.%26aulast%3DGrutter%26aufirst%3DC.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DSelective%2520Detection%2520of%2520Allosteric%2520Phosphatase%2520Inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D6838%26epage%3D6841%26doi%3D10.1021%2Fja4030484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Chen, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaMarche, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fekkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Fortanet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acker, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fei, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firestone, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsiao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keen, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labonte, l.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slisz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stams, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fortin, P. D.</span><span> </span><span class="NLM_article-title">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">535</span><span class="NLM_x">, </span> <span class="NLM_fpage">148</span><span class="NLM_x">–</span> <span class="NLM_lpage">152</span><span class="refDoi"> DOI: 10.1038/nature18621</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1038%2Fnature18621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=27362227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=535&publication_year=2016&pages=148-152&author=Y.+P.+Chenauthor=M.+J.+LaMarcheauthor=P.+Fekkesauthor=J.+Garcia-Fortanetauthor=M.+Ackerauthor=H.+Chanauthor=Z.+Chenauthor=Z.+Dengauthor=F.+Feiauthor=B.+Firestoneauthor=M.+Fodorauthor=H.+Gaoauthor=S.+Hoauthor=K.+Hsiaoauthor=Z.+Kangauthor=N.+Keenauthor=l.+Labonteauthor=S.+Liuauthor=M.+Meyerauthor=M.+Puauthor=E.+Priceauthor=T.+Ramseyauthor=J.+Sliszauthor=P.+Wangauthor=G.+Yangauthor=J.+Zhangauthor=P.+Zhuauthor=W.+R.+Sellersauthor=T.+Stamsauthor=P.+D.+Fortin&title=Allosteric+inhibition+of+SHP2+phosphatase+inhibits+cancers+driven+by+receptor+tyrosine+kinases&doi=10.1038%2Fnature18621"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases</span></div><div class="casAuthors">Chen, Ying-Nan P.; LaMarche, Matthew J.; Chan, Ho Man; Fekkes, Peter; Garcia-Fortanet, Jorge; Acker, Michael G.; Antonakos, Brandon; Chen, Christine Hiu-Tung; Chen, Zhouliang; Cooke, Vesselina G.; Dobson, Jason R.; Deng, Zhan; Fei, Feng; Firestone, Brant; Fodor, Michelle; Fridrich, Cary; Gao, Hui; Grunenfelder, Denise; Hao, Huai-Xiang; Jacob, Jaison; Ho, Samuel; Hsiao, Kathy; Kang, Zhao B.; Karki, Rajesh; Kato, Mitsunori; Larrow, Jay; La Bonte, Laura R.; Lenoir, Francois; Liu, Gang; Liu, Shumei; Majumdar, Dyuti; Meyer, Matthew J.; Palermo, Mark; Perez, Lawrence; Pu, Minying; Price, Edmund; Quinn, Christopher; Shakya, Subarna; Shultz, Michael D.; Slisz, Joanna; Venkatesan, Kavitha; Wang, Ping; Warmuth, Markus; Williams, Sarah; Yang, Guizhi; Yuan, Jing; Zhang, Ji-Hu; Zhu, Ping; Ramsey, Timothy; Keen, Nicholas J.; Sellers, William R.; Stams, Travis; Fortin, Pascal D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">535</span>
        (<span class="NLM_cas:issue">7610</span>),
    <span class="NLM_cas:pages">148-152</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The non-receptor protein tyrosine phosphatase SHP2, encoded by PTPN11, has an important role in signal transduction downstream of growth factor receptor signalling and was the first reported oncogenic tyrosine phosphatase.  Activating mutations of SHP2 have been assocd. with developmental pathologies such as Noonan syndrome and are found in multiple cancer types, including leukemia, lung and breast cancer and neuroblastoma.  SHP2 is ubiquitously expressed and regulates cell survival and proliferation primarily through activation of the RAS-ERK signalling pathway2,3.  It is also a key mediator of the programmed cell death 1 (PD-1) and B- and T-lymphocyte attenuator (BTLA) immune checkpoint pathways.  Redn. of SHP2 activity suppresses tumor cell growth and is a potential target of cancer therapy.  Here we report the discovery of a highly potent (IC50 = 0.071 μM), selective and orally bioavailable small-mol. SHP2 inhibitor, SHP099, that stabilizes SHP2 in an auto-inhibited conformation.  SHP099 concurrently binds to the interface of the N-terminal SH2, C-terminal SH2, and protein tyrosine phosphatase domains, thus inhibiting SHP2 activity through an allosteric mechanism.  SHP099 suppresses RAS-ERK signalling to inhibit the proliferation of receptor-tyrosine-kinase-driven human cancer cells in vitro and is efficacious in mouse tumor xenograft models.  Together, these data demonstrate that pharmacol. inhibition of SHP2 is a valid therapeutic approach for the treatment of cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBs_e02S0Sp7Vg90H21EOLACvtfcHk0lhvEpLncDR77Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVOns7bI&md5=ec8a4b612d5008a2519bd846d45ce019</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature18621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature18621%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%2BP.%26aulast%3DLaMarche%26aufirst%3DM.%2BJ.%26aulast%3DFekkes%26aufirst%3DP.%26aulast%3DGarcia-Fortanet%26aufirst%3DJ.%26aulast%3DAcker%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DZ.%26aulast%3DFei%26aufirst%3DF.%26aulast%3DFirestone%26aufirst%3DB.%26aulast%3DFodor%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DH.%26aulast%3DHo%26aufirst%3DS.%26aulast%3DHsiao%26aufirst%3DK.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DKeen%26aufirst%3DN.%26aulast%3DLabonte%26aufirst%3Dl.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMeyer%26aufirst%3DM.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DPrice%26aufirst%3DE.%26aulast%3DRamsey%26aufirst%3DT.%26aulast%3DSlisz%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DYang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DSellers%26aufirst%3DW.%2BR.%26aulast%3DStams%26aufirst%3DT.%26aulast%3DFortin%26aufirst%3DP.%2BD.%26atitle%3DAllosteric%2520inhibition%2520of%2520SHP2%2520phosphatase%2520inhibits%2520cancers%2520driven%2520by%2520receptor%2520tyrosine%2520kinases%26jtitle%3DNature%26date%3D2016%26volume%3D535%26spage%3D148%26epage%3D152%26doi%3D10.1038%2Fnature18621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Chen, C. H.-T.; Chen, Z.; Fortanet, J. G.; Grunenfelder, D.; Karki, R.; Kato, M.; Lamarche, M. J.; Perez, L. B.; Stams, T. M.; Williams, S.</span><span> </span><span class="NLM_article-title">Preparation of 1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrrolidine derivatives for inhibiting the activity of SHP2</span>. International Patent WO2015107493,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=C.+H.-T.+Chen&author=Z.+Chen&author=J.+G.+Fortanet&author=D.+Grunenfelder&author=R.+Karki&author=M.+Kato&author=M.+J.+Lamarche&author=L.+B.+Perez&author=T.+M.+Stams&author=S.+Williams&title=Preparation+of+1-pyridazin-%2Ftriazin-3-yl-piper%28-azine%29%2Fidine%2Fpyrrolidine+derivatives+for+inhibiting+the+activity+of+SHP2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DC.%2BH.-T.%26atitle%3DPreparation%2520of%25201-pyridazin-%252Ftriazin-3-yl-piper%2528-azine%2529%252Fidine%252Fpyrrolidine%2520derivatives%2520for%2520inhibiting%2520the%2520activity%2520of%2520SHP2%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gee, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhalgat, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upson, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klaubert, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latham, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugland, R. P.</span><span> </span><span class="NLM_article-title">Fluorogenic Substrates Based on Fluorinated Umbelliferones for Continuous Assays of Phosphatases and Beta-Galactosidases</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">41</span><span class="refDoi"> DOI: 10.1006/abio.1999.4202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1006%2Fabio.1999.4202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10452797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADyaK1MXlt1Wktbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1999&pages=41&author=K.+R.+Geeauthor=W.+C.+Sunauthor=M.+K.+Bhalgatauthor=R.+H.+Upsonauthor=D.+H.+Klaubertauthor=K.+A.+Lathamauthor=R.+P.+Haugland&title=Fluorogenic+Substrates+Based+on+Fluorinated+Umbelliferones+for+Continuous+Assays+of+Phosphatases+and+Beta-Galactosidases&doi=10.1006%2Fabio.1999.4202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorogenic Substrates Based on Fluorinated Umbelliferones for Continuous Assays of Phosphatases and β-Galactosidases</span></div><div class="casAuthors">Gee, Kyle R.; Sun, Wei-Chuan; Bhalgat, Mahesh K.; Upson, Rosalyn H.; Klaubert, Dieter H.; Latham, Katherine A.; Haugland, Richard P.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">273</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-48</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">Fluorogenic substrates based on 4-methylumbelliferone (4-MU) have been widely used for the detection of phosphatase and glycosidase activities.  One disadvantage of these substrates, however, is that max. fluorescence of the reaction product requires an alk. pH, since 4-MU has a pKa ≈ 8.  In an initial screening of five phosphatase substrates based on fluorinated derivs. of 4-MU, all with pKa values lower than that of 4-MU, we found that one substrate, 6,8-difluoro-4-methylumbelliferyl phosphate (DiFMUP), was much improved for the detection of acid phosphatase activity.  When measured at the preferred acid phosphatase reaction pH (5.0), DiFMUP yielded fluorescence signals that were more than 10-fold higher than those of 4-methylumbelliferyl phosphate (MUP).  DiFMUP was also superior to MUP for the detection of protein phosphatase 1 activity at pH 7 and was just as sensitive as MUP for the detection of alk. phosphatase activity at pH 10.  A β-galactosidase substrate was also prepd. based on 6,8-difluoro-4-methylumbelliferone.  This substrate, 6,8-difluoro-4-methylumbelliferyl β-D-galactopyranoside (DiFMUG), was found to be considerably more sensitive than the commonly used substrate 4-methylumbelliferyl β-D-galactopyranoside (MUG), for the detection of β-galactosidase activity at pH 7.  DiFMUP and DiFMUG should have great utility for the continuous assay of phosphatase and β-galactosidase activity, resp., at neutral and acid pH.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZOR_jnhxiLrVg90H21EOLACvtfcHk0ljIdGKEW10MWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlt1Wktbs%253D&md5=879424dc5f8830990218385ccb9d8fe0</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4202%26sid%3Dliteratum%253Aachs%26aulast%3DGee%26aufirst%3DK.%2BR.%26aulast%3DSun%26aufirst%3DW.%2BC.%26aulast%3DBhalgat%26aufirst%3DM.%2BK.%26aulast%3DUpson%26aufirst%3DR.%2BH.%26aulast%3DKlaubert%26aufirst%3DD.%2BH.%26aulast%3DLatham%26aufirst%3DK.%2BA.%26aulast%3DHaugland%26aufirst%3DR.%2BP.%26atitle%3DFluorogenic%2520Substrates%2520Based%2520on%2520Fluorinated%2520Umbelliferones%2520for%2520Continuous%2520Assays%2520of%2520Phosphatases%2520and%2520Beta-Galactosidases%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D273%26spage%3D41%26doi%3D10.1006%2Fabio.1999.4202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">SHP2 activation has been extensively reviewed:</p></div><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Barford, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">Revealing Mechanisms for SH2 Domain Mediated Regulation of the Protein Tyrosine Phosphatase SHP-2</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span><span class="refDoi"> DOI: 10.1016/S0969-2126(98)00027-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS0969-2126%2898%2900027-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=9551546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1998&pages=249-254&author=D.+Barfordauthor=B.+G.+Neel&title=Revealing+Mechanisms+for+SH2+Domain+Mediated+Regulation+of+the+Protein+Tyrosine+Phosphatase+SHP-2&doi=10.1016%2FS0969-2126%2898%2900027-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2</span></div><div class="casAuthors">Barford, David; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (London)</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-254</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Ltd.</span>)
        </div><div class="casAbstract">A review with 33 refs.  The crystal structure of the protein tyrosine phosphatase SHP-2 reveals the mechanism of auto-inhibition of phosphatase activity by its SH2 domains.  Phosphotyrosine peptide stimulation of the phosphatase activity, resulting from peptide binding to the N-terminal SH2 domain, is linked to conformational changes within the protein, including an unprecedented allosteric transition of the N-terminal SH2 domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9DfZ8YhMKJLVg90H21EOLACvtfcHk0ljIdGKEW10MWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFSlsrw%253D&md5=d2e136ed9c10302c18d06cb45ed42bf6</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2898%2900027-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252898%252900027-6%26sid%3Dliteratum%253Aachs%26aulast%3DBarford%26aufirst%3DD.%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DRevealing%2520Mechanisms%2520for%2520SH2%2520Domain%2520Mediated%2520Regulation%2520of%2520the%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP-2%26jtitle%3DStructure%26date%3D1998%26volume%3D6%26spage%3D249%26epage%3D254%26doi%3D10.1016%2FS0969-2126%2898%2900027-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalaitzidis</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neel, B. G.</span><span> </span><span class="NLM_article-title">The Tyrosine Phosphatase SHP2 (PTPN11) in Cancer</span> <span class="citation_source-journal">Cancer Metastasis Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">182</span><span class="refDoi"> DOI: 10.1007/s10555-008-9126-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1007%2Fs10555-008-9126-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=18286234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=179-182&author=G.+Chanauthor=+Kalaitzidisauthor=B.+G.+Neel&title=The+Tyrosine+Phosphatase+SHP2+%28PTPN11%29+in+Cancer&doi=10.1007%2Fs10555-008-9126-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">The tyrosine phosphatase Shp2 (PTPN11) in cancer</span></div><div class="casAuthors">Chan, Gordon; Kalaitzidis, Demetrios; Neel, Benjamin G.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer and Metastasis Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">179-192</span>CODEN:
                <span class="NLM_cas:coden">CMRED4</span>;
        ISSN:<span class="NLM_cas:issn">0167-7659</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Diverse cellular processes are regulated by tyrosyl phosphorylation, which is controlled by protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs).  De-regulated tyrosyl phosphorylation, evoked by gain-of-function mutations and/or over-expression of PTKs, contributes to the pathogenesis of many cancers and other human diseases.  PTPs, because they oppose the action of PTKs, had been considered to be prime suspects for potential tumor suppressor genes.  Surprisingly, few, if any, tumor suppressor PTPs have been identified.  However, the Src homol.-2 domain-contg. phosphatase Shp2 (encoded by PTPN11) is a bona fide proto-oncogene.  Germline mutations in PTPN11 cause Noonan and LEOPARD syndromes, whereas somatic PTPN11 mutations occur in several types of hematol. malignancies, most notably juvenile myelomonocytic leukemia and, more rarely, in solid tumors.  Shp2 also is an essential component in several other oncogene signaling pathways.  Elucidation of the events underlying Shp2-evoked transformation may provide new insights into oncogenic mechanisms and novel targets for anti-cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbJ8OYsBzvg7Vg90H21EOLACvtfcHk0ljIdGKEW10MWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlt1Ckur4%253D&md5=fb514f60b97f8ff0dcc0dbd57cab2c9a</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1007%2Fs10555-008-9126-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10555-008-9126-y%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DG.%26aulast%3DKalaitzidis%26aulast%3DNeel%26aufirst%3DB.%2BG.%26atitle%3DThe%2520Tyrosine%2520Phosphatase%2520SHP2%2520%2528PTPN11%2529%2520in%2520Cancer%26jtitle%3DCancer%2520Metastasis%2520Rev.%26date%3D2008%26volume%3D27%26spage%3D179%26epage%3D182%26doi%3D10.1007%2Fs10555-008-9126-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Poole, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, M. L.</span><span> </span><span class="NLM_article-title">A SHPing Tale: Perspectives on the Regulation of SHP-1 and SHP-2 Tyrosine Phosphatases by the C-terminal Tail</span> <span class="citation_source-journal">Cell. Signalling</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1323</span><span class="NLM_x">–</span> <span class="NLM_lpage">1332</span><span class="refDoi"> DOI: 10.1016/j.cellsig.2005.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.cellsig.2005.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=16084691" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD2MXptVWnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2005&pages=1323-1332&author=A.+W.+Pooleauthor=M.+L.+Jones&title=A+SHPing+Tale%3A+Perspectives+on+the+Regulation+of+SHP-1+and+SHP-2+Tyrosine+Phosphatases+by+the+C-terminal+Tail&doi=10.1016%2Fj.cellsig.2005.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19cR"><div class="casContent"><span class="casTitleNuber">19c</span><div class="casTitle"><span class="NLM_cas:atitle">A SHPing tale: Perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail</span></div><div class="casAuthors">Poole, Alastair W.; Jones, Matthew L.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1323-1332</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphorylation is a ubiquitous signaling mechanism and is regulated by a balance between the action of kinases and phosphatases.  The SH2 domain-contg. phosphatases, SHP-1 and SHP-2, are the best studied of the classical non-receptor tyrosine phosphatases, but it is intriguing that despite their close sequence and structural homol. these 2 phosphatases play quite different cellular roles.  In particular, whereas SHP-1 plays a largely neg. signaling role suppressing cellular activation, SHP-2 plays a largely pos. signaling role.  Major sequence differences between the 2 mols. are apparent in the ∼100 amino acid residues at the extreme C-terminus of the proteins, beyond the phosphatase catalytic domain.  Here, the authors review how the differences in the tails of these proteins may regulate their activities and explain some of their functional differences.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQNdG8bGaIjLVg90H21EOLACvtfcHk0ljTT8HZjnnAJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXptVWnsLY%253D&md5=2980ba96216967f7b89fb347415199c4</span></div><a href="/servlet/linkout?suffix=cit19c&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2005.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2005.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DPoole%26aufirst%3DA.%2BW.%26aulast%3DJones%26aufirst%3DM.%2BL.%26atitle%3DA%2520SHPing%2520Tale%253A%2520Perspectives%2520on%2520the%2520Regulation%2520of%2520SHP-1%2520and%2520SHP-2%2520Tyrosine%2520Phosphatases%2520by%2520the%2520C-terminal%2520Tail%26jtitle%3DCell.%2520Signalling%26date%3D2005%26volume%3D17%26spage%3D1323%26epage%3D1332%26doi%3D10.1016%2Fj.cellsig.2005.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Butterworth, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overduin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barr, A. J.</span><span> </span><span class="NLM_article-title">Targeting Protein Tyrosine Phosphatase SHP2 for Therapeutic Intervention</span> <span class="citation_source-journal">Future Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1423</span><span class="NLM_x">–</span> <span class="NLM_lpage">1437</span><span class="refDoi"> DOI: 10.4155/fmc.14.88</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.4155%2Ffmc.14.88" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=25329198" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1423-1437&author=S.+Butterworthauthor=M.+Overduinauthor=A.+J.+Barr&title=Targeting+Protein+Tyrosine+Phosphatase+SHP2+for+Therapeutic+Intervention&doi=10.4155%2Ffmc.14.88"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19dR"><div class="casContent"><span class="casTitleNuber">19d</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting protein tyrosine phosphatase SHP2 for therapeutic intervention</span></div><div class="casAuthors">Butterworth, Sam; Overduin, Michael; Barr, Alastair J.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1423-1437</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Protein tyrosine phosphatases have been the focus of considerable research efforts aimed at developing novel therapeutics; however, these targets are often characterized as being 'undruggable' due to the challenge of achieving selectivity, potency and cell permeability.  More recently, there has been renewed interest in developing inhibitors of the tyrosine phosphatase SHP2 (PTPN11) in the light of its broad role in cancer, specifically juvenile myelomonocytic leukemia, and recent studies that implicate SHP2 as a key factor in breast cancer progression.  Recent significant advances in the field of SHP2 inhibitor development raise the question: are we on the verge of a new era of protein tyrosine phosphatase-directed therapeutics This article critically appraises recent developments, assesses ongoing challenges and presents a perspective on possible future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEVdQ5GiIy9LVg90H21EOLACvtfcHk0ljTT8HZjnnAJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslOhu7jO&md5=85c071c906c6c047d524460df5e0a9b5</span></div><a href="/servlet/linkout?suffix=cit19d&amp;dbid=16384&amp;doi=10.4155%2Ffmc.14.88&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc.14.88%26sid%3Dliteratum%253Aachs%26aulast%3DButterworth%26aufirst%3DS.%26aulast%3DOverduin%26aufirst%3DM.%26aulast%3DBarr%26aufirst%3DA.%2BJ.%26atitle%3DTargeting%2520Protein%2520Tyrosine%2520Phosphatase%2520SHP2%2520for%2520Therapeutic%2520Intervention%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2014%26volume%3D6%26spage%3D1423%26epage%3D1437%26doi%3D10.4155%2Ffmc.14.88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Clare, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nobbs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romanos, M. A.</span><span> </span><span class="NLM_article-title">Voltage-Gated Sodium Channels as Therapeutic Targets</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">506</span><span class="NLM_x">–</span> <span class="NLM_lpage">520</span><span class="refDoi"> DOI: 10.1016/S1359-6446(00)01570-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2FS1359-6446%2800%2901570-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=11084387" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVKqtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=506-520&author=J.+J.+Clareauthor=S.+N.+Tateauthor=M.+Nobbsauthor=M.+A.+Romanos&title=Voltage-Gated+Sodium+Channels+as+Therapeutic+Targets&doi=10.1016%2FS1359-6446%2800%2901570-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Voltage-gated sodium channels as therapeutic targets</span></div><div class="casAuthors">Clare, J. J.; Tate, S. N.; Nobbs, M.; Romanos, M. A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">506-520</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 60 refs. Voltage-gated sodium channels (VGSCs) play a central role in the generation and propagation of action potentials in neurons and other cells.  VGSC modulators have their origins in empirical pharmacol. and are being used as local anesthetics, antiarrhythmics, analgesics and antiepileptics, and for other disorders.  However, the identification of a multigene family of VGSCs, along with tools to study the different subtypes in pathophysiol., is now providing a rational basis for selective intervention.  Recent advances have addressed the tech. challenges of expressing and assaying these complex proteins, enabling the correlation of empirical pharmacol. with subtypes and the screening of individual subtypes for novel inhibitors with increased potency and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptiZ3aRMaOo7Vg90H21EOLACvtfcHk0ljTT8HZjnnAJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVKqtL0%253D&md5=484b625c930128754c2c679bd127a944</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2800%2901570-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252800%252901570-1%26sid%3Dliteratum%253Aachs%26aulast%3DClare%26aufirst%3DJ.%2BJ.%26aulast%3DTate%26aufirst%3DS.%2BN.%26aulast%3DNobbs%26aufirst%3DM.%26aulast%3DRomanos%26aufirst%3DM.%2BA.%26atitle%3DVoltage-Gated%2520Sodium%2520Channels%2520as%2520Therapeutic%2520Targets%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2000%26volume%3D5%26spage%3D506%26epage%3D520%26doi%3D10.1016%2FS1359-6446%2800%2901570-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Large, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalinichev, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carignani, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbati, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sartori, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruffo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, D. N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alvaro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, K. D.</span><span> </span><span class="NLM_article-title">The Relationship Between Sodium Channel Inhibition and Anticonvulsant Activity in a Model of Generalised Seizure in the Rat</span> <span class="citation_source-journal">Epilepsy Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">106</span><span class="refDoi"> DOI: 10.1016/j.eplepsyres.2009.02.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.eplepsyres.2009.02.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=19329281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1eqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2009&pages=96-106&author=C.+H.+Largeauthor=M.+Kalinichevauthor=A.+Lucasauthor=C.+Carignaniauthor=A.+Bradfordauthor=N.+Garbatiauthor=I.+Sartoriauthor=N.+E.+Austinauthor=A.+Ruffoauthor=D.+N.+C.+Jonesauthor=G.+Alvaroauthor=K.+D.+Read&title=The+Relationship+Between+Sodium+Channel+Inhibition+and+Anticonvulsant+Activity+in+a+Model+of+Generalised+Seizure+in+the+Rat&doi=10.1016%2Fj.eplepsyres.2009.02.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">The relationship between sodium channel inhibition and anticonvulsant activity in a model of generalised seizure in the rat</span></div><div class="casAuthors">Large, Charles H.; Kalinichev, Mikhail; Lucas, Adam; Carignani, Corrado; Bradford, Andrea; Garbati, Nicoletta; Sartori, Ilaria; Austin, Nigel E.; Ruffo, Alberto; Jones, Declan N. C.; Alvaro, Giuseppe; Read, Kevin D.</div><div class="citationInfo"><span class="NLM_cas:title">Epilepsy Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-106</span>CODEN:
                <span class="NLM_cas:coden">EPIRE8</span>;
        ISSN:<span class="NLM_cas:issn">0920-1211</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Summary: The development of novel anticonvulsant drugs with improved efficacy for the treatment of epilepsy is hindered by a lack of information regarding the quant. relationship between target mechanism and in vivo efficacy.  In the present study we have examd. the correlation between the potency of structurally diverse compds. at voltage-gated sodium channels in vitro and their efficacy in a rodent model of acute generalised seizures induced by electroshock.  We obsd. a significant correlation between the estd. affinity (Ki) of the compds. for the inactivated state of human recombinant NaV1.2 channels and the unbound brain concn. required for anticonvulsant efficacy.  Furthermore, the data suggest that an unbound concn. equiv. to less than 50% of the Ki is sufficient for anticonvulsant effect.  We noted that increasing sodium channel blocking potency was assocd. with increasing brain tissue binding and lipophilicity.  These data suggest that there is a balance between sodium channel blocking potency in vitro and good pharmacokinetic characteristics necessary for anticonvulsant efficacy in vivo.  Finally, we examd. the sodium channel blocking potency of sodium valproate in relation to its anticonvulsant efficacy in vivo.  We found that a higher unbound concn. of the drug in the brain was required for anticonvulsant efficacy than would be expected given its sodium channel blocking potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ9SvFTQSLj7Vg90H21EOLACvtfcHk0ljTT8HZjnnAJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1eqs7g%253D&md5=6efa4dd1f79ea320cff094315a4c9efd</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1016%2Fj.eplepsyres.2009.02.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.eplepsyres.2009.02.018%26sid%3Dliteratum%253Aachs%26aulast%3DLarge%26aufirst%3DC.%2BH.%26aulast%3DKalinichev%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DA.%26aulast%3DCarignani%26aufirst%3DC.%26aulast%3DBradford%26aufirst%3DA.%26aulast%3DGarbati%26aufirst%3DN.%26aulast%3DSartori%26aufirst%3DI.%26aulast%3DAustin%26aufirst%3DN.%2BE.%26aulast%3DRuffo%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DD.%2BN.%2BC.%26aulast%3DAlvaro%26aufirst%3DG.%26aulast%3DRead%26aufirst%3DK.%2BD.%26atitle%3DThe%2520Relationship%2520Between%2520Sodium%2520Channel%2520Inhibition%2520and%2520Anticonvulsant%2520Activity%2520in%2520a%2520Model%2520of%2520Generalised%2520Seizure%2520in%2520the%2520Rat%26jtitle%3DEpilepsy%2520Res.%26date%3D2009%26volume%3D85%26spage%3D96%26epage%3D106%26doi%3D10.1016%2Fj.eplepsyres.2009.02.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Patani, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavoie, E. J.</span><span> </span><span class="NLM_article-title">Bioisosterism: a Rationale Approach in Drug Design</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">3147</span><span class="NLM_x">–</span> <span class="NLM_lpage">3176</span><span class="refDoi"> DOI: 10.1021/cr950066q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr950066q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1996&pages=3147-3176&author=G.+A.+Pataniauthor=E.+J.+Lavoie&title=Bioisosterism%3A+a+Rationale+Approach+in+Drug+Design&doi=10.1021%2Fcr950066q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fcr950066q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr950066q%26sid%3Dliteratum%253Aachs%26aulast%3DPatani%26aufirst%3DG.%2BA.%26aulast%3DLavoie%26aufirst%3DE.%2BJ.%26atitle%3DBioisosterism%253A%2520a%2520Rationale%2520Approach%2520in%2520Drug%2520Design%26jtitle%3DChem.%2520Rev.%26date%3D1996%26volume%3D96%26spage%3D3147%26epage%3D3176%26doi%3D10.1021%2Fcr950066q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">For example:</p></div><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Burger, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishiguchi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bellamacina, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindval, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atallah, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McBride, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beans, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamez, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feucht, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zavorotinskaya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holash, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia, P. D.</span><span> </span><span class="NLM_article-title">Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">1193</span><span class="NLM_x">–</span> <span class="NLM_lpage">1197</span><span class="refDoi"> DOI: 10.1021/ml400307j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400307j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=1193-1197&author=M.+T.+Burgerauthor=W.+Hanauthor=J.+Lanauthor=G.+Nishiguchiauthor=C.+Bellamacinaauthor=M.+Lindvalauthor=G.+Atallahauthor=Y.+Dingauthor=M.+Mathurauthor=C.+McBrideauthor=E.+L.+Beansauthor=K.+Mullerauthor=V.+Tamezauthor=Y.+Zhangauthor=K.+Huhauthor=P.+Feuchtauthor=T.+Zavorotinskayaauthor=Y.+Daiauthor=J.+Holashauthor=J.+Castilloauthor=J.+Langowskiauthor=Y.+Wangauthor=M.+Y.+Chenauthor=P.+D.+Garcia&title=Structure+Guided+Optimization%2C+in+Vitro+Activity%2C+and+in+Vivo+Activity+of+Pan-PIM+Kinase+Inhibitors&doi=10.1021%2Fml400307j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors</span></div><div class="casAuthors">Burger, Matthew T.; Han, Wooseok; Lan, Jiong; Nishiguchi, Gisele; Bellamacina, Cornelia; Lindval, Mika; Atallah, Gordana; Ding, Yu; Mathur, Michelle; McBride, Chris; Beans, Elizabeth L.; Muller, Kristine; Tamez, Victoriano; Zhang, Yanchen; Huh, Kay; Feucht, Paul; Zavorotinskaya, Tatiana; Dai, Yumin; Holash, Jocelyn; Castillo, Joseph; Langowski, John; Wang, Yingyun; Chen, Min Y.; Garcia, Pablo D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1193-1197</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Proviral insertion of Moloney virus (PIM) 1, 2, and 3 kinases are serine/threonine kinases that normally function in survival and proliferation of hematopoietic cells.  As high expression of PIM1, 2, and 3 is frequently obsd. in many human malignancies, including multiple myeloma, non-Hodgkins lymphoma, and myeloid leukemias, there is interest in detg. whether selective PIM inhibition can improve outcomes of these human cancers.  Herein, we describe our efforts toward this goal.  The structure guided optimization of a singleton high throughput screening hit in which the potency against all three PIM isoforms was increased >10,000-fold to yield compds. (e.g., I) with pan PIM Kis < 10 pM, nanomolar cellular potency, and in vivo activity in an acute myeloid leukemia Pim-dependent tumor model is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqw9BIpeJhw1rVg90H21EOLACvtfcHk0lhMTUhOciyqYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ejt7nK&md5=f4644a2ad9bcd35c952676e492eb3b71</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fml400307j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400307j%26sid%3Dliteratum%253Aachs%26aulast%3DBurger%26aufirst%3DM.%2BT.%26aulast%3DHan%26aufirst%3DW.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DNishiguchi%26aufirst%3DG.%26aulast%3DBellamacina%26aufirst%3DC.%26aulast%3DLindval%26aufirst%3DM.%26aulast%3DAtallah%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DMathur%26aufirst%3DM.%26aulast%3DMcBride%26aufirst%3DC.%26aulast%3DBeans%26aufirst%3DE.%2BL.%26aulast%3DMuller%26aufirst%3DK.%26aulast%3DTamez%26aufirst%3DV.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHuh%26aufirst%3DK.%26aulast%3DFeucht%26aufirst%3DP.%26aulast%3DZavorotinskaya%26aufirst%3DT.%26aulast%3DDai%26aufirst%3DY.%26aulast%3DHolash%26aufirst%3DJ.%26aulast%3DCastillo%26aufirst%3DJ.%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DM.%2BY.%26aulast%3DGarcia%26aufirst%3DP.%2BD.%26atitle%3DStructure%2520Guided%2520Optimization%252C%2520in%2520Vitro%2520Activity%252C%2520and%2520in%2520Vivo%2520Activity%2520of%2520Pan-PIM%2520Kinase%2520Inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D1193%26epage%3D1197%26doi%3D10.1021%2Fml400307j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Eriksson, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höglund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindhagen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleskog, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassan, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ekholm, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fhölenhag, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Löthgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scobie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrow, V.</span><span> </span><span class="NLM_article-title">Identification of AKN-032, a Novel 2-Aminopyrazine Tyrosine Kinase Inhibitor, with Significant Preclinical Activity in Acute Myeloid Leukemia</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">1507</span><span class="NLM_x">–</span> <span class="NLM_lpage">1516</span><span class="refDoi"> DOI: 10.1016/j.bcp.2010.08.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.bcp.2010.08.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2010&pages=1507-1516&author=A.+L.+Erikssonauthor=M.+H%C3%B6glundauthor=E.+Lindhagenauthor=A.+Aleskogauthor=S.+B.+Hassanauthor=C.+Ekholmauthor=K.+Fh%C3%B6lenhagauthor=A.+J.+Jensenauthor=A.+L%C3%B6thgrenauthor=M.+Scobieauthor=R.+Larssonauthor=V.+Parrow&title=Identification+of+AKN-032%2C+a+Novel+2-Aminopyrazine+Tyrosine+Kinase+Inhibitor%2C+with+Significant+Preclinical+Activity+in+Acute+Myeloid+Leukemia&doi=10.1016%2Fj.bcp.2010.08.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2010.08.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2010.08.002%26sid%3Dliteratum%253Aachs%26aulast%3DEriksson%26aufirst%3DA.%2BL.%26aulast%3DH%25C3%25B6glund%26aufirst%3DM.%26aulast%3DLindhagen%26aufirst%3DE.%26aulast%3DAleskog%26aufirst%3DA.%26aulast%3DHassan%26aufirst%3DS.%2BB.%26aulast%3DEkholm%26aufirst%3DC.%26aulast%3DFh%25C3%25B6lenhag%26aufirst%3DK.%26aulast%3DJensen%26aufirst%3DA.%2BJ.%26aulast%3DL%25C3%25B6thgren%26aufirst%3DA.%26aulast%3DScobie%26aufirst%3DM.%26aulast%3DLarsson%26aufirst%3DR.%26aulast%3DParrow%26aufirst%3DV.%26atitle%3DIdentification%2520of%2520AKN-032%252C%2520a%2520Novel%25202-Aminopyrazine%2520Tyrosine%2520Kinase%2520Inhibitor%252C%2520with%2520Significant%2520Preclinical%2520Activity%2520in%2520Acute%2520Myeloid%2520Leukemia%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D80%26spage%3D1507%26epage%3D1516%26doi%3D10.1016%2Fj.bcp.2010.08.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Lin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malkani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cubbon, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hale, J. J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Evaluation of Aminopyrazine Derivatives as Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">5402</span><span class="NLM_x">–</span> <span class="NLM_lpage">5408</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1016%2Fj.bmcl.2015.09.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=5402-5408&author=S.+Linauthor=S.+Malkaniauthor=M.+Lombardoauthor=Y.+Yangauthor=S.+G.+Millsauthor=K.+Chapmanauthor=J.+E.+Thompsonauthor=W.+X.+Zhangauthor=R.+Wangauthor=R.+M.+Cubbonauthor=E.+A.+O%E2%80%99Neillauthor=J.+J.+Hale&title=Design%2C+Synthesis%2C+and+Biological+Evaluation+of+Aminopyrazine+Derivatives+as+Inhibitors+of+Mitogen-Activated+Protein+Kinase-Activated+Protein+Kinase+2+%28MK-2%29&doi=10.1016%2Fj.bmcl.2015.09.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%26aulast%3DMalkani%26aufirst%3DS.%26aulast%3DLombardo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DMills%26aufirst%3DS.%2BG.%26aulast%3DChapman%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DW.%2BX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DCubbon%26aufirst%3DR.%2BM.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DE.%2BA.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520Aminopyrazine%2520Derivatives%2520as%2520Inhibitors%2520of%2520Mitogen-Activated%2520Protein%2520Kinase-Activated%2520Protein%2520Kinase%25202%2520%2528MK-2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D5402%26epage%3D5408%26doi%3D10.1016%2Fj.bmcl.2015.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Artursson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavelin, S.</span><span> </span><span class="NLM_article-title">Caco-2 and Emerging Alternatives for Prediction of Intestinal Drug Transport: A General Overview</span> <span class="citation_source-journal">Methods Princ. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">72</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span><span class="refDoi"> DOI: 10.1002/3527601473.ch4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1002%2F3527601473.ch4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=72-82&author=P.+Arturssonauthor=S.+Tavelin&title=Caco-2+and+Emerging+Alternatives+for+Prediction+of+Intestinal+Drug+Transport%3A+A+General+Overview&doi=10.1002%2F3527601473.ch4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1002%2F3527601473.ch4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F3527601473.ch4%26sid%3Dliteratum%253Aachs%26aulast%3DArtursson%26aufirst%3DP.%26aulast%3DTavelin%26aufirst%3DS.%26atitle%3DCaco-2%2520and%2520Emerging%2520Alternatives%2520for%2520Prediction%2520of%2520Intestinal%2520Drug%2520Transport%253A%2520A%2520General%2520Overview%26jtitle%3DMethods%2520Princ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D18%26spage%3D72%26epage%3D82%26doi%3D10.1002%2F3527601473.ch4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ungell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlsson, J.</span><span> </span><span class="NLM_article-title">Cell Cultures in Drug Discovery: an Industrial Perspective. Methods and Principles in Medicinal Chemistry</span> <span class="citation_source-journal">Drug Bioavailability: Estimation of Solubility, Permeability, Absorption, and Bioavailability</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">90</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><span class="refDoi"> DOI: 10.1002/3527601473.ch5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1002%2F3527601473.ch5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2003&pages=90-131&author=A.+Ungellauthor=J.+Karlsson&title=Cell+Cultures+in+Drug+Discovery%3A+an+Industrial+Perspective.+Methods+and+Principles+in+Medicinal+Chemistry&doi=10.1002%2F3527601473.ch5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1002%2F3527601473.ch5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F3527601473.ch5%26sid%3Dliteratum%253Aachs%26aulast%3DUngell%26aufirst%3DA.%26aulast%3DKarlsson%26aufirst%3DJ.%26atitle%3DCell%2520Cultures%2520in%2520Drug%2520Discovery%253A%2520an%2520Industrial%2520Perspective.%2520Methods%2520and%2520Principles%2520in%2520Medicinal%2520Chemistry%26jtitle%3DDrug%2520Bioavailability%253A%2520Estimation%2520of%2520Solubility%252C%2520Permeability%252C%2520Absorption%252C%2520and%2520Bioavailability%26date%3D2003%26volume%3D18%26spage%3D90%26epage%3D131%26doi%3D10.1002%2F3527601473.ch5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lirl6NSywLxWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>BUSTER, version 2.8.0; <span class="NLM_publisher-name">Global Phasing Ltd</span>, <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Devlopment of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Devlopment+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Devlopment%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHP','PDB','5EHP'); return false;">PDB: 5EHP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2SHP','PDB','2SHP'); return false;">PDB: 2SHP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR','PDB','5EHR'); return false;">PDB: 5EHR</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i30"><a href="/doi/suppl/10.1021/acs.jmedchem.6b00680">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_71700"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b00680">10.1021/acs.jmedchem.6b00680</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Selectivity assays, Xray data table, and additional pharmacology results (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Machine-readable representation of structures with key data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_001.pdf">jm6b00680_si_001.pdf (294.56 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b00680/suppl_file/jm6b00680_si_002.csv">jm6b00680_si_002.csv (0.65 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last"><a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHP">5EHP</a> for SHP2 in compex with compound <b>2</b>; <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5EHR">5EHR</a> for SHP2 in complex with compound <b>1</b>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b00680&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b00680" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b00680" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677b2ba929603de9","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
